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CHAPTER I 
GENERAL INTRODUCTION 
I.l Some historical notes 
Many reports on scientific research end with suggestions for further investigations. 
In his thesis on the Major Histocompatibility Complex (MHC) of the dog (1973) 
H.M. Vriesendorp states: "As already mentioned, the true and final picture of the 
detailed structure of the SO part of a Major Histocompatibility System will not be 
available until after a detailed biochemical characterization of the antigens 
involved. Till that time the two loci concept will be a useful but still unverified 
model". 
Since then MHC antigens of several species have been biochemically investigated 
(Finkelman et al., 1975 (the guinea pig), Giphart et al., 1978 (the rhesus monkey), 
Katagiri et al., 1975 (the rat), Kimball et al., 1979 (the rabbit), Lunney and Sachs, 
1978 (the miniature swine), Parham and Ploegh, 1980 (the owl monkey), Phillips et 
al., 1978 (the Syrian hamster), Strominger et al., 1981 (man and mouse), Ziegler and 
Pink, 1975 (the chicken). In this thesis the isolation and biochemical characteriza-
tion of dog MHC antigens is described. 
Terminology has changed since 1973. The Major Histocompatibility System is 
now called Major Histocompatibility Complex (MHC), as it has been shown to 
contain several loci. It is a chromosomal region that codes for several molecules 
(MHC antigens) which serve important functions in the immune system. It has 
originally been discovered in the mouse because of its role in the rejection of 
transplantable tumours. Since its first discovery, MHC's have been detected in 
several species (G6tze, 1977). Several histocompatibility systems exist, but the 
MHC presents the major transplantation barrier, hence its name. Genetic 
differences between recipient and donor have turned out to be crucial for transplant 
survival. When a recipient recognizes structures on donor tissue as non-self, an 
immune response will be mounted which leads to destruction of the transplant. 
In his Nobel lecture in 1930, Landsteiner (1931) stressed the parallel between the 
problems of matching for blood transfusion and transplantation. He suggested that 
"serum reactions" might be useful to detect the elements which are important for 
the outcome of organ transplantation. Gorer started to work on this basis and 
discovered an antigen on mouse red blood cells. Matching for this antigen had a 
major effect on the survival of a transplantable tumour (Gorer, 1937). In co-
operation with Snell he defined the first histocompatibility complex to be 
described, the H-2 complex in the mouse. A brief account of these early s~udies is 
given by Snell in his 1980 Nobel lecture (Snell, 1981). 
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The dog MHC antigens are named DLA antigens (Dog Leucocyte Antigen) 
(Vriesendorp eta!., 1977). Two types of antigen have been defined in the MHC of 
the dog with possible relevance for transplantation. They were initially named 
according to the techniques with which they could be demonstrated; SO or 
serologically defined antigens and LD or lymphocyte defined antigens. They are 
described further below. A schematic view of the arrangement of the MHC loci on 
the chromosome is presented in Fig. 1 and discussed more in detail in section 1.2. 
In the mouse a new nomenclature has been adopted (Klein, 1979). The products of 
the SO loci are now called class I antigens. Class II antigens are the former I -region 
associated (Ia) antigens. Class I and class II antigens are described in somewhat 
more detail below. In addition class III and class IV antigens have been recognized 
in mice. Amongst the class III antigens are serum proteins such as some 
complement components, and the class IV antigens are coded for by the former Tla 
(thymus leukaemia antigen) region (Snell, 1981). Class III and class IV antigens will 
not be considered here. Dog equivalents of these antigens have not yet been 
described. The dog equivalent of the class I antigens are the former SO antigens. 
The controversy whether lymphocyte defined (LD) antigens, immune response (Ir) 
gene products and !-region associated (Ia) antigens are identical has not yet been 
resolved. In Fig. 1 it is assumed that LD antigens are class II antigens, but formally 
they cannot be called class II. 
'\ ... • • • ... 
dog 
D A c B E 
? 
BF 
'\ I ... ... • • rhesus monkey D/DR LD 2 B A 
BF 
c2 c4 
'\ ... ... ... I • • • o-man SB D/ DC B c A 
PL3 DR MB Qa, Tla like 
LB 
ss ( c 4) 
'\ • ... I • • 0 mouse K A,E D L Qa, Tla 
8 Class I I Class Ill 
•class II Q Class IV 
Figure I. Simplified scheme of the genetic organization of the DLA complex, compared to the 
organization of the RhLA, HLA and H-2 complexes. 
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In all species investigated so far, great homology has been found for MHC 
products in function, structure,_ and genetic organization. Class I antigens consist of 
two polypeptide chains of 44,000 and 12,000 daltons. They are found on all tissues, 
and play a role in the recognition of self versus non-self by cells of the immune 
system. They are the principle targets for cell-mediated cytotoxicity in graft 
rejection (Snell eta!., 1976) and they are involved in the recognition of viral and 
tumour antigens by syngeneic cytotoxic T cells (Schrader and Edelman, 1976, 
Zinkernagel, 1979). The heavy chain of class I antigens is coded for by MHC genes, 
but the light chain is coded for by a different chromosome. For example, in the 
human MHC, the HLA complex, the heavy chain of class I antigens is coded for by 
chromosome 6 (van Someren eta!., 1974) and the light chain by chromosome 15 
(Goodfellow eta!., 1975). 
Class II antigens have a more restricted tissue distribution than class I antigens. 
They occur mostly on B lymphocytes, macrophages, activated T cells and certain 
tumours. Class II antigens consist of polypeptide chains of 34,000 and 29,000 
daltons. They are involved in the communication between various cells of the 
immune system, e.g. for antigen presentation (macrophage - T cells), helper 
function (T cells- B cells) and suppression (T cells- T cells) (McDevitt, 1976). The 
genes of the class II antigens are closely linked to immune response (lr) genes that 
determine the outcome of the immune response against certain synthetic antigens, 
such as GT and GA (McDevitt and Landy, 1972). 
The Major Histocompatibility Complex of the dog contains the genetic code for 
DLA antigens. Class I antigens and LD antigens have been defined in the dog 
(Vriesendorp eta!., 1977). Detection of class I antigens is done by serological typing 
of peripheral blood lymphocytes (PEL) in the one-stage or the two-stage micro-
lymphocytotoxicity test (Smid-Mercx eta!., 1975). The antigens are defined by their 
reaction pattern to a panel of antisera. The existence of the LD antigens is 
concluded from the outcome of mixed lymphocyte reactions (MLR's) (Yunis and 
Amos, 1971). The reaction pattern in MLR with reference cells from dogs, 
homozygous for LD antigens, is used to define these antigens. 
The expression of DLA class I and LD antigens is codominant. This means that the 
class I and LD antigens from both parents can be detected. The genes of the MHC 
of one chromosome, which segregate together in a family are called a haplotype. 
Class I antigens in the dog were identified before LD antigens, and therefore the 
first correlations between histocompatibility typing and transplant survival were 
made using class I profiles. The first evidence for the existence of a major histo-
compatibility complex in the dog was found in littermate beagles (Westbroek eta!., 
1971 ). Mean survival times of skin, small bowel and orthotopic hearttransplants in 
that model were shown to be significantly prolonged in DLA identicallittermates, 
as compared to littermates that differed in one or two haplotypes (Vriesendorp et 
al., 1971). In kidney transplantation between unrelated donor-recipient combina-
tions in mongrel dogs, the LD antigens have more influence on transplant survival 
than the class I antigens (Bijnen eta!., 1979a, Westbroek et a!., 1975). 
In our laboratory typing for both DLA class I antigens and LD antigens has been 
12 
put at the service of transplantation research. For organs that are technically 
difficult to transplant (e.g. liver, pancreas), donor and recipient are matched so as 
to minimize immunological reactions leading to rejection. Kidney transplantation, 
however, has been used as a model system to test the influence of matching on graft 
survival, using related and unrelated dogs. The MLR test, defining LD (in)com-
patibility was thoroughly investigated, and using this test the influence of class I, 
LD and minor histocompatibility antigens on the outcome of kidney grafting was 
assessed (Bijnen et al., 1979a and 1979b ). 
The history of canine histocompatibility testing has been summarized by Vriesen-
dorp et al. in 1977. International co-operation in this field was started by a 
workshop held in Rotterdam in 1972, followed by a second workshop in 1974 in 
Portland, Oregon, U.S.A. (Joint reports, 1973 and 1976). A third workshop is 
planned for 1983 in Seattle, Washington, U.S.A. 
!.2 DLA genetics 
A model for the genetic organization of the DLA complex is reproduced in a 
simplified form in Fig. I (Vriesendorp, 1980). For comparison, simplified models 
of the MHC's of man, mouse and rhesus monkey are also depicted. In the dog it is 
not known on which chromosome the MHC is located. The MHC is located on 
chromosome 6 in man (van Someren et al., 1974) and on chromosome 17 in the 
mouse (J. Klein, 1975). In both cases the light chain is coded for by a different 
chromosome, chromosome 15 in man (Goodfellow et al., 1975) and chromosome 2 
in the mouse (Cox et al., 1982). 
DLA-A, -B and -C form the class I loci. Recombination between DLA-A and -B 
has been found (Vriesendorp, 1973). There is not enough information to establish 
the exact location of DLA-C, nor, for that matter, to indisputably establish the 
existence of DLA-C at all. In the most recent review on the subject (Vriesendorp, 
1980) DLA-A is said to have 7 alleles, DLA-B 4 and DLA-C 3. The so-called 
"blank" alleles are as yet undefined, they comprise 27.6% for DLA-A, 42.2% for 
DLA-B and 55.2% for DLA-C. 
Class I antigens are detected in the microlymphocytotoxicity test by means of 
tissue typing sera. Most typing sera have been collected from beagles, either by skin 
transplantation between dogs with a limited DLA difference (e.g. parent and sib) 
and lymphocyte boost, or from pregnancy sera. They are good typing reagents in 
beagles but not in other breeds or mongrel dogs. This is reminiscent of the situation 
in man, where some sera are better suited for typing a particular race than others 
(Histocompatibility testing 1972). Mongrel dogs are especially difficult to type; 
they show a high percentage (50%) of blanks. DLA-D and DLA-E are loci for dog 
LD antigens. They have been separated from the class I loci by recombination (van 
den Tweel et al., 1974). 
Two aspects of typing for DLA antigens are notable. First there is the polymor-
phism. With five loci and at least 27 alleles the number of possible combinations is 
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large. However, in beagles it is observed that certain haplotypes (the genetic 
information on MHC antigens carried by one chromosome) occur more often than 
others. This so-called positive linkage disequilibrium between two alleles causes 
them to occur with a frequency higher than the product of the gene frequencies for 
each allele. In the beagle the linkage disequilibrium has a much greater delta value 
(the parameter of linkage disequilibrium) than in man. Vriesendorp (1973) suggests 
this could be due to the founder or bottleneck effect. This founder effect stands for 
the possibility that in some periods in the past only a limited number of dogs was 
available for breeding. 
As mentioned before, class II antigens have a much more restricted tissue 
distribution than class I antigens. They are most easily isolated from B cells orB cell 
lines (Springer eta!., 1977a). For their incontestable identification anti-class II 
antisera are necessary. These have so far not been recognized in the dog. One of the 
major reasons for this is that it is very difficult to separate dog B and T cells 
(Krakowka and Guyot, 1977). 
Antisera are well defined reagents with which the purification of an antigen can be 
monitored. Typing sera are available for class I antigens, but not for class II 
antigens. Our biochemical analyses are therefore concerned with class I antigens 
only. 
1.3 The biochemical characteristics of the HLA-B7 molecule as a model of a 
class I antigen 
A schematic view of a human MHC class I molecule, the HLA-B7 molecule, 
containing only the most salient features is represented in Fig. 2. Most data 
mentioned in this paragraph are quoted from the review of Ploegh eta!. (198lb). 
The HLA-B7 molecule consists of two polypeptide chains of 44,000 and 12,000 
daltons. The light chain is not directly associated with the membrane, but it is non-
covalently associated with the heavy chain. The light chain is indistinguishable 
from /32-microglobulin (/3 2m), a protein also found in plasma and urine (Bergg:lrd 
and Bearn, 1968). It contains one disulfide loop and it is identical in all HLA class I 
antigens investigated so far. The polymorphism detected by alloantisera is located 
in the heavy chain. This polypeptide chain spans the membrane. The greater part is 
found on the outside of the cell. It can be divided into three reg~ons. From the NHr 
terminal end to the first papain cleavage site amino acids 1-90 form the cd region, 
amino acids 91-180 the a2 and 181-271 the ad region. The transmembrane portion 
comprises 24 residues and the intracellular part 31 residues. The a I region contains 
a carbohydrate side chain, N-linked to amino acid 86 (asparagine). The a2 and a3 
regions each contain a disulfide loop of about 60 amino acids. Two papain cleavage 
sites are present which allow the isolation of the water soluble parts of the heavy 
chain by limited papain digestion. 
The division of the extracellular portion into three regions, approximately similar 
to the fragments obtained by chemical cleavage by Lopez de Castro (1979), is 
reminiscent ofthe immunoglobulin structure. The HLA class I molecule can be said 
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Figure 2. Schematic diagram of a class I antigen. 
CHO: sugar side chain 
cd-o:3: 
S-S: 
H: 
L: 
P: 
domains 
joining of the disulfide loop 
heavy chain 
light chain 
papain cleavage site 
to contain four extracellular domains, al, o:2, cd and {32m. Amino acid sequences of 
{3 2m, the heavy chain and immunoglobulin point to a statistically significant 
homology between {3 2m, the a3 region and the CH3 region of immunoglobulin. 
Comparison of physical-chemical properties of HLA and immunoglobulin, and 
comparison of the immunoglobulin crystalline structure with preliminary data on 
HLA crystals confirm this similarity. 
The membrane binding region of the heavy chain is hydrophobic; it does not 
contain any polar or charged amino acid residues. Immediately after this stretch of 
neutral amino acids some basic residues are found which may play a role in 
anchoring the heavy chain to the membrane. The intracellular part can be 
phosphorylated (Pober et al., 1978). Both the orientation of the heavy chain, with 
the greater part of the molecule outside the cell, and the possibility of phosphoryla-
tion of the intracellular part suggests that HLA could have a function in 
transmembrane signalling. 
The elucidation of amino acid sequences of several antigenically different HLA 
molecules was hoped to shed some light on the structural basis for the 
polymorphism. Comparison of (incomplete) sequences of HLA-A2 with HLA-B7 
shows that amino acid differences are scattered throughout the molecule. Certain 
regions with greater variability are found in residues 65-80, around 110 and around 
175. Differences between allelic products (e.g. HLA-A2 and HLA-A28) are 
somewhat less than those observed between the products of different loci. HLA-A2 
and HLA-A28, however, are cross-reacting and not quite representative of 
"normal" alleles. No other (non-cross-reactive) alleles have been sequenced far 
enough to yield information on typical variability and typical homology regions. 
There is also extensive sequence homology with MHC class I products of other 
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species. Mouse H-2 class I antigens have been best investigated in this respect 
(Nathenson eta!., 1981). For the papain solubilized extracellular parts of H-2Kb 
and HLA-B7, the sequence homology is 71%. The a3 region is the most conserved 
domain. This is the domain which shows homology with {32m and immunoglobulin. 
It is possible to know by amino acid sequence alone if one has an H-2 or an HLA 
molecule. Distinction between products of different loci or alleles within one locus 
is not (yet) possible on the basis of amino acid sequence. Sequencing data can be 
used to speculate about the time of divergence of proteins of different species or 
within a species in evolution, and about mechanisms by which polymorphism 
has developed (Nathenson eta!., 1981, Ploegh eta!., 198lb, Robertson, 1982). 
Studies of the crystal structure of papain solubilized HLA antigens have com-
menced in order to obtain more information on their three-dimensional structure. 
By comparison of three-dimensional structure and amino acid sequence data it will 
be possible to investigate whether or not the most variable regions fold together to 
form the "alloantigenic site". The possible involvement of the sugar side chain in 
the alloantigenic site is disputed by most authors (Parham eta!., 1977, Ploegh eta!., 
1981a), defended by some (O'Neill eta!., 1981). 
Although dog class II antigens have not been described here, occasional references 
are made in this thesis to human and mouse class II products. Therefore a schematic 
view of an HLA class II antigen is given in Fig. 3. It consists of two polypeptide 
chains both of which span the membrane. Similarity between class I, class II and 
immunoglobulin molecules in a structural respect is obvious. Both class II poly-
peptide chains carry carbohydrate residues and polymorphism resides in the light 
chain. Recently, Kaufman eta!. (1982) have shown that the extracellular region of 
the class II antigens consists of four domains (two per chain). Two of them, the 
carboxyl-terminal ones, have sequence homology with immunoglobulin. This is 
comparable to the situation in class I antigens, where the cd region and {32m have 
statistically significant sequence homology with immunoglobulin constant do-
mains. The author suggests that there may have been a common ancestral gene for 
both class I and class II antigens that contained an immunoglobulin-like region. 
Whether the structural similarity of immunoglobulin and MHC molecules bears 
any relation to their function remains to be seen. 
H 
L 
membrane 
Figure 3. Schematic diagram of a class II antigen. 
CHO: sugar side chain 
S-S: joining of the disulfide loop 
H: heavy chain 
L: light chain 
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!.4 Isolation of MHC products 
Methods for the isolation of MHC products must be designed to render the 
membrane bound hydrophobic part of the molecule soluble. Alternatively, only the 
water soluble part may be purified. Reviews have been published summarizing the 
history of the methods applied (Strominger et al., 1981, Walker and Reisfeld, 1982). 
One way to avoid difficulties in releasing MHC antigens from cell membranes is to 
look for them in body fluids. Possibly because of turnover of cells and membrane 
molecules HLA antigens can be found in soluble form in serum and urine (Billing 
and Terasaki, 1974, Reisfeld et al., 1976, Vincent et al., 1976) and be purified by 
conventional biochemical techniques and immuno-adsorbents. 
For structural and functional studies, the isolation of MHC antigens from cell 
membranes is essential. Two techniques have been used, each with its own 
advantages and disadvantages (!.4.1, !.4.2). 
The presence of the nonpolar transmembrane region prevents one from obtaining 
the whole molecule in water soluble form. The water soluble, external part of the 
heavy chain, together with the complete light chain, can be isolated by papain 
digestion. 
1.4.1 Isolation of MHC products by papain digestion 
When membrane bound HLA antigens are treated with papain only the extra-
cellular portion of 34,000 MW is detected together with /32m. The second papain 
cleavage site (Fig. 2) was discovered when HLA antigens were first isolated by 
detergent solubilization and treated with papain afterwards (!.4.2) (Springer et al., 
1974). The molecules isolated by papain digestion retain their alloantigenic 
specificity. HLA molecules were isolated in this way from spleens (Sanderson and 
Batchelor, 1968), lymphoblastoid cell lines (Mann et al., 1968, Turner et al., 1975) 
and platelets (Gockerman and Jacob, 1979). In the mouse one has to resort to using 
organs and sacrificing a lot of animals because lymphoblastoid cell lines are not 
available. Papain digestion of H-2 antigens has been described for antigen from 
spleen (Shimada and Natbenson, 1969) and liver (Henriksen et al., 1979). 
The advantage of using cell lines is that one has a reproducible source of cells of one 
tissue-type. Homozygosity of the cell line facilitates the separation of the products 
from different loci by reducing the number of different class I products from six to 
three. B cell lines transformed by Epstein-Barr virus can express about 36 times as 
much HLA as peripheral blood lymphocytes (McCune et al., 1975). Tissue culture, 
however, is laborious and expensive. In other species, no B cell lines exist so that 
organs must be used for large scale preparations. In small animals like mice, inbred 
strains are available to provide a reproducible source of tissue as starting material. 
Larger animals, like the miniature swine (Metzger et al., 1981) and the dog (van der 
Feltz €t al., 1981) have spleens of a size large enough for the isolation of sufficient 
amounts of MHC products. The papain solubilized molecules can be purified by 
standard protein fractionation techniques. As they are water soluble they can be 
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used for amino acid sequencing and the preparation of crystals for the study of the 
three-dimensional structure. Their biological activity is unhampered as fas as the 
antigenic activity in serological assays is concerned. 
1.4.2 Isolation of MHC products by detergent solubilization 
Intact class I molecules can only be obtained by detergent solubilization. Detergent 
micelles replace the lipid bilayer around the hydrophobic transmembrane part. 
After purification of detergent solubilized products, molecules are found to consist 
of a heavy chain of 44,000 MW and a light chain of 12,000 MW. Hence the size of 
the light chain remains the same in both papain digested and detergent solubilized 
molecules, whereas the heavy chain size varies with the isolation procedure. HLA 
antigens have been isolated by detergent solubilization from platelets (Dautigny et 
al., 1973, Tragardh et al., 1979) and lymphoid cell lines (Springer et al., 1974). 
Although no B cell lines are available in the mouse, tumour cell lines have recently 
been used for large scale isolation of H-2 antigens by detergent solubilization 
(Freed et al., 1979, Rogers et al., 1979). 
The detergent mostly used is NP-40, which is a non-ionicdetergent. Advantages and 
disadvantages of various detergents are discussed by Strominger et al. (1981). 
Because detergents may interfere with gel filtration and other physical-chemical 
techniques, alternative procedures have been developed for further purification 
such as lentil lectin affinity chromatography (Springer et al., 1977b, Snary et al., 
1974) and affinity chromatography employing anti-/32m serum (Robb et al., 1976) 
or anti-HLA monoclonal antibodies (Parham, 1979). 
In the mouse, much work has been done on an analytical scale. Radiolabelled 
preparations have been characterized by immunoprecipitation with hyperimmune 
sera (Schwartz and Nathenson, 1971). In the case of HLA, class I and class II 
antigens have been studied by the same technique using heterologous antisera or 
monoclonal antibodies. The available alloantisera are usually too weak to be 
suitable. 
A combination of detergent solubilization and papain digestion revealed the 
existence of the second papain cleavage site ofHLA antigens (Springer et al., 1974). 
When detergent solubilized HLA antigens were subsequently digested with papain, 
molecules of 39,000 MW and then molecules of 34,000 MW appeared. NH 2-
terminal amino acid sequence determination showed that the NH2-terminal ends of 
both papain digested and detergent solubilized molecules are identical. It was con-
cluded that papain cleaves the molecule towards the carboxyl-terminal end. The 
difference in MW between the two heavy chains is small, therefore papain cleaves 
the heavy chain close to the membrane. 
A disadvantage of using detergent is that detergent must remain present to keep the 
molecules in solution. This precludes testing of the isolated molecules for biological 
activity and the use of standard protein purification techniques. Inhibition of 
cytotoxicity by detergent solubilized molecules can be tested, however, in the 
presence of 30% BSA (Springer et al., 1974). 
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The advantage of detergent solubilization is that one can study the complete 
molecule, including its mode of insertion into the plasma membrane. Functional 
studies can be done by introducing detergent solubilized MHC antigens into 
artificial membranes such as liposomes (Engelhard et al., 1978a, Trag3.rdh et al., 
1979, Turner and Sanderson, 1978). First observations with these liposomes were of 
the orientation of HLA and H-2 antigens. It was similar to that observed in the 
native membrane of the cells. Liposomes containing HLA antigens bind to certain 
bacteria (Klareskog et al., 1978), and to Semliki Forest Virus (Helenius et al., 1978). 
Both HLA class I and class II antigens incorporated in liposomes can stimulate 
secondary cytotoxic T lymphocytes (Engelhard et al., l978b, 1980). 
Whatever the method of isolation ofMHC antigens may be, at one stage or another 
it is dependent on antisera either for characterization, or for the isolation itself. 
Antisera are indispensable for monitoring the isolation procedure, for estimating 
the purity of the products obtained or for the isolation of MHC antigens by 
immunoprecipitation or immunoaffinity columns. Alloantisera are usually not 
suitable for isolation of MHC antigens. In man, either conventional heterologous 
antisera, or monoclonal antibodies can be employed. One of the early conventional 
heterologous antisera used was the anti-/32m serum as described by Robb et al. 
(1976). Sera against urinary /32m are the best sera to use for the isolation and 
characterization of MHC antigens from species like the dog in which no 
monoclonal antibodies are available. This antiserum potentially reacts with all 
class I antigens because of the non-covalent association of the heavy chain with 
{3,m. 
!.5 Recent developments in MHC research 
In man and in the mouse, the two best investigated species as far as the MHC 
antigens are concerned, the search for the biosynthetic pathways and the 
examination of the genetic organization of the MHC have dominated the scene 
during the last few years. It is important to study these subjects in other species as 
well in order to get to know more about the relationship between structure and 
function of the MHC. 
!.5.1 Biosynthesis 
The eluci4ation of the biosynthesis pathways ofH-2 and HLA antigens started with 
investigations in model systems. Cell-free translation of mRNA yielded MHC 
heavy chains with an NHrterminal extension comparable to the signal sequence 
normally found in secretory and plasma membrane proteins (Dobberstein et al., 
1979, Ploegh et al., 1979). The signal sequence is thought to locate the ribosomal 
complex on the endoplasmic reticulum. Glycosylation and cleavage of the signal 
sequence occurred cotranslationally when microsomal membranes had been added 
to the cell-free translation system. /32-microglobulin is also synthesized with a signal 
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sequence. Transfer of /32m into microsomal vesicles results in cleavage of the signal 
sequence (Dobberstein et al., 1979). In the endoplasmic reticulum (E.R.), fl2m 
associates with the heavy chain, as shown by in vivo experiments. During transport 
to the plasma membrane, the glycosylation pattern of the molecule is modified. 
Biosynthesis of HLA has been further studied by pulse-chase labelling in cell lines 
(Krangel et al., 1979, Owen et al., 1980, Ploegh et al., 198la). The cell-free 
translation studies (Ploegh et al., 1979) were followed by in vivo studies of the 
assembly and maturation of HLA antigens in the B cell line T5-l (Krangel et al., 
1979). Initially the HLA heavy chains were not associated with {l2m and were 
glycosylated with "high mannose" residues. Ten to fifteen minutes after complete 
synthesis of the heavy chain fl2m was found complexed with it, in the E.R. Half an 
hour after synthesis the high mannose sugars had been modified to complex sugars 
in the Golgi complex and 30-60 minutes later the antigens appeared at the cell 
surface. Only complex sugar bearing molecules were found at the surface. Other cell 
lines show basically the same course of events although the timing might be slightly 
different (Owen et al., 1980, Ploegh et al., 198la). 
Although not all details are known, it is clear that the change in glycosylation from 
"high rnannose" to "complex" sugars and the association of heavy chain and {3 2m 
are crucial events in the biosynthesis of HLA molecules. The pathway of 
glycosylated molecules was compared to that of molecules synthesized in the 
presence of tunicamycin, an inhibitor of N-linked glycosylation. Conclusions were 
that glycosylation is not necessary for insertion in microsomal vesicles, intracellular 
transport or (timing of) surface expression (Owen et al., 1980, Ploegh et al., 198la). 
Lack of carbohydrate does not affect the association oflight chain and heavy chain 
or the conformation of the molecule as measured by the reaction with (allo-) 
antisera and the susceptibility to lysis with proteolytic enzymes (Ploegh et al., 
198la). 
Ploegh et al. (1979) and Owen et al. (1981) have studied the role of fl2m by 
comparing biosynthesis in "normal" cell lines with that in the Daudi line which 
does not express HLA antigens on the cell membrane, presumably because it does 
not synthesize /3 2m. From early studies on Daudi cells it was clear that they do 
synthesize glycosylated heavy chains with the signal sequence removed (Ploegh et 
al., 1979). These heavy chains, however, remain in the cell. In vivo association with 
fl2m in cell hybrids "rescues" the Daudi HLA antigens (Arce-Gomez et al., 1978). 
Together with fl 2m, HLA heavy chains which were not those of the hybridization 
partner appeared at the cell surface of the hybrid cells. It was concluded that these 
must be the Daudi HLA heavy chains. Attempts to bring about in vitro association 
of heavy chains and {l2m have not met with succes (Ploegh et al., 1979). Glyco-
sylation of Daudi cell heavy chains does not proceed further than the high man nose 
stage (Sege et al., 1981). The Daudi heavy chain remains sensiiive to endoglyco-
sidase H, an enzyme that can remove the sugar residues in the high mannose form 
but not the complex sugars. It seems probable that heavy chains in Daudi cells do 
not reach the Golgi complex but stay in the endoplasmic reticulum. By looking at 
the glycosylation in the biosynthesis of HLA class II antigens in Daudi cells, Sege 
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and colleagues (1981) concluded that class II antigens are synthesized normally, 
hence there is no general defect in glycosylation or modification in Daudi cells. 
Therefore it seems that /3 2m is essential for the transport of the HLA heavy chain 
within the cell (e.g. from the E.R. to the Golgi complex) and from within the cell to 
the extracellular side of the cell membrane. 
The association of heavy chain and {31m can go wrong because of some defect in 
{31m, as described above, but a failure in the heavy chain can also affect the 
association. One report describing a failure of association of {31m and heavy chain 
because of a structurally altered heavy chain has recently appeared (Krangel et al., 
1982). This also results in lack of processing and transport to the cell surface. 
Association of {32m with the heavy chain is necessary for the conformation of the 
final product. Certain antisera, which are directed against the heavy chain, can only 
react with the heavy chain when it is associated with {3 2m. An example of such an 
antiserum is the monoclonal antibody W6/32, described by Parham et al. (1979). 
Only one group has described the phenomenon that the heavy chain kept its 
alloantigenic conformation after dissociation from /3 2m (Nakamura et al., 1975). 
Whether {3 2m can associate with nascent chains or only with finished heavy chains is 
not clear. Generally there is an excess of {3 2m intracellularly so that cotranslation of 
the two subunits is not necessary. 
1.5.2 The genetic organization of the MHC 
Lack of sufficient pure material has hampered the amino acid sequence determina-
tion of many different allelic products. Amino acid sequencing is also very time 
consuming. Cloning of the DNA sequences coding for these products and inferring 
the amino acid sequences from these is faster and more efficient. It does not suffer 
from the restriction imposed by scarcity of material. Moreover, when eDNA is 
available, the genomic organization of the MHC complex can be investigated. This 
may give some clues as to how the extreme polymorphism of the MHC has arisen. 
So by looking at the genes we can obtain information about their products and the 
function of those products. 
A prerequisite for studies of genomic DNA is the availability of the right probes. 
Molecular cloning of eDNA for both HLA and H-2 antigens was performed by 
Ploegh et al. (1980) and Kvist and colleagues (1981). Investigations generally start 
from enriched mRNA. This is transcribed into eDNA. eDNA is inserted into 
plasmids and these are used to transform E. coli. After propagation, individual 
transformants are screened by isolation of their DNA and hybridization with HLA 
or H-2 mRNA. In vitro translation of mRNA hybridized to the DNA from the 
plasmids is used to detect those clones that contain DNA coding for HLA or H-2. 
Then a restriction map is constructed and the nucleotide sequence of the inserted 
HLA or H-2 DNA is determined. 
The characterization of eDNA poses new problems. Because of the lack of 
sufficient amino acid sequence data, it is difficult to find out for which allelic 
product a particular DNA restriction fragment or recombinant DNA clone is 
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coding. In order to solve this problem, Orr eta!. (I982) analysed HLA loss mutants 
with the pHLA-1 probe (Ploegh eta!., 1980) by Southern blotting. Genomic DNA 
from a heterozygous cell line was digested with a restriction enzyme and hybridized 
to probe pHLA-1. DNA from variants of the same line, which had lost one or more 
alleles, was digested with the same restriction enzyme as the parent line and 
hybridized to the probe. By comparing Southern blot patterns individual 
restriction fragments could be correlated to the expression of specific HLA alleles. 
Another approach was taken by Korman et a!. (1982). They purified polysomes 
carrying nascent polypeptides by an immunoaffinity column containing a mono-
clonal antibody against HLA determinants. This prepurified mRNA yields 
excellent starting material for the preparation of eDNA. As the antigenic specificity 
of the purified mRNA is known, full length eDNA prepared from this mRNA will 
have a nucleotide sequence related to that particular antigen. 
eDNA probes have been used to investigate genomic DNA in man and in the 
mouse. An H-2 probe was found to hybridize to 15-20 restriction fragments on a 
Southern blot of mouse DNA that had been treated with Bam HI and Eco Rl, 
respectively. Therefore it was concluded that 15-20 copies of H-2 class I genes are 
present in the haploid genome (Cami et al., 1981). There is a discrepancy between 
the number of genes and the number of products. The 15-20 copies are more than 
one would expect to correlate with the different class I loci, but less than one would 
expect for all existing alleles. 
The estimate from Malissen's experiments (Malissen et al., 1982) of the number of 
class I gene copies for HLA is about 30 copies per haploid genome. Some of these 
copies could be non-functional, so-called pseudogenes (Steinmetz et al., 1981). 
The distribution of class I antigens into domains turns out to be parallelled in the 
DNA sequences. H-2 genes contain 8 exons, one for the signal sequence, three for 
the external domains, one for the transmembrane part and three for the 
cytoplasmic region (Steinmetz et al., 1981). In man, a similar picture is found, but 
there are two exons instead of three for the cytoplasmic region, and the 
transmembrane part and the cytoplasmic part are each partly coded for by the fifth 
ex on (Malissen et al., 1982). Whether the complexity of the cytoplasmic region will 
reveal differentiation in function is not known. 
As mentioned before, DNA sequencing can replace amino acid sequencing. In the 
case of the carboxyl-terminal end of the H-2 heavy chain, containing the 
hydrophobic transmembrane stretch, DNA sequencing was a good alternative 
from which the amino acid sequence could be deduced (Bregegere eta!., 1981). 
Information on a recent meeting on the subject held in Oxford has been reported in 
Science (Marx, !982) and Nature (Robertson, 1982). As a mechanism for the way in 
which the polymorphism in MHC products has arisen, gene conversion is favoured. 
Gene conversion is the process whereby genetic information can be transferred 
from one gene to another related gene anywhere in the genome. It seems to be the 
only way in which to account for stretches of variety in MHC antigens, as a number 
of point mutations seems unlikely. Pseudogenes could then function as a ''reservoir 
of polymorphic variation". 
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!.6 Function of MHC antigens 
The isolation (I.4) and the characterization (!.3) ofMHC antigens, the experiments 
relating to the biosynthesis (!.5.1) and the genetic organization (!.5.2) of MHC 
antigens all have as an ultimate goal the examination of the function of the MHC 
antigens. Although MHC antigens have first been detected in transplantation 
experiments, their normal biological role cannot be in transplantation rejection, as 
organ transplantation is an artefact. 
The best studied function of MH C class I antigens is the so-called MHC restriction 
(Doherty and Zinkernagel, 1975). The killing of virus-infected cells by cytotoxic T 
cells depends on the identity of the MHC class I antigens on the infected cells and 
the effector cells. The cytotoxic T cells are specific both for the foreign antigen and 
a "self' MHC product. MHC restriction has been demonstrated for the first time in 
the mouse in choriomeningitis infected target cells (Zinkernagel and Doherty, 
1974). It has also been reported in man and mouse for cell-mediated lympholysis 
reactions against other viruses (Gardner et al., 1974, McMichael et al., 1977, 
Rickinson et al., 1980), chemically modified cells (Dickmeiss et al., 1977, Shearer, 
1974) and cells expressing the H-Y antigen (Gordon et al., 1975, Goulmy et al., 
1977). The requirement for MHC homology has also been suggested for lysis of 
cells expressing tumour-associated antigens (Schrader and Edelman, 1976, 
Germain et al., 1975, Kaneko et al., 1978). Zinkernagel has put forward a theory in 
which susceptibility to diseases associated with certain MHC haplotypes may 
directly reflect MHC restriction ofT cells (Zinkernagel, 1979). This will be further 
discussed in I. 7. 
MHC restricted effector cells may recognize the foreign antigen and the selfMHC 
product as two entities (dual recognition). Another hypothesis is that the foreign 
antigen or1 the cell surface interacts with the MHC antigen. The resulting change of 
the MHC antigen is then recognized by T lymphocytes (the "altered self' 
hypothesis). These two theories have led to experiments with the objective of 
solving the identity of the T cell receptor. 
In the case of "altered self', MHC antigens could be a receptor for the foreign 
antigen. Helenius and colleagues (Helenius et al., 1978) have shown that HLA-A, 
-Band H-2K, -D antigens can function as receptors for Semliki Forest Virus. Daudi 
cells, which lack surface expression of HLA, were not susceptible to the virus. An 
association of rat MHC antigens with an adenovirus protein in cells transformed by 
this virus has been reported (Kvist et al., 1978). In their immunoprecipitation 
experiments, MHC antigens and a viral antigen were coprecipitated. More recently 
it was shewn that the viral glycoprotein specifically binds to the heavy chain of class 
I antigens in both man and mouse (Signas et al., 1982). The possibility of an 
association between H-2 and viral antigens is disputed by another group of 
investigators (Calafat eta!., 1981). They did not find an association of viral antigens 
and H-2 on the virus-infected cell surface by patching and capping studies. HLA 
antigens incorporated into liposomes can bind to certain bacteria (Klareskog et al., 
1978). 
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It has been shown that some combinations of foreign antigens+ self markers are 
better recognized immunologically than others (McMichael, 1978). In this context, 
polymorphism at the level of the MHC could be very valuable. With the 
codominant expression, heterozygotes are at an advantage as far as fighting viral 
infections is concerned. Arguing on the level of the species, the greater the 
polymorphism, the greater the chance that the viral antigens wil be recognized in 
the context of a self product and that the infected cells will be eliminated. 
The technique of gene transfer into mouse L cells has scope for introducing MHC 
antigens into cells at will and investigation of these together with foreign antigen as 
a target for MHC restricted T cells will be possible. This type of experiment has 
been performed and it has fulfilled expectations; a transferred H-2L d gene brought 
about cell surface expression of an H-2L d antigen which could serve as a restriction 
element in lymphocytic choriomeningitis virus specific killing (Om et al., 1982). 
So it seems essential, in MHC restricted responses, that sufficient "self' MHC 
antigen is present on the target cell membrane. An increase in HLA synthesis was 
found in melanoma cells after culture in the presence of interferon (Basham et aL, 
1982). Different cell lines were studied and an increased cell surface expression of 
HLA correlated with the antiviral function of interferon. This is in agreement with 
a role for increased expression of HLA on infected cells, which would facilitate the 
killing of these cells by MHC restricted T cells. 
The unusual strength of the allogeneic response could be explained by assuming 
that allogeneic MHC antigens are just a different form of "self+ foreign antigen 
X". Alloreactive T cells were found to be highly cross-reactive with TNP (trinitro-
phenyl) modified syngeneic cells (Lemonnier et al., 1977). 
1.7 MHC and disease 
After the demonstration by Lilly et al. (1964) that susceptibility to Gross virus-
induced leukaemia was influenced by H-2linked genes, and thefinding of McDevitt 
and Chinnitz (1969) that Ir genes, which determine the immune response to certain 
antigens are linked to the H-2 system, it was only natural that the relationship 
between MHC antigens and disease was investigated. 
In the dog, some studies have been carried out concerning leucosis, diabetes 
mellitus and autoimmune hemolytic anaemia. With the particular antiserum used, 
it was found that DLA-B7 is more frequent than expected in leucosis dogs, and in 
dogs with diabetes mellitus DLA-A3 and DLA-87 occur more often than expected. 
In autoimmune hemolytic anaemia no correlation with DLA was found. When the 
p values are corrected for the number of comparisons made, the correlations are no 
longer significant (Vriesendorp et al., 1973). 
In man, statistically significant associations were mostly found between HLA and 
immunopathological diseases (Dausset and Svejgaard, 1977). The strength of the 
association can be tested by calculating the relative risk (R.R.): the chance to get the 
disease when a particular MHC antigen is present in relation to the chance to get the 
disease without the MHC antigen present. In man, the correlation with the highest 
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R.R. found so far is that between HLA-B27 and ankylosing spondylitis with a 
relative risk of 88 for Caucasoids. 
Several hypotheses have been proposed for the way in which the MHC influences 
susceptibility to disease. These include the following mechanisms: I) the MHC 
antigens themselves may function as cell surface receptors for particular pathogens. 
2) MHC antigens and certain pathogens may cross-react. This is the so-called 
mimicry. In the case of cross-reaction between MHC products and infectious 
agents, disease could be a consequence of tolerance. 3) the MHC antigens might 
have nothing to do with the disease, but be closely linked to the relevant genes. No 
evidence for this has been found. 
In man, most of the associations with (immunopathological) diseases are with 
HLA-DR. One is tempted to think here that immune response genes are directly 
involved (Oliver, 1978). Most HLA-linked diseases are chronic or subacute. 
Generally they do not influence the capacity for reproduction as they occur later in 
life and therefore, they are not important for '"natural selection". Zinkernagel 
(1979) speculates that the MHC associated diseases are caused by autoaggressive 
MHC restricted T cells. It is true that most HLA associated chronic diseases have 
an autoimmune component. These diseases may be caused by non- or poorly 
cytopathic agents that cause chronic infections. If so, there may be a balance for 
immunoprotection versus damage caused either by an infectious agent or by the 
ensuing immune response. MHC restricted effector cells may turn autoaggressive. 
After an investigation of the relationship between HLA and infectious diseases, de 
Vries and van Rood (1982) conclude that maybe the association of immuno-
pathological diseases with certain HLA antigens may be an unfortunate side effect 
of the occurrence of these antigens which are favourable for other reasons, e.g. the 
resistance to infectious diseases. 
HLA-AIIB8/DR3 is a haplotype with which several immunopathological diseases 
are associated. Individuals positive for HLA-Al/B8/DR3 have enhanced immune 
responsiveness. This could be due to a decreased suppressor cell function 
(Am binder et al., 1982). On the other hand, this haplotype may play an important 
role in recovery from viral infection and in survival of patients with lymphoma or 
leukaemia (Oliver, 1977). 
Concluding, one can remark that each HLA determinant has its own capacity for 
immune response, which may be favourable in certain cases and less favourable in 
others. Polymorphism is maintained to maximize the chance that amongst the 
various individuals there are always some of the species who survive. 
1.8 MHC antigens on tumour cells 
Much attention has been focused on the phenomenon of alien MHC antigens on 
tumour cells. As tumour cells are abnormal, any difference between tumour cells 
and normal cells is worth investigating in order to find the reason for the tumour 
cell behaviour. The occurrence of alien MHC antigens could explain something 
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about tumour cell function, and at the same time it may explain something about 
MHC function. 
Especially in inbred strains of mice, several tumours have been found which carry 
H-2 class I antigens that cannot be accounted for by the genetic make-up of the 
strain. The evidence for the presence of alien histocompatibility antigens on tumour 
cells was in most cases first found in transplantation studies (Martin and Imamura, 
1980, Parmiani et al., 1979). Further investigations comprised serological assays 
(cytotoxicity, absorption, blocking) (Parmiani et al., 1979, Schirrmacher et al., 
1980a, Schmidt et al., 1980), assays for cell-mediated immunity (Festenstein et al., 
1980, Imamura and Martin, 1980, Parmiani et al., 1979, Schirrmacher et al., !980b) 
and biochemical studies (Parmiani et al., 1979, Schmidt et al., 1980). 
In spite of these indications, the presence of alien histocompatibility antigens on 
tumour cells has only been really established in a few cases. When more refined 
techniques were applied such as peptide mapping and immunoprecipitation, some 
''alien" histocompatibility antigens turned out to be caused by contamination with 
other cell lines (Robinson et al., 1981) or cross-reactive viral antibodies in the sera 
were responsible for the "extra" reactions (P.A. Klein, 1975). The H-2 antisera are 
induced by using normal cells so it is not surprising that they may behave differently 
when used on tumour cells. Even if the presence of real alien histocompatibility 
antigens is established, their function is unkriown. It is doubtful whether they 
function as tumour associated transplantation antigens (Parmiani, 1980). 
Robinson and colleagues found by cloning of a sarcoma tumour, MCG4, which 
had been shown to possess foreign H-2 specificities (Schirrmacher eta!., 1980)that 
four different haplotypes could be demonstrated (Robinson eta!., 1981). Typing for 
independent genetic markers (/3 2m, gpi 1) identified one contaminant. So it is 
essential to use cloned tumours, homogeneous typing reagents, and to type for 
genetic markers not linked to the MHC. It is evident that biochemical studies, 
preferably at the DNA level, are required to give the ultimate proof ofthe presence 
of "alien" histocompatibility antigens. Reviews on the subject ar given in the 
Journal of Immunogenetics (1980), Transplantation Proceedings (1980, 1981) and 
by Festenstein and Schmidt (1981). 
There are several possible mechanisms of expression of alien histocompatibility 
antigens: alien histocompatibility antigens as hidden normal antigens, mutation of 
H-2 structural genes or derepression of silent genes. Epigenetic mechanisms are 
also conceivable, like changes in translation, glycosylation, membrane insertion or 
specific association with additional molecules. In view of what is now known about 
the number of MHC class I genes per haploid genome, which is much greater than 
the number of class I loci previously defined (Cami eta!., 1981, Malissen eta!., 
1982), the derepression hypothesis might be correct. DNA methylation patterns of 
the gene·s coding for MHC antigens should be compared in normal and tumour 
cells. There are many examples of an inverse correlation between the level of 
methylation and the transcriptional activity of a gene (Felsenfeld and McGhee, 
1982). Derepression of genes for histocompatibility antigens as the cause of 
appearance of alien antigens is suggested by Festenstein and Schmidt (1981), 
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Parmiani eta!. (1979) and Robinson and Schirrmacher (1979). The expression of 
alien H-2 antigenic specificities, as distinguished from actual alien H-2 molecules, 
may be much more common. Under certain circumstances, normal H-2k molecules 
on tumour cells can express alien alloantigenic specificities. This can only be 
explained by some conformational alteration in the H-2k molecules, which were the 
"normal" H-2 antigens in the tumour studied (Rogers eta!., 1981). 
Changes in histocompatibility antigens on tumour cells could have several 
implications for tumour immunology. Not only gain of''alien'' histocompatibility 
antigens occurs, loss of the original histocompatibility antigens has been found, 
too. A loss of antigenic determinants might cause a less efficient associative 
recognition by MHC restricted cytotoxic T cells. 
One can envisage that the presence of extra histocompatibility antigens might have 
different effects. The alien antigens might function as a target for the immune 
response. Alternatively, the alien histocompatibility antigens may not be suited to 
function as restricting elements, or they may interfere with associative recognition, 
so that the tumour cells can escape T cell.cytotoxicity. They may also stimulate 
suppressor cells which would facilitate their escape. Normally, cells bearing 
alloantigens are eliminated by the immune system. With the alien antigen bearing 
tumour cells this is not always the case. Sonde! and Hank (1981) have proposed a 
theory of "alien-selected escape". If tumorigenesis requires involvement of a 
pathogen which leaves a surface antigen X on the cells, the alien histocompatibility 
antigens may be altered by X in such a way that they look like "self' and cannot be 
recognized by syngeneic cytotoxic T cells. This is a different version from 
what happens normally, according to the "altered self' hypothesis (!.6) where the 
"self' antigens are changed by a viral antigen into "altered self', and where the 
"altered self' antigens are the target for MHC restricted T cells. 
The data on alien histocompatibility antigens on human tumour cells are scarce. A 
structural relationship between /32m and tumour associated antigens is suggested by 
Thomson et a!. (1978), who could isolate tumour associated antigens by affinity 
chromatography employing an anti-,B 2m serum. Some investigators report that 
most tumour cells do not display changes in HLA phenotype (Mayer et a!., 1982, 
McAlack, 1980, Pollack eta!., 1981). Ferrone and colleagues (1980) on the other 
hand, have found evidence for the expression of alien histocompatibility antigens 
on tumour cells of different histological origin together with other changes in 
surface markers on human and mouse tumour cell lines. 
Several human tumour lines express DR alloantigens although these do not cause 
stimulation in primary mixed lymphocyte reactions (Pollack eta!., 1981). What is 
now known to be anti-HLA-DR reactivity in HLA-A, -B, and -C typing sera may 
have caused "extra reactions" on tumour cells. 
Manipulation of the immune response in favour of tumour destruction has been 
attempted by several groups. In vitro stimulation of human or mouse cells with a 
pool of allogeneic cells has been shown to give rise toT cells and non-T cells which 
could lyse autologous or syngeneic abnormal cells in vitro (Bach eta!., 1980). This 
would imply that the antigens recognized by these effector cells on autologous 
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abnormal cells are alien histocompatibility antigens or cell surface antigens that are 
cross-reactive with alloantigens. In vivo experiments, also based on the assumption 
that tumour cells bear alien histocompatibility antigens, were performed by Truitt 
et al. (1980). Mice were immunized with a pool of allogeneic cells. Bone marrow 
from these mice was grafted into H-2 compatible leukaemic mice. This caused a 
significant graft versus leukaemia reactivity whereas lethal graft versus host disease 
was kept to a minimum. 
These results do not necessarily mean that alloantigens on tumour cells are the 
target cells for the immune response. 
The tumours used for the experiments of the two groups just mentioned were not 
described to contain alien histocompatibility antigens. Another example of the 
growth inhibition of a tumour after pool immunization with five different 
allogeneic cells is that ofYC8 (Parmiani and Sensi, 1981). This tumour was shown 
to lack detectable amounts of alien H-2 antigens. The mechanism for the effect of 
pool immunization on tumour growth remains ill defined. Activation ofNK cells is 
a possibility, or activation of cytotoxic T cells to alloantigens cross-reactive with 
tumour associated antigens. 
In conclusion: Many of the early experiments on alien histocompatibility antigens 
on tumour cells have been shown to lack unambiguous evidence for the existence of 
these alien antigens. With the use of more refined techniques the number of cases of 
real alien histocompatibility antigens on tumour cells has dropped. The relevance 
of alien histocompatibility antigens on tumour cells as a target for the immune 
response is dubious. The presence of alien histocompatibility antigens on tumour 
cells has become a field of interest for the investigator of the MHC rather than for 
the tumour immunologist. Bone marrow transplantation or adoptive immuno-
therapy with cells after allogeneic stimulation may be clinically relevant, but their 
beneficial effect has probably nothing to do with the presence of alien histocom-
patibility antigens on tumour cells. 
!.9 Problem orientation, rationale of the thesis 
Most of the subjects in the previous sections, illustrating the main topics of MHC 
research, have not been studied in the dog. One of the reasons for this is that the 
biochemistry of DLA antigens has not yet been thoroughly investigated. As 
mentioned before, the dog as a laboratory animal has so far been mainly used for 
transplantation research. As a preclinical model the dog is very suitable, because of 
its size, temperament, longevity, large litter size and relatively short gestation 
period. Moreover it is out bred, as opposed to most other laboratory animals and 
therefore it reflects more realistically the human situation. 
Tissue typing is a requirement for transplantation research. To broaden the basis 
upon which clinically relevant experiments can be done, it is necessary to further 
investigate the molecular nature of the MHC antigens which form, after all, the 
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main transplantation barrier. The problems encountered with organ transplanta-
tion have been brought to a cellular level by serological and MLR typing, and the 
next step is to investigate these antigens at the molecular level. Research into the 
biochemical properties of DLA antigens can benefit from the experience obtained 
and the techniques developed in studies on the H-2 and HLA antigens (!.3-!.5). 
It is necessary to know if the homology of the dog with other species on the level of 
organ transplantation, serology and MLR can be extended to homology on the 
molecular level. Class I antigens are investigated in this study as only class I specific 
antisera and anti-,B2m antiserum are available. As mentioned before, antisera are 
indispensable and must be used either for monitoring the isolation procedure or for 
the isolation itself. 
Very little is known about the biochemical properties of DLA antigens. It is of 
interest to know whether DLA class I antigens are similar to class I antigens of 
other species. If for example the DLA alloantigenic determinant would turn out to 
be carbohydrate in nature, the DLA loci would have a regulatory function through 
glycosylating enzymes, rather than the structural function which they have when 
they code directly for a protein determinant. If the DLA antigenic determinant 
would be solely carbohydrate, this would be quite different from what has been 
found in other species, and it would have implications for the genetic organization 
of the DLA complex. 
For DLA antigens the chemical composition, the tertiary structure, the role of {3 2m 
and the location of the alloantigenic site are unknown. 
The questions we wanted to answer were: 
I. What is a good method for the isolation of DLA antigens? 
Ia. papain digestion? (see chapter II) 
lb. detergent solubilization? (see chapter IV) 
2. What is the molecular weight of the isolated molecules and what is their chemical 
composition? (see chapters ll, IV, VI) 
3. What is the role of {32m? (see chapter III) 
3a. Is {3 2m part of the DLA antigens? (see chapters II, IV) 
3b. Can an anti-{3 2m serum be used for the immunoprecipitation of DLA 
antigens? (see chapter IV) 
4. Do DLA antigens have a two chain structure like MHC antigens of other 
species? 
Do alloantisera and anti-{32m sera give comparable immunoprecipitation 
patterns? (see chapter V) 
5. What is the location and the nature of the alloantigenic determinant? (see 
chapter VII) 
6. Is there a difference (quantitative or qualitative) in DLA antigens between 
tumour cells and PBL of the tumour bearer? (see chapter VII) 
The rationale for investigating these questions can be understood from the 
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description of the isolation and characterization of HLA and H-2 antigens (!.4 and 
!.3). The outline of the thesis is such that the various experiments follow one 
another in a chronological order. At the end of each chapter the results are 
discussed in the light of the previous findings and in relation to the experiments in 
the following chapter. 
Gaps in our knowledge ofMHC antigens concern the relationship of structure and 
function and the organization of their genes. All species investigated so far have 
shown similar structures and genetic organization. More information about dog 
MHC antigen structure will provide evidence which either confirms previous data 
or contradicts them. In the first case yet another species will be added to the number 
of species which show homologous features and which can be used to draw up the 
evolutionary time scale. 
Confirmation of the MHC class I antigen model by data on DLA class I antigens 
will give this model a more general validity. 
If there is a discrepancy between previous data and the results of the investigation of 
dog MHC antigens, this may stimulate a closer examination of the difference(s) in 
order to clear up some of the unknown aspects of the MHC antigens. 
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CHAPTER II 
PURIFICATION AND CHARACTERIZATION OF PAPAIN 
SOLUBILIZED DLA CLASS I ANTIGENS* 
11.1 Introduction 
The Major Histocompatibility Complex antigens of many species have been found 
to be very similar to each other (Gotze, 1977). In all species investigated so far the 
class I antigens consist of two non-covalently bound chains, one variant, the other 
invariant (Arnoux et al., 1974, Finkelman et al., 1975, Giphart et al., 1978, Katagiri 
et al., 1975, Kimball et al., 1979, Parham and Ploegh, 1980, Phillips et al., 1978, 
Strominger et al., 1981, Ziegler and Pink, 1975). The invariant chain is identical to 
/32-microglobulin (/32m). /3 2m was first discovered in urine of patients with tubular 
dysfunction (Berggard and Beam, 1968). It has a molecular weight of 11,800 
daltons. The MW of the other chain varies with the isolation procedure used. For 
HLA it ranges from 34,000 daltons after papain digestion (Sanderson and 
Batchelor, 1968) to 44,000 daltons after detergent solubilization (Dautigny et al., 
1973). 
The two techniques used most for large scale isolation of class I antigens are 
detergent solubilization (Dautigny et al., 1973, Freed et al., 1979) and papain 
digestion (Sanderson and Batchelor, 1968, Shimada and Nathenson, 1969) of crude 
membranes. Large scale preparations of HLA have been obtained from Epstein-
Barr virus (EBV)-transformed B cell lines (Strominger et al., 1975), spleens 
(Sanderson and Batchelor, 1968) and pooled platelets (Tragardh et al., 1979b). 
DLA antigens have not yet been studied at the molecular level. In order to isolate 
DLA class I antigens and to compare their biochemical properties with those of 
other MHC antigens, techniques that have been used to purify human (HLA) and 
mouse (H-2) histocompatibility antigens have been applied. There are no dog 
lymphoid cell lines available and dog lymphocytes do not have an Epstein-Barr 
virus receptor (G. Klein, personal communication). Therefore, spleens have been 
taken as a source of DLA antigens. In order to monitor the purification, it is 
necessary to test the biological activity of the product at the various purification 
stages. The biological activity is most easily measured when the DLA antigens are 
water soluble. Papain digestion has been chosen for the isolation of DLA antigens 
as it renders molecules water soluble. IfDLA antigens are homologous to HLA and 
H-2 antigens, this procedure will release most of the molecule inCluding the aBo-
antigenic site. The methods described by Parham et al. (1977) were adapted to suit 
the dog material. 
*This chapter was published in a modified version in Transplantation 32 (1981) 253-255. 
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1!.2 Materials and methods 
1!.2.1 Preparation of crude spleen cell membranes 
Spleens were obtained from tissue-typed beagles and mongrel dogs. Small chopped 
pieces were passed through a sieve, and collected in 0.01 M Tris-HCl pH 8.0. The 
wet weight of the sifted pieces was determined, and they were washed six times with 
15 ml of buffer per 10 grams of material. Each time they were centrifuged for 10 
minutes at 3000 X g and 4'C. The low speed supernatants, containing the 
membranes obtained by hypotonic lysis, were combined and centrifuged for I hour 
at IOO,OOOXg and 4'C. 
1!.2.2 Papain digestion 
After ultracentrifugation the membrane pellet was homogenized with an Ultra-
Turrax TP 18-10 (Janke and Kunkel, Staufen i. Breisgau, F.R.G.). The pellet was 
resuspended to 6 mg protein/ml and treated with 60 units of papain/ml (type IV, 
Sigma Chemical Co., St. Louis, MO, U.S.A.) in 0.01 M Tris-HCI pH 8.0 containing 
5 mM cysteine for 45 minutes at 37°C. The enzyme was inactivated by immediate 
cooling to 0°C. The solubilized proteins were separated from the membranes by 
centrifugation for I hour at 100,000 X g and 4'C. 
11.2.3 Column chromatography 
In order to remove the papain, the ultracentrifugation supernatant was applied to a 
DE 52 (Whatman, Maidstone, England) column under conditions in which HLA 
antigens are retained by the column whereas the papain appears in the flow-
through, assuming that DLA antigens would behave similarly. A 10-15 ml DE 52 
column, equilibrated with 0.01 M Tris-HCI pH 8.0 was used. After the column was 
washed with ten bed volumes of buffer, the putative DLA containing glycoproteins 
were eluted with 0.25 M NaCl in 0.01 M Tris-HClpH 8.0. Fractions of 1.5-1.75 mil 
half hour were collected. The first 5-10 fractions of the protein peak (as measured 
with an Uvicord II ultraviolet analyzer, LKB, Bromma, Sweden) were pooled and 
applied to a Sephadex G-150 column (Pharmacia, Uppsala, Sweden). A column of 
68 X 2.6 em was used with 0.14 M NH4HC03 pH 8.0 as running buffer. G-150 
fractions that contained polypeptide chains of 34,000-39,000 MW (as measured by 
SDS-polyacrylamide gel electrophoresis) were pooled and applied to a 1.5 X 3 em 
Sepharose-lentil lectin column (Pharmacia, Uppsala, Sweden), equilibrated with 
0.01 M TI;is-HCI pH 7.8, 0.001 M MnCI2, 0.0001 M CaC12, 0.14M NaCI, 0.00025 M 
dithioerythritol (lectin column buffer). After application of the sample, the column 
was washed, equilibrated in lectin column buffer containing 2.5% a-methyl-D-
mannoside and slowly eluted (flow rate 3-3.5 ml/hour). All chromatographic 
separations were performed at 4°C. 
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1!.2.4 Gel electrophoresis 
Electrophoresis was performed on 10 X 14 X 0.1 em 12.5% SDS-polyacrylamide 
gels according to laemmli (1970). Gels were stained with Coomassie Brilliant Blue 
R-250 as described by Vesterberg (1971). All chemicals for electrophoresis were 
from Bio-Rad, Richmond, CA, U.S.A. 
1!.2.5 Protein assay 
Protein concentrations were determined using the Bio-Rad protein assay (Bio-Rad, 
Richmond, CA, U.S.A.) with human serum albumin as a standard. 
1!.2.6 Inhibition of cytotoxicity assay 
The ability of the purified material to inhibit the standard microlymphocyto-
toxicity test (Smid-Mercx et al., 1975) was assayed. Target cells were Ficoll-
lsopaque purified peripheral blood lymphocytes (PBL) from tissue-typed beagles. 
Fractions of the Sephadex G-150 column and the lentil lectin eluate were dialyzed 
against 0.15 M NaCI. Typing serum was diluted two-fold in putative DLA 
containing column fractions and 40% normal dog serum (NDS). It was tested 
against appropriate target cells. Parallel to this, the same dilution range of typing 
serum in 0.15 M NaCl, 40% NDS, without G-150 or lentil lectin column fractions, 
was tested against the same target cells. As a control non-DLA containing fractions 
were also tested for inhibitory activity in the microlymphocytotoxicity test. 
Specificity control was a typing serum and target cells mismatched for the DLA-
type of the spleen donor. All dilutions were left at 4'C for 16 hours before use. 
1!.3 Results 
At first large scale preparation ofDLA antigens was started from Ficoll-Isopaque 
purified spleen lymphocytes. We had thought that starting from selected material 
would facilitate the following purification. As the yields were very small, it was 
decided to use small chopped spleen pieces passed through a sieve, without 
bothering too much about the initial purity of the material. A summary of the 
methods used is given in Fig. I. DE 52 ion exchange chromatography mainly 
separates papain from the digested material. The choice of DE 52 fractions for 
further purification was consequently based upon protein concentration only. A 
profile of a representative G-150 column, which separates the digested material 
according to MW, is shown in Fig. 2. Fractions eluted from this column were 
analysed by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) in reducing 
conditions (Fig. 3). Fractions 29-33 contained polypeptide chains of 37,000 MW 
and 12,000 MW, more or less contaminated with a few other proteins. As a MW of 
34,000-37,000 daltons is what one would expect for a papain-solubilized MHC 
molecule, these fractions, together with some others, were tested for their ability to 
inhibit a standard microlymphocytotoxicity assay (Table 1 ). 
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small chopped spleen pieces 
sieve 
hypotonic lysis in 0.01 M Tris-HCI, pH 8.0 
3000 x g, 10 min 
whole· cells and nuclei 
hypotonic lysis 
and centrifugation supernatant 
repeated 5 times 
nuclei 
(discard) 
I 
combined supernatants 
I 1QQ,QQQ X g, 1 h 
crude membranes 
100,000 X g, 1 h 
insoluble protein 
and membranes 
homogenize with Ultra Turrax, 
resuspend, treat with 60 units 
papain/ 6 mg membrane protein 
45 min, 37°C 
papain solubilized protein+ papain 
' 
DE 52 ion exchange chromatography 
0.25 M NaCI elution 
papain solubilized protein, papain removed 
Sephadex G-150 chromatography 
soluble protein 
(discard) 
Lentil lectin affinity chromatography 
elution with 2.5% a:-methyl-0-mannoside 
purified DLA antigens 
monitor by testing for inhibition of the microlymphocytotoxicity 
----
test and by SDS-polyacrylamide gel electrophoresis. 
Figure I. Method used for the isolation of papain solubilized DLA antigens from spleens. 
41 
:? DLA 
c 
0 1~ 1::- 2 3 5 6 J~ .j. .j. .j. + .j. ~ ~ 
0 5 10 15 20 25 30 35 .1() 45 50 55 60 65 
fractions 
Figure 2. Gel chromatography on a Sephadex G-150 column (68 X 2.6 em) of papain digested 
membrane proteins eluted with 0.25 M NaCI from a DE 52 column. 
6 ml fractions, flow rate 12 ml/h, eluent 0.14 M NH4HC03 • 
The arrows denote the marker substances: 1: Blue Dextran; 2: aldolase (MW 158,000); 3: albumin 
(MW 67,000); 4: ovalbumin (MW 43,000); 5: chymotrypsinogen A (MW 25,000); 6: cytochrome c 
(MW 12,300). 
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Figure 3. SDS-polyacrylamide gel electrophoresis (12.5% acrylamide) of fractions from a Sephadex 
G-150 column (Fig. 2). 
lanes a-p: fractions 18, 22, 27, 29-39, 42, 52. 
lane q: molecular weight standards: 94,000 phosphorylase b; 67,000 albumin; 43,000 ovalbumin; 30,000 
carbonic anhydrase; 20,100 trypsin inhibitor; 14,400 lactalbumin. 
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Table I. Inhibition of cytotoxicity by DLA containing column fractionsa 
Antigen preparation 
(made to 40% NOS) 
0.15 M NaC\ 
G-150 fraction 18 
G-150 fraction 23 
G-150 fraction 26 
G-150 fraction 29 
G-150 fraction 30 
G-150 fraction 31 
G-150 fraction 32 
G-150 fraction 33 
G-150 fraction 36 
G-150 fraction 51 
lentil lectir:t eluate 
Antigen preparation 
(made to 40% NOS) 
0.15 M NaCI 
G-150 fraction 18 
G-150 fraction 31 
G-150 fraction 51 
III 
_b 
Ill 
Dilution of an anti-DLA-A2 serum in 
40% NDS/0.15 M NaCI 
I/2 l/4 
± 
+ 
+ 
++ 
+++ 
+++ 
+± 
++ 
Dilution of an anti-DLA-86 serum in 
40% NDS/0.15 M NaC\ 
l/2 l/4 
I/8 
+ 
+ 
++ 
+++ 
+++ 
+++ 
++± 
+ 
± 
+++ 
I/8 
3 target cells: peripheral blood lymphocytes typed as DLA-A2, 85, C R20/ A9, 86, C 12. Peripheral blood 
lymphocytes from the spleen donor were DLA-A2, 85, C R20/ A9, 84, C-. The anti-DLA-B6serumis a 
specificity control. 
bscores: 
no inhibition 
± 0-12.5% inhibition 
+ 12.5%-25% inhibition 
+± 25%-37,5% inhibition 
++ 37.5%-50% inhibition 
++± 50o/o-62.5% inhibition 
+++ 62.5%-75% inhibition 
The preparation described here was isolated from a beagle with tissue-type 
A2,BS,R20/ A9,B4,C-. For testing specific inhibition, an anti-DLA-A2 serum was 
chosen and, as a control, an anti-DLA-B6 serum. Target cells were PBL from a 
beagle of tissue-type A2,B5,R20/ A9,B6,CI2. 
The anti-DLA-A2 serum was titrated to see at which dilution the serum would no 
longer be cytotoxic. The anti-DLA-A2 serum in a dilution of 1/8 killed 100% of the 
target cells; in a dilution of 1/16 it killed only 50% of the target cells. In Table I the 
inhibition of cytotoxicity is shown. When cytotoxicity was 100%, inhibition was 0% 
and vice versa. Dilutions of the anti-DLA-A2 serum up to 1/8 caused 100% 
cytotoxicity (Table I, line 1). Thereafter, from 1/16, less cytotoxicity was observed 
solely because of the dilution of the serum. Real inhibition therefore took place 
when serum diluted less than 1/16 was not able to kill all cells. This real inhibition 
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could have been caused by soluble DLA antigen present in the column fractions 
with which the antiserum was diluted during the 16 hour preincubation period. As 
serum dilutions for the microlymphocytotoxicity test in the dog have to be in 
0.15 M NaCl, 40% NDS, fractions of the Sephadex G-150 column (Figs. 2,3) had to 
be dialyzed against 0.15 M NaCl, and made to 40% NDS. 
The absolute amount of DLA antigens in the column fractions was not known. 
As judged from the SDS-PAGE patterns, the 37,000 MW band of the highest 
intensity was present in fraction 32. The minimum amount of fraction 32 protein 
which would inhibit the (100%) cytotoxicity caused by the 118 diluted antiserum 
(Table l, line 1) for at least 75% was determined (Table 1, line 8). Similar volumes 
of the other column fractions were added to the anti-DLA-A2 serum in 0.15 M 
NaCl, 40% NDS in such a way that a 111-l/8 dilution range was obtained. They 
were tested in the assay. Fraction 32 turned out to be the most Inhibitory fraction, 
fraction 18 did not inhibit at all, and all other fractions had intermediate inhibitory 
activity. A 100% inhibition has not been observed, possibly attributable to the 
presence of other antibodies in the antiserum used, e.g. anti-class II antibodies. 
Specificity controls were performed by using an anti-DLA-B6 serum, mismatched 
for the DLA type of the spleen donor. This serum was not inhibited (Table l). 
Sephadex G-150 fractions 29-33 were pooled and applied to a Sepharose-lentil 
lectin column. Some purification was achieved, as judged by the SDS-PAGE 
pattern (compare Fig. 3 to Fig. 4). 
a b c 
,-94K 
-67K 
-43K 
-30K 
_, -14.4K 
d 
Figure 4. SDS~polyacrylamide gel electropho-
resis (12.5% acrylamide) of fractions from a 
Sepharose-lentillectin column. 
Fractions 29-33 from a Sephadex G-150 co-
lumn (Figs 2,3) were applied to the lentil 
lectin affinity column. The 2.5o/o o:-methyi-
D-mannoside eluate was pooled into two fnic-
tions and samples were applied to the slab gel. 
lane a: flow-through of the column, lane b: 
eluate fraction 5-8, lane c: eluate fraction 9-10, 
lane d: molecular weight standards as de-
scribed for Fig. 3. 
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Based on the results of the inhibition test, an amount of lentil lectin eluate as 
inhibitory for the anti-OLA-A2 serum as fraction 32 was calculated. In fact, this 
amount of lentil lectin eluate was slightly less inhibitory (Table 1), probably 
because there was some loss of DLA antigens in the last purification step. 
The molecular weight of the polypeptide chains was estimated by SOS-PAGE 
(Fig. 4) to be 37,000 and 12,000 daltons, respectively. 
II.4 Discussion 
OLA antigens can be isolated from spleens by methods that have been developed 
for large scale preparation of HLA and H-2 antigens (Sanderson and Batchelor, 
1968, Shimada and Nathenson, 1969). They behave like proteins in the isolation 
procedure and must have a carbohydrate moiety because of their binding to lentil 
lectin. Lentil lectin binds to a-0-glucosyl and a-0-mannosyl residues (Sharon and 
Lis, 1972). Under reducing conditions the isolated molecules appear to be 
composed of two polypeptide chains of an apparent molecular weight of 37,000 and 
12,000 daltons (Fig. 4). SOS-PAGE is not an accurate method for the determina-
tion of the MW of glycoproteins (Segrest et al., 1971). For the present studies, 
however, a rough estimate was sufficient. 
The recovery of DLA antigens was about twice as much as that published by 
Triigardh et al. (1979a) from human spleens; 2.7 mg from 21,800 mg of crude 
membranes. It should be possible to get a better yield, even without using B lym-
phoid cell lines, which are known to have an increased expression ofHLA antigens 
(McCune et al., 1975). Parham et al. (1977) obtained 4 mg HLA antigens from 
1750 mg of crude membranes from a B cell line. It is possible to get a similarly high 
yield from spleens, as shown by Metzger et al. (1981) who obtained 3.6 mg SLA 
(swine MHC antigens) from 735 mg of crude membranes. One of the reasons for 
differences in recovery of MHC antigens from spleens could be that Triig8.rdh et al. 
need more purification steps than the other group, with the unavoidable loss of 
material at each step. 
The OLA antigens were obtained by applying conventional biochemical 
techniques, without the use of antisera. Their biological activity was demonstrated 
by their capability to react with the alloantisera with which they were originally 
defined. The alloantisera available have been characterized by their reaction in a 
microlymphocytotoxicity test with beagle and mongrel dog PBL as target cells 
(Vriesendorp et al., 1977). The isolated molecules were shown to inhibit this 
cytotoxicity in a specific way, i.e. they inhibited only a reaction of a typing serum 
(anti-OLA-A2) matched with the spleen donor (A2,B5,R20/A9,B4,C-); this is 
shown in Table 1. OLA preparations isolated from other spleens by the same 
methods as those described here were also able to specifically inhibit the micro-
lymphocytotoxicity test (results not shown). It was not possible to test earlier steps 
in the isolation procedure than the G-150 fractions, due to the presence of non-
specific inhibition. 
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Another technique which can be used to investigate the alloantigenic state of the 
isolated molecules is immunoprecipitation of radiolabelled cell surface antigens 
with various antisera. This will be described in chapter V. This technique has also 
been used to demonstrate that fl2-microglobulin probably forms the light chain of 
the MHC class I antigens (Grey et al., 1973, Rask et al., 1974). The experiments 
described here indicate only that a polypeptide chain of 12,000 daltons is isolated 
together with a polypeptide chain of 37,000 daltons. The MW of fl2 m is 
approximately 12,000 daltons as well, so the DLA light chain could very well be 
identical to {3 2m. Immunoprecipitation of DLA antigens with an antiserum against 
{32m will be necessary to really prove this. Such experiments are described and 
discussed in chapter IV. 
Lyophilization of DLA antigens causes dissociation of the two chains. It is then 
possible, by lentil lectin affinity chromatography, to separate the heavy chain from 
the light chain, as the latter contains no carbohydrate. A rabbit antiserum was 
raised against the heavy chain. Immunoprecipitations with this antiserum are 
described in chapter V. 
Further evidence for the identity of the molecules isolated here, and for possible 
homologies with HLA and H-2 antigens, will come from amino acid sequence 
analyses as described in chapter IV. 
In the isolation procedure described here it is not possible to discriminate between 
an intracellular or a celt surface location for the DLA antigens. However, the 
microlymphocytotoxicity test can only work when the target antigens are on the cell 
surface. Immunoprecipitation experiments, referred to above, can be designed in 
such a way that only surface proteins are detected. In chapter IV, further 
confirmation of the cell surface location of the DLA antigens will be presented. 
In the HLA system, it is possible to separate different antigens by ion exchange 
chromatography (Turner et al., 1975). So far this has not been described for DLA 
antigens. SLA antigens from inbred miniature swine isolated by papain digestion of 
spleen cells are relatively homogeneous (Metzger et al., 1981), whereas SLA 
antigens from non-inbred swine show substantial biochemical differences (Arnoux 
et al., 1974). For the separation of different SLA antigens, DEAE chromatography 
is the method of choice. 
Many gel patterns of lentil lectin eluates of DLA antigens show an additional band 
of 30,000 MW. Possibly these are the dog equivalents of HLA-DR antigens. HLA-
DR antigens bind to lentil lectin through their carbohydrate chains (Springer et al., 
1977). As no class II specific antisera are available it is not possible to further 
characterize the 30,000 MW molecules. 
The DLA antigens described in this chapter resemble MHC class I antigens of 
other species in the molecular weight of the polypeptide chains and their behaviour 
in biochemical and immunological procedures. They form a sufficiently pure 
starting material for amino acid sequence studies, which will make comparison 
with MHC antigens from other species even more valuable. 
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through a filter of sand and NaN3 was added to a concentration of0.02%. The urine 
was dialyzed extensively at 4"C against tap water in Thomas (Philadelphia, PA, 
U.S.A.) dialysis tubing with a cut-off at 8000 MW. After dialysis the urine was 
lyophilized. It was dissolved in 40 ml ofO.Ol M Tris-HCI pH 7.4, I M NaCI, 0.02% 
NaN3, to a protein concentration of 25 mg/ml (reading the absorbance at 280 nm, 
using bovine serum albumin as a standard). The mixture was stirred at 4°C for 30 
minutes and centrifuged for 10 minutes at 10,000 X g. The supernatant was divided 
into 10 ml .aliquots and applied to a Sephadex G-150 (Pharmacia, Uppsala, 
Sweden) column of 68 X 2.6 em in 0.1 M NH4HC03 pH 7.8, 0.02% NaN 3 at a flow 
rate of 20 mllhour, with 10 ml fractions. Low molecular weight fractions were 
pooled and concentrated in an Ami con (Lexington, MA, U.S.A.) 400 ml ultrafiltra-
tion cell, equipped with a UM 2 (MW cut-off 1000) filter. Aliquots of the pooled 
low MW fractions were applied to a Sephadex G-75 superfine column (Pharmacia, 
Uppsala, Sweden) of 1.5 X 90 em in 0.1 M NH4HC03 pH 7.8, 0.02% NaN 3 , at a flow 
rate of 9 mllhour, with 1.8 ml fractions. Fractions were analysed by SDS-
polyacrylamide gel electrophoresis (111.2.2) and enzyme linked immunosorbent 
assay (ELISA, !11.2.4). All chromatographic separations were performed at 4'C. 
!11.2.2 Gel electrophoresis 
SDS-polyacrylamide gel electrophoresis was conducted according to Laemmli 
(1970) on 12.5% acrylamide gels of 10 X 14 X 0.1 em. Gels were stained with 
Coomassie Brilliant Blue R-250 (Vesterberg, 1971). All chemicals for electrophore-
sis were from Bio-Rad, Richmond, CA, U.S.A .. 
III.2.3 Antisera 
A rabbit anti-dog-/32m serum was kindly given to us by Dr. M.D. Paulik (Royal 
Oak, MI, U.S.A.). More antiserum was raised in two rabbits. Aliquots of purified 
/32 m (III.2.1) (0.5 mg in 0.5 ml 0.9% NaCI) were emulsified in 0.5 ml complete 
Freund's adjuvant (Difco, Detroit, MI, U.S.A.) and injected subcutaneously at five 
different sites on the back. Seven boosts, in incomplete Freund's adjuvant (Difco, 
Detroit, Ml, U.S.A.), were performed at three week intervals. After each boost the 
sera were tested in the ELISA (III.2.4). 
III.2.4 ELISA 
The ELISA was performed by the (modified) procedure of Engvall and Ruoslahti 
(1979). Terasaki trays (Greiner, Nurtingen, F.R.G.) were coated with 50 ILg/ml 
poly-L-Iysine (Sigma, St. Louis, MO, U.S.A.). Each well was filled with 10 ILl of a 
100 ILg/ml protein solution to be tested for the presence of /32 m. After 30 minutes 
the trays were washed with 2% bovine serum albumin in phosphate buffered saline 
(BSA/PBS) and 5 ILl of dilutions of rabbit anti-dog-/32 m in 4% BSA/PBS/0.05% 
NNPIO (a non-ionic detergent from Servo, Delden, the Netherlands) were added. 
After one hour of incubation, the trays were washed again and 5 ,ul of a goat anti-
rabbit-IgG coupled to horse radish peroxidase (Nordic, Til burg, the Netherlands), 
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diluted 1:200 in 4% BSA/PBS/0.05% NNPlO was added for one hour. After 
another wash, 5-aminosalicylic acid (Merck, Darmstadt, F.R.G.), 0.8 mg/ml, 
pH 6.5, and 0.05% H 20 2 were added in a 9:1 ratio, 10 f.Ll per well. The reaction was 
terminated after 30 minutes by the addition of 1 M NaOH, and the intensity of the 
brown colour was recorded for each well. As a control non-immune rabbit serum 
and non-/3 2m containing fractions or lysozyme (Sigma, St. Louis, MO, U.S.A.) 
were used. 
III.2.5 Immunochemical techniques 
Double diffusion tests according to Ouchterlony (1958) were performed in 1% agar 
(Difco, Detroit, MI, U.S.A., agar noble) in PBS. The immunoelectrophoresis 
method of Scheidegger (1955) was used. After serum incubation, both Ouchterlony 
and immunoelectrophoresis plates were washed extensively with 0.9% NaCI and 
distilled water. The slides were dried and they were stained with 0.05% thiazine red 
and 0.05% amido black in 10% acetic acid and 90% methanol. For destaining a 
solution of 10% acetic acid and 50% methanol was used. 
II!.2.6 Cytotoxicity testing 
The cytotoxicity of the sera, raised against dog j32m was tested in the two-stage 
microlymphocytotoxicity test (Smid-Mercx et al., 1975). 
Ill.2. 7 Analytical isoelectric focusing 
Isoelectric focusing was performed on slab gels of 10.5 X 0.15 em with a length 
according to the number of samples analysed. The gels contained 6.75 M Urea 
(Merck, Darmstadt, F.R.G.), 7% acrylamide, 0.19% N,N'-methylene-bis-acryl-
amide (Bio-Rad, Richmond, CA, U.S.A.), 2% v/v NNPlO (Servo, Delden, the 
Netherlands) and 2.5% w/v Ampholine carrier ampholytes (LKB, Bromma, 
Sweden) consisting of 11.2% pH 4-6, 11.2% pH 5-7, 5.2% pH 9-11 and 73.2% 
pH 3.5-10 ampholytes. The urea was deionized and filtered on a 0.45 f.Lm filter 
before use. The gels were polymerized with 0.025% ammoniumpersulphate and 
0.025% TEMED (Bio-Rad, Richmond, CA, U.S.A.). Electrode buffers were I M 
NaOH at the cathode and 1M H 1PO, for the anode. For the isoelectricfocusing an 
LKB (Bromma, Sweden) 2117 Multiphor flat bed gel apparatus was employed. The 
glass plate was water-cooled to a temperature of 7°C. After focusing, the pH 
gradient was determined by cutting out equal pieces of gel across the width, soaking 
them in distilled water for 2 hours at room temperature and measuring the pH. 
III.3 Results 
In order to isolate dog urinary {3 2m, we have used methods most of which work by 
separation on a molecular weight basis. A summary of the procedure is given in 
Fig. l. 
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urine from a kidney transplant recipient 
10,000 x g, 10 min 
pellet 
(discard) 
high MW fractions 
dialyze against tap water 
lyophilize 
dissolve in high salt solution 
stir 30 min at 4°C 
supernatant 
Sephadex G-150 chromatography 
low MW fractions 
Sephadex G-75 chromatography 
purified /3 2 m 
-------monitor by ELISA and SDS-polyacrylamide gel electrophoresis. 
Figure 1. Method used for the isolation of dog (3 2m from urine. 
The isolation of {3 2m by gel chromatography (Fig. 2) was monitored by SDS-poly-
acrylamide gel electrophoresis (Fig. 3). On these gels, human {32m was used as a 
reference. Fractions 23-34 of the Sephadex G-150 column contained a protein of 
the same molecular weight as human /32m ( 12,000 daltons). The protein concentra-
tion of aliquots of these and some adjacent non-,82m containing fractions was 
adjusted to 100 !Lglml and they were tested for reactivity with Dr. Paulik's 
antiserum against dog {32m in the ELISA. Fractions 26-33 were positive, whereas 
fractions 15, 18, 23, 34-36 hardly reacted. The reactive fractions were pooled, 
concentrated and further purified on Sephadex G-75. Some G-75 fractions were 
rechromatographed on the same column. The isolated {3 2m was pure as far as it 
could be detected by SDS-PAGE. 
This purified {32m was used to prepare rabbit anti-dog-/32m antisera (III.2.3). After 
each boost, the titre of the sera was determined in the ELISA (III.2.4). For the 
ELISA, the {3 2m used for injection was taken as the antigen and Dr. Paulik's 
antiserum as a positive control. Non-immune rabbit serum and G-150 fraction 18 
or lysozyme were used as a negative control. After seven boosts, the sera of both 
rabbits employed reacted with /3 2m above background up until a dilution of 1:105 • 
The sera produced were compared to the serum given to us by Dr. Poulik in an 
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Figure 2. Gel chromatography on a Sephadex G-150 column (68 X 2.6 em) of dialyzed and con-
centrated urinary proteins from a kidney transplant recipient. 
10 ml fractions. flow rate 20 mllh, eluent 0.1 M NH4HC03 , 0.02% NaN 3 • Molecules of a MW similar to 
that of human {3 2m are found in the fractions between the arrows. 
94k· 
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Figure 3. SDS-polyacrylamide gel electrophoresis ( 12.5% acrylamide) of fractions from the Sephadex 
G-150 column of Fig. 2. 
lane a: human /3 2m 
lane b: molecular weight standards: 94,000 phosphorylase b; 67,000 albumin; 43,000 ovalbumin; 30,000 
carbonic anhydrase; 20,100 trypsin inhibitor; 14,400 lactalbumin; 
lanes c-o: fractions 12, 15, 18, 23, 26, 29-36 of the G-150 column of Fig. 2. 
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Figure 4. Ouchterlony double diffusion test of two rabbit anti-dog-j32m sera. The centre well contained 
dog f31m, concentrated G-75 fraction 24. The other wells contained: well I: anti-dog-,62m serum from 
rabbit 1; \Veil 2: rabbit anti-dog-,62m serum from Dr. Paulik; well 3: anti-dog-,62m serum from rabbit I, 
diluted 1/2; well 4: as wei13; well 5: rabbit anti-dog-,82m serum from Dr. Paulik, diluted 1/2; we!\6: anti-
dog-f32m serum from rabbit 2 . 
• 
·•. 
Figure 5. Immunoelectrophoretic analysis of purified /3 2m. Buffer: 0.12 M sodium barbital pH 8.6. 
Upper well: G-75 fraction 23; bottom well: G-75 fraction 24; trough: anti-dog-,62m serum from rabbit 
2. 
Ouchterlony test (F1g. 4). The antisera were used undiluted or diluted 1/2. A G-75 
fraction containing pure {3 2m as judged by SDS-PAGE was concentrated by 
lyophiliZation and redissolution in 1/10 of the original volume. Lines of identity 
were observed between Dr. Poulik's antiserum (well 2 and 5) and the two newly 
raised antisera (well I, 3, 4 and 6). Immunoelectrophoresis (Fig. 5) was done to 
investigate whether the dog {3 2m had the same mobility in this system as human 
{32m. Several G-75 fractions were tested in immunoelectrophoresis at pH 8.6. G-75 
fraction 24 (Fig. 5, bottom well) contained {3 2m which had a mobility similar to that 
described by Berggard and Beam (1968), in the /32-globulin region. G-75 fraction 23 
+ 
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(Fig. 5, upper well) was contaminated by two components other than f3 2m. 
Unfortunately, no antiserum against total urinary proteins was available, so only 
impurities that react with the unpurified anti-,8 2m sera could be detected. The 
isoelectric point reported for dog {3 2m is 5.1-5.3 in preparative isoelectric focusing 
(Paulik, 1975). Various G-75 column fractions were tested in analytical isoelectric 
focusing on urea containing slab gels (Fig. 6). As a reference, human /32m was also 
applied; the isoelectric point detected was pi 6.9 and the dog /3 2m had an isoelectric 
point of 6.4. One other major band was visible both in human and in dog /32m pre-
parations. 
If the antisera are to be used for the characterization of DLA antigens, they must 
react with (the DLA antigens on) viable peripheral blood lymphocytes. This was 
tested for in the two-stage microlymphocytotoxicity test (Table 1). The anti-/32m 
serum was indeed cytotoxic, albeit to a different degree, to PBL from dogs of 
PH 
4-
5 -
6-
7-
-
8-
9_ 
a b c 
Figure 6. Analytical isoelectric focusing of {32m. Aliquots of purified {3 2m were applied to a thin layer 
isoelectric focusing gel in a pH gradient of 3.5-10. Isoelectric focusing was performed for 1 Y2 h, at 
1000 V. 
lane a: 
lane b: 
lane c: 
dog {3 2m G-75 fraction 21 
dog {3 2m G-75 fraction 22 
human {32m. 
Table I. The microlymphocytotoxicity test with anti-dogf32m antisera. 
dog peripheral blood reaction with 
lymphocytes typed as: anti-DLA-A9 anti-/32m (I) anti-/32m (2) anti-/32m, no C' 
A9, B6, C12 /A2, 85, Cll 1/16* 1/8 ND no dead cells 
AJ+JO, B-, C- /A9, 86, C- 1/2 1/128 11128 no dead cells 
A2, B5, C11, R20 /A9, B4, C12 1/2 1/16 11128 no dead cells 
A9 B6, C12 I A3+10, B-, C- ND 1/2 ND ND 
A7 B-, C- /A9, 84, C12 ND 1/16 ND ND v. 
"' 
A7, B-, C- /A9 B4, C12 ND 1/2 ND ND 
A1, 813, C- /A9, B6, C12 ND 1/128 ND ND 
A9, B6, Cl2 /A7, B-, C- ND 1/2 ND ND 
A9, B6, Cl2 /A7, B-, C- ND 1/128 ND ND 
*the highest dilution of antiserum whereby 75% of the cells is dead. ND: not done. 
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different tissue-type. As a positive control, an alloantiserum was used, and a 
control without rabbit complement was added to exclude toxic factors in the anti-
{32m serum other than antibodies. The fact that the antiserum reacted with 
lymphocytes of different tissue-type is an indication that the antigenic determinant 
on {32m reacting with the antiserum is the same in different DLA molecules. 
Ill.4 Discussion 
The main evidence for the assumption that the isolated protein is indeed {3 2m is the 
reaction of the protein with rabbit anti-dog-,82m serum from Dr. Paulik in the 
ELISA and the Ouchterlony test. It is further supported by our observation that the 
serum reacts with lymphocytes of different DLA types. The ELISA was used to 
identify dog {3 2m. Column fractions containing /32m by this criterion and of 
sufficient purity, as judged by SDS-PAGE, were pooled and used to raise anti-P2m 
antisera in two rabbits. After each boost, the sera were tested in the ELISA to 
monitor the titre and specificity. In an Ouchterlony test lines of identity were 
formed between the antiserum given to us and the antisera we raised ourselves 
(Fig. 4). The immunoelectrophoresis (Fig. 5) of dog p,m indicates that the mobility 
of dog f'2m is the same as that of human !'2m tested in .similar conditions. Berggiud 
and Beam (1968) reported that after immunoelectrophoresis at pH 8.6, f'2m would 
be found in the f'2-globulin region, with a mobility slightly lower than that of 
transferrin. Two extra curves were seen when G-75 fraction 23 (Fig. 5, upper well) 
was investigated. This implies that fraction 23 contains impurities, and that the 
antiserum can react with them and is therefore not directed exclusively against {3 2m. 
Whether this has any implications for the possible reaction of the anti-/32m antisera 
with DLA antigens remains to be seen. 
The isoelectric point (pi) of dog p,m determined here (6.4, Fig. 6) differs from 
that reported before: 5.1-5.3 (Paulik, 1975). The pi of human f' 2m (6.9, Fig. 6), 
however, is also different from the value reported (5.4-5.6, Paulik, 1975). The 
absolute difference between the two values reported and the two values found here 
is about the same, 0.5 pH units. The values established by Paulik were found after 
preparative isoelectric focusing in a column, which is known to be more accurate 
than the method used here, where cathodic drift can occur. Two homologues of 
p2m of different pi have been found in man (Hallet al., 1977), the rat (Lodgberg et 
al., 1979), the rabbit (Bjorck and Berggard, 1981) and the guinea pig (Cigen et al., 
1978). In Fig. 6 both human and dog f'2m have two components, a major one of pi 
6.9 and 6.4, respectively, and another one of slightly lower pl. 
The antisera react with dog peripheral blood lymphocytes (Table I) of different 
tissue-type. If the determinant recognized is part of the DLA molecules, it is 
unlikely that it will be polymorphic as the reaction was not dependent on typing for 
class I antigens. The antisera raised in the two rabbits will be used to investigate if 
DLA antigens can be immunoprecipitated with them, either from detergent cell 
Iysates or from papain solubilized D LA antigens prepared from dog spleens 
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(described in chapter IV). Inhibition of cytotoxicity of the antisera by purified j32m 
did not give clear-cut results. This is probably due to the extra specificities present 
in the serum (Fig. 5). When it can be demonstrated that DLA antigens are purified 
f3 2m can be tested. Reaction of DLA antigens with anti-/32m sera indicates that {3 2m 
is the light chain of these molecules. If an immunoprecipitation reaction between 
DLA antigens and an anti-/32m serum can be inhibited by purified urinary {3 2m, the 
evidence becomes even stronger. Experiments along these lines have been 
performed and they are discussed in chapter IV. One group has described 
dissociation of MHC antigens after incubation with anti-,B2m antiserum (Naka-
muro et al., 1975). If the antisera against dog j32m behave similarly, it may be 
difficult to obtain immunoprecipitates containing intact DLA molecules. 
From one anti-,B2m antiserum, IgG has been isolated using Sepharose-protein A. 
This IgG has been coupled to CNBr-activated Sepharose. Small amounts of 
purified j32m could be bound by this affinity column, but it was extremely difficult 
to elute the j32m again, either with 3M KSCN, 3.5 M MgC12 orO.S M glycine pH 2.8. 
Robb et al. (1976) eluted their anti-j32m affinity column with purified j32m. Due to 
lack of material, we could not do this. Another, as yet untried, possibility is elution 
with a high pH buffer as described for elution from affinity columns with 
monoclonal anti-MHC antibodies (Parham, 1979). Therefore, even if j32m turns out 
to be the light chain of the DLA antigens, lentil lectin chromatography remains for 
the time being a better method for large scale isolation of DLA antigens than anti-
j32m affinity chromatography. 
The function of {32m is not known. Membrane-bound {3 2m may have an influence 
on the control of cellular functions. Indirect evidence for this is found in 
experiments that show that xenoantisera to {3 2m affect mixed lymphocyte reactivity 
and PHA stimulation (Bach et al., 1973) and B cell stimulation (Moller and 
Persson, 1974). Investigations on Daudi cells, which produce HLA heavy chains, 
but are devoid of j32m, indicate that j32m may be important for the transport of 
HLA to the membrane and for the creation of determinants recognized by 
alloantibodies (Ploegh et al., 1979, Sege et al., 1981). This is discussed more 
extensively in chapter !.5.1 and chapter V!II.3.1. 
So far, we did not develop the dog system far enough to investigate similar 
questions in this species. 
Concluding, we can say that {3 2m has been isolated from dog urine and that 
antisera have been raised against it. For large scale isolation of DLA antigens by 
affinity chromatography the antiserum is not as useful as lentil lectin (chapter II). 
Small scale isolation and characterization of radiolabelled DLA antigens by the 
anti-j32m sera will be discussed in chapters IV, VI and VII. 
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CHAPTER IV 
CHARACTERIZATION OF DLA CLASS I ANTIGENS BY 
IMMUNOCHEMICAL TECHNIQUES USING AN 
ANTI-/32-MICROGLOBULIN SERUM* 
IV.! Introduction 
Like other MHC antigens, DLA class I antigens have originally been characterized 
in vitro by serological means. Antisera can be used both for characterization and 
for isolation of the antigens to which they are directed. In chapter II the isolation of 
DLA antigens by conventional biochemical techniques was described. Their 
biological activity was determined by their ability to inhibit the reaction of 
alloantisera with peripheral blood lymphocytes in the microlymphocytotoxicity 
test. In this chapter and the following one, antisera were used for the isolation of 
DLA antigens. This was done by immunoprecipitation; subsequently they were 
analysed on SDS-polyacrylamide gels. For a number of species immunochemical 
methods have been successfully applied in order to further elucidate the structure of 
the MHC antigens (Finkelman et al., 1975, Giphart et al., 1978, Katagiri et al., 
1975, Kimball et al., 1979, Lunney and Sachs, 1978, Parham and Ploegh, 1980, 
Phillips et al., 1978, Schwartz and Nathenson, 1971, Wernet and Kunkel, 1973, and 
Ziegler and Pink, 1975). 
The MHC antigens consist of two polypeptide chains of MW 43,000-47,000 and 
12,000. Antisera against MHC antigens can be directed against determinants on the 
light chain and/or on the heavy chain. In this chapter only one antiserum was used. 
It was raised against purified urinary {3 2m (chapter 111.2.3). 
In all species studied so far, {3 2m forms the light chain of the MHC class I 
antigens. Our first aim was to investigate if the rabbit-anti-dog-/32m serum would 
react with DLA antigens in the immunoprecipitation technique. The molecules 
isolated by papain digestion of crude spleen cell membranes had been shown to 
have DLA-like activity (chapter II.3), so they were used for the first immunopreci-
pitation experiments with the anti-/32m serum. At the same time, NH 2-terminal 
amino acid sequences of both heavy and light chain of the papain solubilized 
molecules were determined to verify their identity. Once it is established that anti-
dog-/32m serum can be employed for the isolation of papain solubilized DLA 
antigens by immunoprecipitation, more experiments can be done using this 
technique to examine the structure and the location of the DLA antigens. 
For these experiments peripheral blood lymphocytes were radiolabelled with 35 S-
methionine or by lactoperoxidase-catalysed iodination. These are typical methods 
for protein labelling. In this way the protein nature of the DLA antigens could be 
*This chapter was published in a modified version in H. Peeters (Ed.) Protides of the biological fluids, 
29th col!., Pergamon Press, Oxford, 1982, pp. 243-246. 
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confirmed. Detergent was used to release membrane integrated molecules from 
peripheral blood lymphocytes. If the anti-/32m serum would react with detergent 
solubilized molecules, these would most probably be DLA antigens. The two chain 
structure could then be corroborated and the MW of the heavy chain should be 
somewhat larger than that found for papain solubilized DLA antigens (37,000 
daltons, chapter 1!.3). 
The location of the DLA antigens could be examined using the immunoprecipita-
tion technique. Lactoperoxidase-catalysed iodination is supposed to exclusively 
label proteins on the cell surface, as lactoperoxidase cannot pass the cell membrane. 
When 35S-methionine is incorporated, both surface and intracellular proteins are 
labelled. When intact cells are incubated with the antiserum, however, immune 
complexes can only be formed with antigens on the outside of the celL Both 
lactoperoxidase-catalysed iodination and incubation of intact cells with antiserum 
have been tested in order to assess the location of the DLA antigens. 
IV.2 Materials and methods 
IV.2.1 Antisera 
For the anti-,B2m serum rabbits were immunized with dog {3 2m as described in 
chapter III.2.3. Normal rabbit serum was a pool of serum from non-immunized 
rabbits. Goat anti-rabbit-IgG was obtained from Miles, Slough, England. 
IV.2.2 Radiolabelling of prepurified DLA antigens from spleen cells 
DLA antigens were isolated from spleen cells and purified as described in chapter 
11.2. The procedure of Fraker and Speck (1978) was modified to label dog MHC 
products. Small glass test tubes were coated with 2 fl.g of I ,3,4,6-tetrachloro-3a,6a-
diphenylglycoluril (IODOGENTm, Pierce, Rockford, IL, U.S.A.). A reaction 
mixture consisting of 0.11 pg KI, 30 pg protein and 14 pCi Na 125I (Arnersham 
International plc, Amersham, England) in a volume of 100 fl.] sodium phosphate 
buffer (0.05 M, pH 7.4) was added to the coated test tube. After 15 minutes at room 
temperature the mixture was placed into a clean tube and applied to a 0.9 X 15 em 
Sephadex G-75 column (Pharmacia, Uppsala, Sweden). The running buffer was 
phosphate buffered saline pH 7.4, 1% bovine serum albumin. The labelled protein 
fractions were pooled. 
IV.2.3 Immunoprecipitation of radiolabelled DLA antigens from spleen cells 
Antigen preparations were incubated with rabbit anti-dog-{3 2m serum or normal 
rabbit serum for 1 hour at room temperature. An excess of goat anti-rabbit-IgG 
was added and the precipitates were left at 4 oc for 16 hours. The precipitates were 
washed once in 0.2 M Tris-HCl pH 8.0, 0.5% BSA, 0.5% NNPlO (Servo, Delden, 
the Netherlands), once in 0.05 M Tris-HCl pH 8.0, 0.05% BSA, 0.05% NNPlO, once 
in 0.0625 M Tris-HCl pH 6.8 and once in 0.1% SDS. After washing, the precipitates 
were boiled in Laemmli sample buffer (Laemmli, 1970) for 5 minutes. 
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IV.2.4 Radiolabe!Iing of DLA antigens from peripheral blood lymphocytes 
Peripheral blood lymphocytes from tissue-typed beagles were isolated from 
heparinized blood and purified by centrifugation on Ficoll-lsopaque. They were 
surface labelled using lactoperoxidase-catalysed iodination (Vitetta et al., 1971). 
Alternatively, they were labelled metabolically using 35S-methionine (Amersham 
International pic, Amersham, England; specific activity 800-1000 Ci/mMol). To 
increase the metabolism of the lymphocytes, they were stimulated by PHA-M 
(Difco, Detroit, Ml, U.S.A.) for 72 hours in a 5% C02 humidified atmosphere at 
37 "C. PHA-M, final dilution l/360-l/960 (v/v) out of a stock solution of 1% in 
0.85% saline, was added to 106 cells per ml in RPM! 1640 medium supplemented 
with glutamine to a final concentration of 2 mM, penicillin and streptomycin to a 
final concentration of 50 U/ml and 50 11g/ml (all from Gibco Europe, Paisley, 
Scotland) and 10% normal dog serum. After stimulation, the percentage and the 
viability of lymphobiasts was determined (both generally about 90%), the cells were 
washed and resuspended at 106 cells per ml in methionine-deficient RPM! 1640 
supplemented with glutamine, penicillin, streptomycin and 10% dialyzed foetal calf 
serum (Gibco Europe, Paisley, Scotland). Preincubation of the cells in this medium 
for 30 minutes was necessary to deplete the endogenous methionine pool. After 30 
minutes, 35S-methionine was added, 0.1-1 mCi to 107 cells. The cultures were 
incubated for 16 hours at 37°C in the C02 incubator. Incorporation was measured 
by TCA precipitation of aliquots from cell suspensions or membrane extracts. 
IV.2.5 Antigen preparation from radiolabelled peripheral blood lymphocytes 
As 35S-methionine is incorporated into both intracellular and cell surface proteins, 
prepurification was carried out by preparing membranes from the cells before 
detergent solubilization. Cells were washed and lysed in 0.01 M Tris-HCl pH 8.0 
and centrifuged for 10 minutes at 1000 X g. This was repeated five times. The 
supernatants were collected and centrifuged for l hour at 50,000 X g and 4"C. The 
resulting pellet, containing the crude membranes, was solubilized, with occasional 
shaking, in 0.75% non-ionic detergent NNPIO (Servo, Delden, the Netherlands) in 
PBS containing 0.125% EDTA and 0.02% NaN 3, for 30 minutes on ice. The 
membrane extract was centrifuged for 1 hour at 100,000 X gin a Beckman airfuge 
at 4°C and the pellet was discarded. The supernatant contained the crude antigen 
preparation. Crude membranes from unlabelled cells of irrelevant DLA specificity 
were added to reduce non-specific interactions in immunoprecipitation. Further 
purification of membrane extracts was done by lentillectin-Sepharose (Pharmacia, 
Uppsala, Sweden) affinity chromatography. For 2.5 X 106 cell equivalents 0.5 ml of 
packed lentil lectin-Sepharose beads was used. The beads were washed in Oc5% 
NNP10 in PBS. Antigen preparation and lentillectin-Sepharose were incubated for 
30 minutes at room temperature. After thorough washing the antigen was eluted 
with 0.1 M a-methyl-0-mannoside in 0.5% NNPlO in PBS. The eluted material was 
dialyzed for 16 hours at 4"C against 0.5% NNPlO in PBS and then used for 
immunoprecipitation. 
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Samples from the experiments described under IV.2.7 and !V.2.8 were reduced and 
alkylated (Dobberstein et aL, 1979) and analysed on 7.5-15% linear gradient gels of 
15 X 30 em. 
All chemicals for electrophoresis were from Bio-Rad, Richmond, CA, U.S.A. 
Marker proteins are listed in the relevant figure legends. 14C-labelled marker 
proteins were obtained from NEN, Dreieich, F.R.G. 
IV.3 Results 
Cell surface molecules were isolated either by papain digestion from spleens or by 
detergent solubilization from peripheral blood lymphocytes. Both types of cell 
extract and intact cells were used for the following immunoprecipitation studies. A 
summary of immunoprecipitation schedules is given in Fig. la. 
spleen cells 
I 
papain digestion of 
crude membranes and 
further purification 
(chapter II) 
I 
labelling of purified 
antigens with 125 1 
(IV.2.2} 
incubation with 
antiserum 
(IV.2.3} 
I 
isolation of immune 
complexes by double 
i mmunoprecipitation 
(IV.2.3} 
I 
analysis by SDS-poly-
acrylamide gel 
• electrophoresis 
(IV.2.10} 
I 
results: IV .3.1 
peripheral blood lymphocytes 
I ~ 
labelring of purified 
PHA-stimulated lym-
phocytes with 35 $-
methionine (IV.2.4) 
I 
membrane preparation, 
detergent solubilization, 
~entillectin affinity 
chromatography (IV.2.5) 
I 
preclearing with normal 
rabbit serum, Sepharose-
protein A (IV.2.6~ 
incubation with 
antiserum 
(IV.2.6} 
I 
isolation of immune 
complexes with 
Sepharose-protein A 
(IV.2.6} 
analysis by SDS-poly-
acrylamide gel 
electrophoresis 
(IV.2.10} 
I 
results: IV.3.2 
labelling of purified 
lymphocytes with 
125 1 {IV.2.4) 
I 
incubation with 
antiserum 
(IV.2.6} 
detergent 
solubilization 
(IV.2.6} 
I 
isolation of immune 
complexes by double 
immunoprecipitation 
(IV.2.6} 
I 
analysis by 80S-poly-
acrylamide gel 
electrophoresis 
(IV.2.10} 
I 
results: IV.3.3 
Figure la. Summary of the immunoprecipitation schedules used. 
incubation of anti-)32 m serum 
with purified )32 m or ovalbumin 
(IV.2.7)16 h, 4°C. 
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~ 
labelling of purified PH A-
stimulated lymphocytes 
with 35 S-methionine 
(IV.2.4) 
---------------
30 min 16,000 x g 
I 
insoluble protein 
{discard) 
low speed centrifugation 
non reactive material 
incubation of intact labelled cells 
with the antiserum, 1 h on ice 
I 
solubilization in 0.5% NP-40 
I 
I 
detergent solubilized protein 
and immune complexes 
incubation with Staph A 
15 min on ice 
Staph A bearing immune complexes 
elution with sample buffer 
analysis on SDS-poly-
acrylamide gels 
Figure lb. Inhibition of immunoprecipitation (IV.2.7). 
IV.3.1 Immunoprecipitation of 1251 labelled DLA antigens obtained fi·om spleens by 
papain digestion 
DLA antigens were isolated and purified as described in chapter 11.2. After 
purification on Sepharose-lentil lectin they were radiolabelled and incubated with 
rabbit anti-dog-/32m serum (see section IV.2.2, IV.2.3). The antiserum should react 
with all DLA molecules independent of tissue-type. Most sera raised against 
urinary {3 2m will precipitate the whole class I molecule, i.e. both heavy and light 
chain (Poulik et a!., 1979). 
In Fig. 2 the results of the immunoprecipitation are shown. Normal rabbit serum, 
used as a control, does not precipitate any labelled mate~ial (lane a). The anti-{3 2m 
serum brings down two components of an a proximate MW of 37,000 and 12,000. 
The biochemically purified DLA antigens (chapter 11.2) show exactly the same 
pattern on SDS-polyacrylamide gels after staining for protein (chapter II, Fig. 4). 
So, the DLA antigens that were isolated by conventional biochemical techniques 
can react with an antiserum against /32m. 
Knowing this, we could use the technique of immunoprecipitation ofradiolabelled 
DLA antigens by anti-/32m serum to perform several experiments on an analytical 
scale. First, we wanted to establish whether DLA antigens could be isolated from 
peripheral blood lymphocytes by detergent solubilization. 
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a b 
Figure 2. SDS-polyacry!amide gel electrophoresis (12.5% acrylamide) of WI labelled, papain solu-
bilized DLA antigens after immunoprecipitation with: normal rabbit serum (lane a) or rabbit anti-dog-
/32m serum (lane b). Molecular weight standards: 94,000 phosphorylase b, 67,000 albumin, 43,000 
ovalbumin, 30,000 carbonic anhydrase, 20,100 trypsin inhibitor, 14,400 lactalbumin. 
IV.3.2 Immunoprecipitation of 35S-methionine labelled DLA antigens obtained from 
peripheral blood lymphocytes by detergent solubilization 
The molecular weight of the detergent solubilized MHC molecules is always greater 
than that of papain digested molecules, as detergent solubilizes the whole molecule, 
including the transmembrane and intracellular part. DLA molecules were pre-
cipitated from 35 S-methionine labelled, detergent solubilized cells (see section 
IV.2.4; IV.2.5, IV.2.6). 35 S-methionine incorporation was used as an alternative to 
1251 labelling as the iodination procedure modifies the tyrosine residues in the 
protein. Metabolic labelling only incorporates a radiolabelled amino acid where 
normally the same, but non-radioactive amino acid would be. 
The anti-/32m serum brings down two polypeptide chains of 41,700 and 12,000 MW 
(Fig. 3, lane b). Normal rabbit serum (lane a) precipitates a band which appears to 
be heavy chain, but in a much smaller amount than in lane b. This band could 
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Figure 3. SDS-polyacrylamide gel electrophoresis (12.5% acrylamide) of ''S-methionine labelled, 
detergent solubilized DLA antigens after immunoprecipitation with: normal rabbit serum (lane a) 
or rabbit anti-dog-,B2m serum (lanes b, c). 
lanes a,b: ;"S-methionine labelled membrane extract. 
lane c: 3-'S-methionine labelled membrane extract after lentil lectin-Sepharose purification. 
Molecular weight standards as described for Fig. 2. 
represent actin, a common contaminant of immunoprecipitates from lymphocytes 
(Barber and Delovitch, 1979). The 41,700 MW band in lane b would then be a 
mixture of actin and heavy chain. A relatively pure cell extract was used for Fig. 3, 
lane a,b, as membranes were prepared from the cells before detergent was added. 
Further purification on lentillectin-Sepharose separates actin, which appears in the 
flow-through, from the MHC antigen heavy chains. A lentil lectin purified antigen 
preparation and the anti-/3 2m serum were used for the precipitation· in lane c. The 
same two bands as in lane b are visible. 
In order to distinguish between an intracellular and an extracellular location of the 
DLA antigens experiments were done using intact cells rather than cell extracts for 
the incubation with anti-/32m serum. 
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IV.3.3. Immunoprecipitation of 125/ labelled DLA antigens from intact peripheral 
blood lymphocytes reacted with antiserum before detergent solubilization 
Both lactoperoxidase-catalysed iodination and incubation of intact cells with 
antiserum are ways of demonstrating the presence or absence of proteins on the 
outside of the cell membrane. 125! labelled peripheral blood lymphocytes were 
incubated with anti-/32m serum (see section IV.2.4 and IV.2.6) and solubilized 
afterwards. In Fig. 4 lane b the resulting gel pattern is shown. Here again, two 
polypeptide chains of 41,700 and 12,000 daltons are visible. Normal rabbit serum 
(lane a) did not precipitate any material. 
94K 
_ 67K 
- 30K 
- 20.1K 
- 14.4 K 
a b 
Figure 4. SDS-polyacrylamide gel electrophoresis (12.5% acrylamide) of 12 '1 labelled, detergent 
solubilized DLA antigens after incubation of the intact cells with: normal rabbit serum (lane a) or 
rabbit anti-dog-/32m serum (lane b). 
Molecular weight standards as described for Fig. 2. 
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IV .3.4 Inhibition of immunoprecipitation 
The reaction of anti-j3 2m serum with intact peripheral blood lymphocytes was 
inhibited by purified {32m. After detergent solubilization and reaction with Staph A 
no DLA antigens could be detected by SDS-polyacrylamide gel electrophoresis. 
The method of inhibition ofimmunoprecipitation is shown in Fig. 1 b (p. 67). The gel 
is pictured in Fig. 5. In lane a undiluted antiserum was used and the resulting pattern 
contains two major bands of 43,000 and 12,000 daltons. Actin and the heavy chain 
have fused to form one broad band. In lanes b andc no light chain is observed at all, 
and in the heavy chain area only actin remains. Dilution of the anti-j3 2rn serum l/3 
and 119 with purified /32m (IV.2.7) inhibited immunoprecipitation completely. 
Control dilutions in ovalbumin (lanes d and e) did not have this effect. 
Another way to show that the anti-{3 2m serum precipitates two-chain molecules by 
reacting with one chain is to incubate the serum with separated light and heavy 
chains. 
46k-
_he 
30k 
I 
18.4k -
12.3k- -
a b c 
Figure 5. SDS-polyacrylamide gel electrophoresis (7.5-!SCJo linear gradient gel) of -''S-methionine 
labelled, detergent solubilized DLA antigens after incubation of the intact cells with: rabbit 
anti-dog-,Bc_m serum (lane a), rabbit anti-dog-/32m serum diluted 1/3 and 1/9 with a solution of purified 
f3 2m (lanes b,c) or rabb1t ant1-dog-/32m serum diluted 1/3 and 119 with a solution of ovalbumin 
(lanes d,e). 
Molecular weight standards: 46,000 ovalbumin, 30,000 carbonic anhydrase, 18.367lactoglobulin A, 
12,300 cytochrome c. he: heavy chain: /3 2m: f3rmicroglobulin. 
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IV.3.5 Immunoprecipitation of denatured DLA polypeptide chains 
Anti-j32m serum was incubated with 35 S-methionine labelled detergent solubilized 
DLA antigens which had been dissociated by boiling in I% SDS (IV.2.8). Figure 6 
shows the resulting gel pattern; only the light chain is precipitated. No heavy chain 
is visible, only a faint band representing actin. This is an indication for the fact that 
the antiserum reacts with the light chain and that in the case of precipitation of 
native DLA antigens the heavy chain is merely coprecipitated. Apart from 
dissociation, 1% SDS also causes denaturation. Therefore this experiment does not 
preclude that the anti-,82m serum can react with the native heavy chain. 
- 46k 
-30 k 
18.4 k 
- 12.3 k 
Figure 6. SDS-polyacrylamide gel electrophoresis (7.5-15% linear gradient gel) of l 5S-methionine 
labelled, detergent solubilized DLA antigens after dissociation and denaturation, and subsequent 
immunoprecipitation with rabbit anti-dog-/32m serum. 
Molecular weight standards as described for Fig. 5. 
IV.3.6 NH2-terminal amino acid sequence determination, amino acid composition 
Unequivpcal proof of the identity of a protein is only given by its amino acid 
sequence. NH2-terminal sequences of the two component chains of papain 
solubilized DLA molecules were determined (IV.2.9). 
Papain solubilized, lentil lectin purified DLA molecules from several spleens were 
pooled. The heavy and light chains were separated by gel filtration in I M propionic 
acid. The light chain was obtained in sufficient quantity and purity to identify 24 
amino acids. In Fig. 7a these residues are shown, compared to the NH2-terminal 
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5 10 15 
dog 
urinary 11, m v - Q H p K Q v y s R H p A 
DLA light V/Y- Q L P/M- P/M- K V!Y- Q V/Y- V/Y- K F E P/M- A 
chain H G N/S w A A N/S H NIS 
(H7) 
(A?) 
20 
E/Q- N/D - G K p N/D - F L NID 
E N/S- G K P/M- N/S - F L NIS 
F (T?) (Q?) (A?) {P/M?) 
Figure 7a. NHrterminal amino acid sequence of DLA light chains compared to the NHrterminal 
amino acid sequence of dog urinary /3 2m (Smithies and Paulik, 1972). 
Amino acid symbols: A: alanine, R: arginine, N: asparagine, D: aspartic acid, B: asparagine and/or 
aspartic acid, C: cysteine, Q: glutamine, E: glutamic acid, Z: glutamine and/or glutamic acid, G: glycine, 
H: histidine, 1: isoleucine, L: leucine, K: lysine, M: methionine, F: phenylalanine, P: proline, S: serine, T: 
threonine, W: tryptophan, Y: tyrosine, V: valine. 
V/Y: no distinction could be made between valine and tyrosine. 
L H : the amino acid in this position can be either leucine or histidine. 
(H?): histidine cannot be excluded in this position. 
Table I. Amino acid composition of the DLA light chain compared to the amino acid compositions 
of human (Bergg:lrd and Beam, 1968) and bovine (Groves and Greenberg, 1982) {31m. 
DLA light chain* human ;32m** bovine {3 2m** 
O+N 11.5 12 II 
T 6.0 5 2 
s 7.0 lO 8 
E+Q 13.7 II 12 
p 7.5 5 9 
c 0.4 2 2 
G 5.3 3 3 
A 3.3 2 
v 5.8 7 5 
M 0.7 I 
I 3.3 5 6 
L 7.6 7 8 
y 3.1 6 6 
F 5.7 5 4 
H 3.9 4 4 
K 6.3 8 9 
w NO 2 2 
R 3.4 5 5 
NO: not determined. *: residues/100 residues 
Amino acid symbols: see Fig. 7. **: residues/molecule 
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sequence published for dog urinary /3 2m (Smithies and Paulik, 1972). Under the 
experimental conditions used no distinction could be made between respectively 
valine and tyrosine, proline and methionine, and asparagine and serine. Serine, 
threonine, histidine and arginine PTH-amino acid derivatives give relatively small 
yields on sequencing and are therefore hard to detect. The amino acid composition 
of the light chain (Table I) agrees well with the amino acid composition of human 
and bovine {3 2m. 
A double sequence was found at most positions; both possible amino acids 
appeared with nearly identical intensity. In spite of all these restrictions sufficient 
homology is found of the sequence for the light chain with that published for 
urinary /3 2m to justify the conclusion that the DLA light chain is identical to /32m. 
The heavy chain was less pure, it was estimated that only 25-30% of the reaction 
mixture consisted of heavy chain. The impurities did not interfere with the NH 2-
terminal sequence determination and they represent therefore small quantities of 
several proteins. Seven positions could be identified. In Fig. 7b these residues are 
compared with the NH2-terminal sequences of HLA-A2, HLA-B7, H-2Kb, H-2Kd, 
H-2Db and H-2Dd Homology with either one is found in 6 out of 7 positions 
determined. 
H-2Kb 
H-2Kd 
H-2Db 
H-2Dd 
HLA·A2 
HLA-87 
DLA papain 
digested 
heavy chain 
G - p 
G - p 
G - p 
G - s 
G - s 
G - s 
G- P/M 
N/S 
- H - s -
- H - s -
- H - s 
- H - s -
- H - s -
- H - s 
- P/M? - N/S 
(P/M?) 
5 
L R -Y - F - v 
L R - y - F -V 
M- R - y- F - E 
L - R - y - F - v 
M- R - y- F - F 
M- R - y- F - y 
L 
- X - X - F - V/Y 
Figure 7b. NH 2-terminal· amino acid sequence of DLA heavy chains, solubilized by papain digestion, 
compared to the NH 2-terminal amino acid sequences of H-2Kb, H-2KJ, H-201:1, H-2DJ, HLA-A2 and 
HLA-87. Data are from Nathenson et al. (1981) and Orr et al. (1979). 
P/M?: possibly proline or methionine are in this position. 
X: the amino acid in this position is not known. 
Further legends: see Fig. 7a. 
IV .4 Discussion 
An antiserum raised against urinary /3 2m has been shown to react with molecules 
far larger than /3 2m, consisting of two polypeptide chains of 12,000 and 37,000 or 
41,700 daltons according to the isolation procedure. Most anti-/32m sera in other 
species can be used in this way, but sometimes such an antiserum dissociates the two 
component chains (Nakamuro et al., 1975). With our antiserum, this did not 
happen. The 37,000/12,000 dalton molecules were precipitated from dog spleen cell 
75 
membrane preparations which had been treated with papain and purified (Fig. 2). 
A similarly prepared membrane protein had the capacity to inhibit a microlympho-
cytotoxicity test of dog peripheral blood lymphocytes and tissue typing sera 
(chapter Il.3). This protein also consisted of two polypeptide chains of 12,000 and 
37,000 MW as measured from SDS-polyacrylamide gels after staining for protein. 
The inhibition of the microlymphocytotoxicity test, which was specific, indicates 
that the isolated molecules are DLA antigens; i.e. dog MHC class I antigens. The 
fact that a similarly purified protein reacts with an anti-,B2m serum strongly 
suggests that {32m is identical to the light chain of the DLA class I antigens, as has 
been shown for the MHC class I antigens of all species so far investigated 
(references for this are given in chapter 111.1). 
The same anti-,B2m serum has been used to immunoprecipitate molecules from 
peripheral blood lymphocytes after detergent solubilization (Fig. 3). Like other 
MHC antigens, DLA antigens can be released from the cell membrane by detergent 
solubilization. The MW of the heavy chain is approximately 41,700. This is in 
accordance with data on detergent solubilized MHC class I antigens of other 
species where a molecular weight of around 43,000 daltons is found for detergent 
solubilized heavy chains, somewhat larger than the MW of the papain solubilized 
heavy chain. In the dog the difference in MW between the papain and detergent 
solubilized heavy chains is approximately 5000 daltons. 
The protein nature of the DLA antigens which had been indicated by their 
behaviour in the biochemical isolation procedure (chapter II.2) is corroborated by 
the fact that they incorporate a radiolabelled amino acid, 35 S-methionine. 
Lactoperoxidase-catalysed iodination is also a typical procedure for protein 
labelling, by which 125I becomes attached to tyrosine residues. 
DLA antigens most probably contain a carbohydrate moiety, because they are 
retained on a lentil lectin affinity column (chapter 11.2.3). Incorporation of radio-
labelled sugars as described in chapter VI is needed to confirm this. 
From the microlymphocytotoxicity test it is clear that DLA class I antigens are 
located on the outside of the cell membrane. This location is confirmed by the 
experiments described here. Lactoperoxidase-catalysed iodination of peripheral 
blood lymphocytes, incubation of the intact cells with the anti-,B2m serum and 
detergent solubilization resulted in a gel pattern (Fig. 4) similar to that obtained 
with a cell extract (Fig. 3). 35S-methionine labelled cells, which are internally 
labelled as well as externally, gave an identical result when incubated with the 
antiserum before detergent solubilization (Fig. 5). 
Thus it is shown that DLA antigens from different sources (spleen, PEL cell or 
membrane extract) isolated by different means (papain digestion or detergent 
solubilization) can be immunoprecipitated by an anti-,B2m serum. Contamination 
by actin is sometimes found in control precipitates with normal rabbit serum 
(Fig. 3). Actin can be removed from the antigen preparation by lentil lectin affinity 
chromatography. It is generally present in immunoprecipitates from peripheral 
blood lymphocytes (Barber and Delovitch, 1979). 
A clear distinction of heavy chain and actin can be obtained by analysing samples 
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on gradient gels rather than uniform gels. This type of gel has been used for the 
experiments shown in Figs. 5 and 6. The molecular weight of the DLA heavy chain 
is estimated to be 43,000 daltons on these gels. 
The assumption that the DLA light chain is identical to {32m is confirmed by the fact 
that immunoprecipitation of anti-/32m serum and detergent solubilized DLA 
antigens can be inhibited by purified {32m (Fig. 5). The determinants which are 
normall:1 recognized on DLA molecules are blocked by this urinary protein. 
More direct proof of the anti-j32m serum reacting with the light chain was obtained 
from the experiments with dissociated DLA chains. The antiserum could react with 
single, denatured light chains (Fig. 6) without reacting with the heavy chain. This 
does not preclude the possibility that the antiserum can react with the native heavy 
chain or the whole complex. It is unlikely, however, that the antiserum only reacts 
with the light chain when it is denatured and dissociated. Most probably the anti-
{32m serum normally reacts with detergent solubilized DLA molecules through the 
light chain. 
As only papain solubilized DLA antigens had been isolated on a large scale, these 
were chosen for the sequence determinations. Sequencing of small quantities of 
protein is possible, but it requires a lot of time and expense (Nathenson eta!., 1981). 
Although the DLA light chain yielded a partly double sequence, comparison with 
the sequence published for urinary dog {32m (Smithies and Poulik, 1972) showed 
that in 23 out of 24 positions sequenced, it was possible to detect the same amino 
acid both in urinary {32m and in the DLA light chain (Fig. 7a). As the light chain 
from both papain digested and detergent solubilized DLA antigens reacts with the 
same anti-,B2m serum, we can safely claim that they will be identical to each other 
and to {3 2m. Formal proof of the identity of proteins is only given by the identity of 
their amino acid sequences. For this purpose a stretch of 24 NH2-terminal amino 
acids is enough. In man, identity of the HLA light chain and urinary ,B2m was 
shown by agreement of their 16 NH 2-terminal amino acids (Bridgen eta!., 1976). 
Similar evidence has now been obtained in the dog. The amino acid composition of 
the DLA light chain is not very different from the amino acid composition 
determined for ,B2m in other species. 
The sequence of the NH 2-terminal end of the heavy chain was more difficult to 
establish. Still, 6 out of7 positions determined are identical to the amino acids in the 
corresponding positions of HLA-A2, HLA-B7, H-2K or H-20. Comparison with 
heavy chains of other species (Nathenson eta!., 1981) shows similar homology. 
The yield of PTH-amino acids was 25-30% of the amount determined by analysis of 
the amino acid composition. The identity of the contaminating material is not clear. 
In addition to the NH 2-terminal glycine, at least four other NH 2-terminal amino 
acids were present. As the preparation was purified by lentil lectin chromato-
graphy, it is unlikely that actin is still there. The NH2-terminal end of the MHC class 
I molecules investigated so far is not a region of great variability. Although DLA 
molecules of different tissue-type ':"'ere pooled for the sequence determination they 
are expected to have similar NH2-terminal ends, and they would therefore not 
contribute to the variety of amino acids detected. The presence of previously 
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undetected DLA class I or class IV antigens cannot be excluded. The heavy chains 
of class IV antigens have a molecular weight very close to that of the class I heavy 
chain (Michaelson et al., I977, Vitetta et al., 1976). Although DLA heavy chain was 
estimated to be only 25-30% of the reaction mixture, the 7 positions determined 
were clearly detected above the background of amino acids from contaminating 
proteins. 
All in all these amino acid sequence data are sufficient reason for us to believe that 
we are indeed working with DLA antigens, and that these DLA antigens can be 
isolated by immunoprecipitation with an anti-/32m serum. 
The two chain structure of DLA antigens precipitated with anti-light chain 
serum has to be confirmed by using antisera directed against the heavy chain 
(chapter V). An advantage of the technique used is that little material is needed 
which can be screened with small amounts of antiserum. The" immunoprecipitation 
technique is further used for an investigation into the nature of the alloantigenic 
determinant(s) of the DLA antigens (chapters VI, VII). 
In conclusion: DLA antigens can be solubilized by detergent. They consist of two 
polypeptide chains of 41,700 and 12,000 daltons. The light chain is identical to {3 2m. 
DLA class I antigens are located on the outside of the cell membrane. Preliminary 
amino acid sequence data point to homology of DLA antigens with HLA and H-2 
antigens. 
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CHAPTER V 
CHARACTERIZATION OF DLA CLASS I ANTIGENS BY 
IMMUNOCHEMICAL TECHNIQUES USING ANTISERA DIRECTED 
AGAINST THE HEAVY CHAIN 
V.l Introduction 
In chapter IV experiments were described which formed the basis of the 
investigations reported here. It was established that DLA antigens could be 
solubilized from the cell membrane by detergent and that they could be 
immunoprecipitated with an anti-/32m serum. This antiserum is directed against the 
light chain of the DLA antigens, and the heavy chain is co-precipitated. After 
dissociation of the two chains in 1% SDS, the anti- {32m serum only precipitated the 
light chain. 
If /32m and the heavy chain are really associated, immunoprecipitation with anti-
heavy chain antisera should also yield two chains. In this case the light chain would 
be co-precipitated with the heavy chain. There are two types of anti-heavy chain 
antisera. One type is monomorphic, or "anti-backbone", i.e. directed against an 
invariable part of the heavy chain. The other type is polymorphic, directed against 
the alloantigenic determinant. Tissue typing sera, or "allo"-antisera belong to the 
latter category. Monomorphic anti-heavy chain sera should react with DLA 
antigens of all specificities, just like (monomorphic) anti-,B2m serum. Alloantisera 
only react with DLA antigens of the corresponding tissue-type. In order to exclude 
the possibility that the determinant recognized by the anti-heavy chain sera is 
located on the light chain, inhibition of immunoprecipitation by purified urinary 
,B2m was tested. 
The location of the DLA antigens on the cell surface was confirmed by the same 
experiments as those described in chapter IV, using anti-heavy chain sera instead of 
anti-,B2m serum. 
With the two types of anti-heavy chain serum it is possible to perform sequential 
immunoprecipitations. When a cell extract is first incubated with an anti-backbone 
serum, no further DLA antigens can be precipitated in a second round by 
alloantisera. When the experiment is done the other way around, the second 
precipitation does yield DLA antigens. Sequential immunoprecipitation can also 
be done with alloantisera directed against products of different loci, as a way to 
prove that these products are indeed located on different molecules. This technique 
has been employed to distinguish H-2K from H-20 glycoproteins (Nathenson and 
Cullen, 1974) and to identify two different rat class I loci (Natori et al., 1979). 
Alloantisera are difficult to work with in the immunoprecipitation technique. Their 
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titre is generally low and their binding weak. Only in the mouse have they been 
applied successfully (Schwartz et al., 1973). In the mouse, however, it is possible to 
raise hyperimmune sera because of the availability of congenic and recombinant 
mice. One of the many dog alloantisera tested could be used to immunoprecipitate 
DLA antigens. 
In this chapter DLA immunoprecipitation patterns obtained with one monomor-
phic and one polymorphic antiserum are described. 
V.2 Materials and methods 
V.2.1 Antisera 
Normal rabbit serum, rabbit anti-,B2m serum and goat anti-rabbit-IgG serum were 
as described in chapter IV.2.1. The preparation of the anti-heavy chain backbone 
(anti-HC) antiserum was carried out using DLA antigens isolated by papain 
digestion (chapter !!.2). After partial purification, the DLA antigens were 
lyophilized and passed over a Sepharose-lentillectin column (Pharmacia, Uppsala, 
Sweden). Lyophilization dissociates the two polypeptide chains. Lentil lectin does 
not have affinity for {3 2m, so the heavy DLA chain could be obtained from the 
eluate of the lentil lectin column whereas {3 2m was not retained by the column. 
Two rabbits were immunized. A quantity of0.5 ml of I mg/ml DLA heavy chain in 
0.15 M NaCl was emulsified with 0.5 ml of complete Freund's adjuvant (Difco, 
Detroit, MI, U.S.A.). It was injected subcutaneously at five sites on the back. Four 
boosts, every two weeks, were given with the same amount of antigen emulsified in 
0.5 ml of incomplete Freund's adjuvant. The titre of the antiserum was determined 
in the ELISA as described in chapter III.2.4. 
Normal dog serum was a pool of serum from non-immunized dogs. Rabbit anti-
dog-IgG was obtained from Miles, Slough, England. Alloantiserum 1302 was 
prepared as described (V riesendorp et al., 1971 ). It was characterized in the second 
workshop on canine immunogenetics (Joint report, 1976). It reacts with DLA-Cll 
and it cross-reacts with DLA-A2 and DLA-85. 
V.2.2 Immunoprecipitation of radiolabe!led DLA antigens from spleen cells 
Radiolabelled DLA antigens from spleen cells were prepared as described in 
chapter IV.2.2. The immunoprecipitation with anti-HC serum was done as 
described for anti-,B2m serum in chapter IV.2.3. 
V.2.3 Immunoprecipitation of radiolabe!led DLA antigens from peripheral blood 
lymphocytes 
Peripheral blood lymphocytes were labelled with 35 S-methionine as described in 
chapte·r fV.2.4. For some experiments antigens were prepared from membranes 
(chapter IV.2.5), for others a direct cell extract was made in lysis buffer (chapter 
IV.2. 7). Immunoprecipitation with the anti-HC serum was done with intact cells 
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and membrane extracts (chapter IV.2.6). Inhibition of immunoprecipitation by 
purified urinary (3 2m and immunoprecipitation of denatured DLA polypeptide 
chains were performed as described before (chapter IV.2.7 and IV.2.8). 
V.2.4 Immunopreczpitation of radio/abe/led DLA antigens from perzpheral blood 
lymphocytes by alloantisera 
Peripheral blood lymphocytes were labelled with 35S-methionine as described in 
chapter IV.2.4. A direct cell extract was made in lysis buffer (chapter IV.2.7). 
Precipitation was done as described in chapter IV.2.7 with modifications. The cell 
extract was made to 0.1% SDS. Preclearing was done twice with 5 .ul rabbit anti-
dog-lgG and 100 1ll Staph A per 2 X 106 cell equivalents. After preclearing the 
antigen preparation was centrifuged for 30 minutes at 100,000 X g and 4°C in a 
Beckman airfuge. Specific incubations were performed with 10 111 alloantiserum 
and 100 1'1 Staph A per 2 X 106 cell equivalents, for 90 minutes on ice. The immune 
complex bearing Staph A were washed as described. All buffers contained 0.1% 
SDS. Elution was according to Dobberstein eta!. (1979). As alloantisera require a 
modification of the usual method, where preclearing is important, all tests were 
done with cell extracts rather than with intact cells, where pre clearing is impossible. 
Therefore, inhibition of immunoprecipitation with urinary {3 2m was also done 
using precleared cell extracts. The alloantiserum, an<! anti-/32m serum as a control, 
were incubated for 16 hours at 4°C with dilutions of urinary {3 2m or ovalbumin as 
described in chapter IV.2.7. For immunoprecipitation 10 ,ul of antiserum dilution 
was used per 106 cell equivalents. Immune complexes were reacted with 100 ,ul 
Staph A per incubation. Washing and elution were as described (chapter IV.2.7). 
V.2.5 Sequential immunoprecipitation 
Aliquots of 106 cell equivalents were precleared twice with the same antiserum and 
then reacted with a different antiserum, or with the first one as a control. 
Immunoprecipitations were done as described previously (chapter IV.2.7). 
V.2.6 Platelet absorption of antisera 
Platelets were prepared from beagle blood collected in anticoagulant citrate glucose 
solution. For the absorptions, 10 10 thrombocytes were incubated with 1 ml of 
antiserum for 1 hour at room temperature. Thereafter 1 ml of fresh antiserum was 
incubated with the same thrombocytes. Elution was done with 1.0 ml 0.5 M glycine 
pH 3.0, I% BSA. The eluates were neutralized and they were stored at -20°C until 
use. 
V.2.7 Gel electrophoresis 
Samples were analysed on 10 X 14 X 0.1 em, 12.5% acrylamide gels (Laemmli, 
1970) or on 7.5-15% linear gradient gels in the system of Dobberstein eta!. (1979). 
Fluorography was done according to Bonner and Laskey (1974). Marker proteins 
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are listed in the relevant figure legends. All chemicals for electrophoresis were from 
Bio-Rad, Richmond, CA, U.S.A. 14C-labelled marker proteins were obtained from 
NEN, Dreieich, F.R.G. 
V.3 Results 
In Fig. 1 a summary is given of the methods used for the studies described in this 
chapter. 
The anti-HC serum reacted with DLA antigens both from spleens and from 
peripheral blood lymphocytes (V.3.1-V.3.3). 
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Figure 1. Summary of the immunoprecipitation schedules used. 
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V.3.1 Immunoprecipitation of 125 I labelled DLA antigens obtained from spleen cells 
by papain digestion 
In Fig. 2 an analysis is shown of the immunoprecipitation of papain solubilized 
DLA antigens with the anti-HC serum. As a reference the anti-,82m precipitation 
pattern is also given (lane a). The proteins recognized by lhe anti-HC serum appear 
in four major bands of39,000, 37,000, 19,000 and 12,000 daltons (lane b). The anti-
/32m serum precipitated polypeptide chains of 37,000 and 12,000 daltons. The 
material used for immunization may have contained the 39,000 and 19,000 MW 
products although they were not detectable on SDS-polyacrylamide gels after 
Coomassie Brilliant Blue staining. A diffuse band of a MW of approximately 
30,000, which is also visible in the precipitate by the anti-HC serum, could represent 
a breakdown product of the heavy chain or the dog equivalent of the class II 
antigens. Products of this MHC region are retained by lentil lectin and could have 
been present in the preparation used for immunization and in the labelled 
preparation. The possible identity of the 39,000,30,000 and 19,000 MW molecules 
is further considered in the discussion (V.4). 
94K 
67K 
- 43K 
-30K 
-20~K 
-
,.. -14.4K 
a b 
Figure 2. SDS-polyacrylamide gel electrophoresis (12.5% acrylamide) of 1251 labelled, papain solu-
bilized DLA antigens after immunoprecipitation with: rabbit anti-dog-,B2m serum (lane a) or rabbit anti-
He serum (lane b). Molecular weight standards: 94,000 phosphorylase b, 67,000 albumin, 43,000 
ovalbumin, 30,000 carbonic anhydrase, 20,100 trypsin inhibitor, 14,400 lactalbumin. 
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V.3.2 Immunoprecipitation of 35S-methionine labelled DLA antigens obtained from 
peripheral blood lymphocytes by detergent solubilization 
A membrane extract was used as a source of DLA antigens for precipitation with 
the anti-HC serum. From Fig. 3 it is clear that the anti-HC serum, which was raised 
against papain solubilized heavy chains of 37,000 MW, can also react with 
detergent solubilized heavy chains of 41,700 MW (lane a). The anti-jl2m serum 
pattern is shown for comparison (lane b). Bands of 30,000-39,000 MW are present 
again sinlilar to those precipitated from spleen-derived DLA antigen preparations. 
94k 
67k 
43k -
30k -
20.1k -
14.4k -
a b 
Figure 3. SDS-polyacrylamide gel electrophoresis (12.5% acrylamide) of 35 S-methionine labelled, 
detergent solubilized DLA antigens after immunoprecipitation with: rabbit anti-HC serum (lane a) or 
rabbit ,anti-dog-/32m serum (lane b). Molecular weight standards as described for Fig. 2. 
V.3.3 Immunoprecipitation of 35 S-methionine labelled DLA antigens from intact 
peripheral blood lymphocytes reacted with antiserum before detergent solubilization 
In order to confirm the cell surface location of the DLA antigens, lymphocytes were 
incubated with the anti-HC serum prior to detergent solubilization. It was 
attempted to inhibit the reaction between DLA antigens and the anti-HC serum 
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Figure 4. SDS-polyacrylamide gel electrophoresis (7.5-15% linear gradient gel) of 35 S-methionine 
labelled, detergent solubilized DLA antigens after incubation of the intact cells with: rabbit anti-
HC serum (lane a), rabbit anti-HC serum diluted 1/3 and l/9 with a solution of purified /3 2m 
(lanes b,c) or rabbit anti-HC serum diluted 113 and 1/9 with a solution of ovalbumin (lanes d,e). 
Molecular weight standards: 46,000 ovalbumin, 30,000 carbonic anhydrase, 18,367 lactoglobulin A, 
12,300 cytochrome c. he: heavy chain, /3 2m: {32-microglobulin. 
with urinary {32m, to exclude the possibility that the anti-HC serum recognizes light 
chain determinants. Similar experiments have been described in chapter IV, where 
the reaction of anti-,82m serum with DLA antigens was inhibited by urinary {32m 
(chapter IV, Fig. lb, 5). Figure 4 represents the gradient gel to which the various 
samples have been applied. Lane a shows the pattern obtained with undiluted anti-
HC serum. The two DLA polypeptide chains are present, as well as intermediate 
bands of 34,000 and 37,000 MW. Urinary {32m inhibits the reaction slightly 
(compare lane b with lane d). The anti-{32m serum was inhibited completely with the 
same amount of urinary {32m (chapter IV, Fig. 5). So, althol!gh the anti-HC serum 
may have some anti-light chain activity, it seems to react mainly with the heavy 
chain. Immunoprecipitation of denatured and dissociated DLA antigens with the 
anti-HC serum did not yield a specific band (results not shown). Unlike the anti-
{32m serum, the anti-HC serum is not able to react with its determinants after 
denaturation of the antigen. 
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V.3.4 Immunoprecipitation of detergent solubilized 35 S-methionine labelled DLA 
antigens by purified anti-HC serum 
One way to render the anti-HC serum more specific for DLA class I antigens was to 
absorb it onto thrombocytes and to elute the reacting antibodies from the thrombo-
cytes afterwards. As reported by Colombani et al. in 1976, thrombocytes do not 
carry class II antigens. Therefore, antisera can be rendered class II specific by 
absorption with thrombocytes. We wanted to render the antiserum specific for class 
I antigens, so rather than using the absorbed serum we isolated the antibodies that 
had reacted with the thrombocytes and used those. Both the anti-,B 2m serum and 
the anti-HC serum were tested after absorption onto and elution from thrombocy-
tes. In Fig. 5 both antisera give exactly the same pattern; a heavy chain with slight 
heterogeneity and the light chain. No intermediate bands of appreciable intensity 
are present. 
46k .. 
.. _he 
30k 
18,4k 
12.3k 
a b 
Figure 5. SDS-polyacrylamide gel electrophoresis (7.5-15% linear gradient gel) of 35$-methionine 
labelled, detergent solubilized DLA antigens after immunoprecipitation with: rabbit anti-dog-/32m 
serum purified by absorption onto and elution from thrombocytes (lane a) or rabbit anti-HC serum 
purified by absorption onto and elution from thrombocytes (lane b). Molecular weight standards as 
described for Fig. 4. he: heavy chain, /32 m: /3 2-microglobulin. 
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V.3.5 Immunoprecipitation of detergent solubilized 35S-methionine labelled DLA 
antigens by alloantisera 
Of the available alloantisera, many were tested for activity in the immunoprecipita-
tion technique. Those sera of all specificities which gave the best results in the one-
or two-stage microlymphocytotoxicity test were tested. These were the strongest 
and most specific alloantisera. They were used untreated, or absorbed with 
erythrocytes or mismatched PBL. As a source of DLA antigens cell extracts, 
membrane extracts or lentil lectin purified membrane extracts were employed. The 
final procedure is described in V.2.4. One antiserum precipitated polypeptide 
chains of a MW comparable to those precipitated by the anti-132m serum (Fig. 6, 
compare lane d with lane b). Microheterogeneity of the heavy chain is clearly visible 
and the heavy chain precipitated by the alloantiserum is slightly different from that 
precipitated by the anti-,82m serum. No other alloantiserum gave this pattern. 
Examples are shown in lane e and f. Absorption onto and elution from 
- 46 
>< 
- 30 
18.4 
12.3 
a b c d e f 
Figure 6. SDS-polyacrylamide gel electrophoresis (7.5-15% linear gradient gel) of "S-methionine 
labelled, detergent solubilized dog peripheral blood lymphocyte membrane antigens after immuno-
precipitation with: normal rabbit serum (lane a), rabbit anti-dog-/32m serum (lane b), normal dog serum 
(lane c), alloantiserum 1302, anti-DLA-Cll (lane d), alloantiserum 057, anti-DLA-Cl2 (lane e) or 
alloantiserum 5453, anti-DLA-B4 (lane f). Molecular weight standards as described for Fig. 4. he: heavy 
chain, /3 2m: 13rmicroglobulin. 
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Figure 7. SDS-polyacrylamide gel electrophoresis (7.5-15% linear gradient gel) of 35 S-methionine 
labelled, detergent solubilized DLA antigens after immunoprecipitation with: rabbit anti-dog-.B2m 
serum diluted l/3 and I/9 with a solution of purified /3 2m (lanes a,b ), rabbit anti-dog-/32m serum diluted 
J/3 and 119 with a solution of ovalbumin (lanes c,d) or alloantiserum 1302 diluted 1/3 and 119 with a 
solution of purified {32m (lanes e,f). Molecular weight standards as described for Fig. 4. he: heavy chain, 
/3 2m: ,82-microglobulin. 
thrombocytes, as performed with the anti-HC serum, could not be employed as it 
resulted in loss of all antiserum activity. 
The DLA antigens precipitated by alloantiserum 1302 (anti-DLA-Cll) were 
from a dog typed as A9,B6,Cl2/ A2,B4,Cll. No precipitate was found after 
reaction of the antiserum with DLA antigens from two control dogs homozygous 
for A9,B6,Cl2 and A9,B4,Cl2, respectively (results not shown). 
The immunoprecipitation of DLA antigens by the alloantiserum could not be 
inhibited by urinary /32m (Fig. 7). As a control the inhibition of the anti-/32m serum 
by urinary /32m is shown. The anti-/32m serum diluted 1/3 and 1/9 with a solution of 
ovalbumin (lanes c and d) can precipitate DLA class I antigens; bands of 43,000 and 
12,000 MW are clearly visible. The same antiserum diluted 1/3 and 1/9 in a solution 
of urinary {32m, however, no longer precipitates similar amounts of 43,000 and 
12,000 MW polypeptide chains (lanes a and b). The light chain is far less intense and 
the heavy chain is no longer visible. When the alloantiserum was diluted in the same 
amount of urinary {3 2m, it was still capable of precipitating DLA heavy and light 
chains (compare lanes e,f with lanes a,b). 
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Sequential immunoprecipitations were performed with different combinations of 
antisera. The anti-/32m serum could still precipitate DLA antigens after preclearing 
twice with the alloantiserum or normal rabbit serum, but not after preclearing with 
anti-j32 m serum. The alloantiserum could only precipitate DLA antigens after 
preclearing with normal rabbit serum; preclearing with an appropriate alloanti-
serum or anti-,B2m serum had removed all DLA antigens reactive with serum 1302 
(results not shown). 
V.4 Discussion 
The main object we pursued in the investigations presented here was to confirm the 
two chain structure of the DLA antigens. If all experiments performed with the 
anti-/32m (anti-light chain) serum could be repeated with anti-heavy chain sera this 
would be firm evidence for the structure of D LA antigens being the same as that of 
MHC antigens of other species. As experiments with alloantisera turned out to be 
difficult, we started with raising an antiserum against papain solubilized heavy 
chains in rabbits. This type of immunization was expected to result in a strong anti-
heavy chain backbone (anti-HC) serum. 
Firstly, papain solubilized DLA antigens, similar to those used for immunization 
but now consisting of both chains, were radiolabelled and incubated with the 
antiserum. The antiserum precipitated DLA heavy and light chains, like the anti-
,62m serum, but it recognized extra proteins of MW 19,000, 30,000 and 39,000 
(Fig. 2). 
The anti-HC serum could also recognize detergent solubilized DLA antigens. The 
papain solubilized heavy chain, against which the antiserum was raised, comprises 
the largest part of the extracellular portion of the DLA antigens. Therefore it was 
not surprising that the antiserum would also precipitate detergent solubilized DLA 
antigens. 
From detergent solubilized membrane molecules, the anti-HC serum precipitated 
extra polypeptide chains, too, of30,000-39,000 daltons (Fig. 3). Even when the anti-
HC serum was incubated with intact cells did extra bands appear (34,000 and 
37,000 daltons; Fig. 4). 
The 39,000 MW band (Fig. 2) could be an early cleavage product of papain. as has 
been shown for HLA (Springer, 1974). In the HLA molecule, however, this papain 
cleavage site is located intracellularly and it is only detected·after papain digestion 
of detergent solubilized molecules. If the 39,000 MW band would represent a 
similar product in the dog, there would have to be two papain cleavage sites 
extracellularly. If the 39,000 MW polypeptide chain is indeed an early cleavage 
product it remains unexplained that the anti-/3 2m serum does not precipitate it. 
The bands of MW other than 37,000 and 12,000 (Fig. 2) or 41,700 and 12,000 
(Fig. 3) could all be breakdown products of DLA antigens. For the molecules of 
34,000 MW and 37,000 MW (Fig. 3) this is unlikely, however, as they were also 
demonstrated on intact cells (Fig. 4). We consider it more likely that some of them 
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represent the dog equivalent of the class II antigens. There are no dog class II 
specific antisera and the purification of B cells is difficult in the dog (Krakowka and 
Guyot, 1977), so it is difficult to investigate this further. The obervation that after 
absorption onto and elution from thrombocytes the anti-HC serum no longer 
contains antibodies reacting to the ''extra" polypeptide chains indicates that some 
of them are class II antigens (Fig. 5). Immunoprecipitation with the absorbedanti-
HC serum should yield the missing products again. 
Preliminary experiments were done with pokeweed mitogen or Staphylococcal 
protein A stimulated cells. Immunoprecipitation of membrane antigens from these 
with the anti-HC serum did not selectively enhance the class 11-like bands. Still, 
Staphylococcal protein A could be useful as in the dog it behaves differently from 
PHA, a typical T cell mitogen (Betton et al., 1980). 
The smallest protein which was recognized by the anti-HC serum and not by the 
anti-j32m serum has a MW of 19,000 daltons, identical to T3, a molecule defined by 
van Agthoven et al. (1981 ). It could also be a breakdown product of the DLA class I 
antigens. It was only detected in spleen cell _preparations after papain digestion; on 
PBL membranes or in detergent solubilized PBL extracts it was not found. This 
would argue against homology with T3. The fact that in addition to class I antigens, 
other chains were precipitated, could mean that the heavy chain preparation used 
for immunization contained small amounts of other proteins. The heavy chain 
preparation was only pure as far as it could be judged from Coomassie Brilliant 
Blue stained SDS-polyacrylamide gels. 
Further evidence for the two chain structure of the DLA antigens was given by 
immunoprecipitation with alloantiserum 1302. This serum is used for typing and 
must therefore be directed against the alloantigenic determinant on the heavy 
chain. The gel pattern obtained with this serum consisted of two polypeptide chains 
of 43,000 and 12,000 MW, just like that of the anti-/32m serum (Fig. 6). The MW of 
41,700 for the heavy chain was found on 12.5% gels (Figs. 2, 3); on gradient gels the 
MW seems somewhat larger,. SDS-PAGE is not an ideal method for MW 
determination. Some heterogeneity was observed in the heavy chain. This could be 
due to differences in amount of sialic acid; it is further discussed in chapter VI.4. 
Control experiments to confirm that both types of anti-heavy chain sera recognized 
determinants on the heavy chain and not on the light chain were done by diluting 
the antisera with urinary {3 2m. Immunoprecipitation of DLA antigens by anti-
heavy chain sera was not inhibited much by /32m (Figs. 4, 7), as opposed to immune-
precipitation by the anti-/32m serum. DLA heavy chains, separated from the light 
chain by lyophilization, should be radiolabelled and used for immunoprecipitation 
by the anti-HC serum. It would then become clear whether the anti-HC serum is 
truly anti-heavy chain. 
The anti-HC serum could not react with the dissociated denatured heavy chain (or 
light chain). It probably needs the native heavy chain conformation for reaction. It 
is difficult to obtain dissociated native heavy chains. Nakamuro et al. (1975) have 
described an anti-human-/32m serum with which they can dissociate the two HLA 
chains without loss of alloantigenic activity of the heavy chain, but in most studies 
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this has not been found to be possible. The DLA heavy chain preparation with 
which we raised the anti-HC serum contained impurities. For this reason no 
attempt was made to inhibit the reaction between the anti-heavy chain sera and 
DLA antigens by isolated heavy chains. For the same reason we did not prove by 
immunoprecipitation that alloantiserum 1302 is directed against the heavy chain 
only. 
The location of DLA antigens on the cell surface was confirmed in that anti-HC 
serum could react with DLA antigens on intact cells (Fig. 4). 
Sequential immunoprecipitation experiments confirmed that alloantiserum 1302 
reacts with some DLA antigens (DLA-Cll) whereas anti-.B2m serum reacts with all, 
or certainly more, DLA antigens. As only one alloantiserum could be used in the 
immunoprecipitation experiments, no further investigation into the DLA antigens 
from different loci or alleles could be performed. 
In conclusion: The two chain structure and cell surface location of the DLA 
antigens were confirmed by experiments with antisera directed against the heavy 
chain. The anti-heavy chain serum prepared after immunization with papain 
solubilized heavy chain may contain antibodies against class II antigens. 
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CHAPTER VI 
DLA CLASS I ANTIGENS CONTAIN A CARBOHYDRATE MOIETY 
VI.l Introduction 
One of the most striking characteristics of the products of the MHC is their extreme 
polymorphism. The alloantigenic site(s) can in theory be protein, carbohydrate or 
both in nature, as the MHC antigens are glycoproteins. The contribution of 
carbohydrate to the antigenic activity of DLA antigens is unclear. It has not even 
been firmly established that DLA antigens contain a carbohydrate group. 
Carbohydrate analysis of H-2 (Shimada and Nathenson, 1969) and HLA class I 
antigens (Mann et al., 1969) has revealed that they contain about 90% protein and 
10% carbohydrate. H-2 antigens include two heterosaccharide chains per molecule 
(Nathenson and Muramatsu, 1971) whereas HLA antigens have one sugar chain 
(Strominger et al., 1981). Both are sugar chains of the complex form, and therefore 
susceptible to cleavage by endo-,B-N-acetylglucosaminidase D from Diplococcus 
pneumoniae (Muramatsu, 1971). HLA and H-2 class I antigens have been 
synthesized by cells in the presence of tunicamycin, an inhibitor of N-linked 
glycosylation (Kuo and Lam pen, 1974). The molecular weight of the HLA andH-2 
heavy chain synthesized in these circumstances is slightly lower than that observed 
in control cases without tunicamycin. Therefore the HLA and H-2 class I antigens 
must contain N-linked oligosaccharides (Dobberstein et al., 1979, Ploegh et al., 
1981). 
The only indication that DLA antigens may contain a carbohydrate group is the 
fact that DLA antigens, like H-2 (Kvist et al., 1977) and HLA (Snary et al., 1974) 
antigens, can be isolated from a relatively crude membrane preparation by lentil 
lectin affinity chromatography (van der Feltz et al., 1981 and Chapter 11.3). Lentil 
lectin has specificity for a-D-glucose and o:-D-mannose residues, and DLA 
antigens can be eluted from lentil lectin with 2.5% a-methyl-0-mannoside. 
In this chapter some more direct evidence for the presence of a carbohydrate chain 
in DLA antigens is presented. PHA-stimulated peripheral blood lymphocytes were 
grown in the presence of 3H-fucose, and immunoprecipitation of cell lysate proteins 
was performed with a rabbit anti-dog-,82m serum. DLA antigens were also 
radiolabelled in their protein moiety in the presence or absence oftunicamyoin and 
analysed for possible changes in the molecular weight of the heavy chain. 
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VI.2 Materials and methods 
VI.2.1 Preparation of 3 H-fucose labelled cell extracts 
Peripheral blood lymphocytes from beagles were isolated from heparinized blood 
by centrifugation on Ficoll Isopaque. PHA stimulation was carried out for 72 or96 
hours in a 5% C02 humidified atmosphere at 37°C. PHA-M (Difco, Detroit, Ml, 
U.S.A.), final dilution of 1/360 out of a stock solution of 1% in 0.85% saline, was 
added to 106 cells per ml in RPM! 1640 medium supplemented with glutamine, final 
concentration 2 mM, penicillin and streptomycin, final concentration 50 U/ml and 
50 !Lglml (all from Gibco Europe, Paisley, Scotland) and 10% normal dog serum. 
Just before labelling, the percentage of lymphoblasts was determined (generally 
about 90%) and the viability was checked by trypan blue exclusion (usually the 
viability was around 90% as well). The cells were washed and resuspended at 106 
cells/ml in RPM! 1640 supplemented with glutamine, penicillin and streptomycin, 
and 10% dialyzed foetal calf serum (Gibco Europe, Paisley, Scotland). 3H-fucose 
was added (Amersham International pic, Amersham, England), 50 fLCi to 107 cells. 
The cultures were incubated for 16 hours at 37°C in the C02 incubator. Either 
whole cells or membranes (see IV.2.5), prepared from celllysates, were solubilized 
for 30 minutes on ice by a non-ionic detergent: 0.75% NNPlO (Servo, Delden, the 
Netherlands) in phosphate buffered saline, containing 0.125% EDTA and 0.02% 
NaN3• After solubilization, the preparations were centrifuged in a Beckman airfuge 
at 100,000 X g for 60 minutes at 4°C. The supernatant contained the solubilized 
membrane proteins. 
VI.2.2 Preparation of35 S-methionine labelled cell extracts in the presence or absence 
of tunicamycin 
Lymphocytes were purified and stimulated with PHA-M as described above. After 
3.5 days of PHA-stimulation cells were spun down and resuspended at 6 X 106 
cells/ml in RPM! 1640 without methionine (Gibco Europe Select-Amine kit) 
supplemented with glutamine, penicillin and streptomycin, and 10% foetal calf 
serum. One half of each culture was preincubated with 3 ,ug/ml tunicamycin 
(Calbiochem-Behring Corp., La Jolla, CA, U.S.A.) for one hour at 37°C, 5% C0 2; 
the other half was preincubated without tunicamycin. After one hour, 35 S-
methionine was added (Amersham International plc, Amersham, specific activity 
800-1100 Ci/mMol), 100 fLCi per3 ml culture, for a total of8 hours. Thereafter cells 
were spun down and solubilized in 0.5 mllysis buffer per culture. This lysis buffer 
consisted of 0.5% NP-40 (Sigma Chemical Co., St. Louis, MO, U.S.A.) in 0.01 M 
Tris-HCI pH 7.3, 0.005 M MgCI2 , 0.02 M NaCI and 0.001 M PMSF). After 30 
minutes on ice lysates were centrifuged at 16,000 X gin an Eppendorf centrifuge for 
15 minutes at 4°C. The supernatant contained the solubilized membrane proteins. 
VI.2.3 Antisera and immunoprecipitation 
A rabbit anti-dog-/32m serum was prepared as described (chapter [[1.2.3). As a 
95 
control, normal rabbit serum was used. For the 3H-fucose labelled cell extracts the 
procedure was as follows: Sepharose-protein A (Pharmacia, Uppsala, Sweden) was 
used as an immunoadsorbent in a 10% (w/v) suspension. All incubations were 
carried out at room temperature. Of the 3H-fucose labelled molecules, 5 X 106 cell 
equivalents were incubated with either 50 ,ul normal rabbit serum or 50 ,ul anti-/32m 
serum, which had previously been reacted for 30 minutes with ·a tenfold volume of 
Sepharose-protein A solution. The incubation of solubilized membrane proteins 
with Sepharose-protein A-attached antiserum took 60 minutes. After this incuba-
tion, the Sepharose-protein A beads, now carrying immune complexes, were 
washed thoroughly with each of the following buffers: twice with 0.5 M Tris-HCl 
pH 8.0, 1% NNPlO, twice with 0.01 M Tris-HCl pH 8.0, 0.1% NNPlO, and twice 
with 0.01 M Tris-HCl pH 8.0. The beads were eluted with dilute acetic acid of pH 
2.8 and the eluates were lyophilized. The 35 S-methionine labelled cell extracts were 
pretreated with normal rabbit serum (5 11l per 9 X 106 cell equivalents). As immuno-
adsorbent protein A bearing Staphylococcus aureus Cowan 1 was used in a 10% 
suspension prepared as described by Kessler (1975). Preclearing was ended by 
adding Staph A, 75 t.d per incubation, for 15 minutes on ice. After centrifugation 
the extracts were treated with 3 ,ul anti-,B2m serum per 3 X 106 cell equivalents for I 
hour on ice, and 50 ,ul Staph A for 15 minutes on ice. The immune complex carrying 
Staph A were washed and eluted as described (chapter IV.2.7). 
VI.2.4 Gel electrophoresis 
3H-fucose labelled samples were analysed on 10 X 14 X 0.1 em 12.5% polyacryl-
amide gels according to Laemmli (1970). Before application to the gel, the 
lyophilized samples (VI.2.3) were dissolved in sample buffer and boiled for 5 
minutes. 35 S-methionine labelled samples were analysed on 15 X 30 X 0.1 em, 7.5-
15% linear gradient gels according to Dobberstein et a!. (1979). Radioactive 
polypeptides were detected by fluorography (Bonner and Laskey, 1974). All 
chemicals for electrophoresis were from Bio-Rad, Richmond, CA, U.S.A. 14C-
labelled marker proteins were obtained from NEN, Dreieich, F.R.G. 
VI.3 Results 
We incubated peripheral blood lymphocytes from different tissue-typed beagles 
with 3H-fucose in order to investigate whether DLA class I antigens incorporate 
this sugar. In Fig. 1, left column, a summary of the immunoprecipitation schedule is 
shown. As a control, lymphocytes were also labelled with 35 S-methionine .. a 
procedure which is known to result in radio labelling of DLA antigens (van der 
Feltz eta!., 1982 and Chapter IV.3). After labelling, cell extracts were made and 
immunoprecipitation with anti-,B2m serum was performed. A representative 
fluorograph is presented in Fig. 2. Fig. 2a shows the heavy chain clearly labelled 
with 3H-fucose (lane a), whereas the light chain, {3 2m, is not. Identical results were 
obtained both with directly solubilized cells and with solubilized membranes. 
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Figure I. Summary of the immunoprecipitation schedules used. 
Normal rabbit serum did not precipitate the DLA molecules. For comparison an 
immunoprecipitate of anti-,82m Serum and 35S-methionine labelled antigen is 
shown in Fig. 2b. The light chain, /32m, is clearly visible. The heavy chain has 
approximately the same molecular weight as the 3H-fucose labelled heavy chain; 
about 42,000 to 44,000 daltons. 
For the investigation of the effect of tunicamycin on the synthesis of DLA class I 
antigens, tissue-typed beagles were used. If DLA antigens contain N-linked sugars, 
labelling with 3H-fucose in the presence of tunicamycin might result in unlabelled 
DLA molecules, as no sugar chain would be attached to the protein chain in these 
circumstances. The absence of a protein band cannot be positively interpreted. 
Therefore, cells were labelled with 35 S-methionine. Immunoprecipitation was 
carried out with anti-,82m serum. The methods used are summarized in Fig. 1, right 
column. In Fig. 3 immunoprecipitates of cells, grown in the presence or absence of 
tunicamyGin are shown. The whole procedure was very similar to that which 
resulted in the gel of Fig. 2b, but in Fig. 3 a linear gradient gel of larger dimensions 
was used, which affords better resolution. 
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Figure 2a. SDS-po!yacrylamide gel electrophoresis (12.5% acrylamidc) of 3H-fucose labelled DLA 
antigens after immunoprecipitation with rabbit-anti-dog-.82m serum (lane a). Molecular weight 
standards (lane b): 69,000 albumin, 46,000 ovalbumin, 30,000 carbonic anhydrase, 18,3671actoglo-
bulin A, 12,300 cytochrome c. he: heavy chain. 
Figure 2b. SDS-polyacrylamide gel electrophoresis (12.5% acrylamide) of 35 S-methionine labelled 
DLA antigens after immunoprecipitation with rabbit anti-dog-j32m serum. Molecular weight standards: 
94,000 phosphorylase b, 67,000 albumin, 43,000 ovalbumin, 30,000 carbonic anhydrase, 20,100 trypsin 
inhibitor, 14,400 lactalbumin. he: heavy chain, {3 2m: (31-microglobulin. 
A band co-migrating with the heavy chain of IgG, and actin, a common 
contaminant of immunoprecipitates from lymphocytes (Barber and Delovitch, 
1979), is present in all precipitates, including the control precipitate with normal 
rabbit serum (lane a). Two other major bands are precipitated from the celllysates 
by the anti-,B2m serum. In the case of cells grown in the absence of tunicamycin 
(lane b) they have apparent molecular weights of 43,000 and 12,000. Some 
heterogeneity of the heavy chain is observed. This could be due to different 
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Figure 3. SDS-polyacrylamide gel electrophoresis (7.5-15% linear gradient gel) of 35S-methionine 
labelled, detergent solubilized DLA antigens after immunoprecipitation with normal rabbit serum 
(lane a), or rabbit anti-dog-/3 2m serum (lanes b,c). 
lanes a,b: labelling in the absence of tunicamycin. 
lane c: labelling in the presence of tunicamycin. 
MW markers as described for Fig. 2a. 
he: heavy chain, {32m: /3 2-microglobulin. 
numbers of sialic acid moieties per heavy chain, as was shown to be the case for 
HLA antigens (Parham et al., 1974). In lane c the gel pattern of an immunopreci-
pitate from cells grown in the presence of tunicamycin is shown. The difference 
from lane b is evident. The apparent MW of the DLA heavy chain is clearly reduced 
as compared to the actin band. Almost complete inhibition of N-linked glycosyla-
tion must have occurred at the concentration of tunicamycin used (3 ,ug/ml). Two 
faint bands were found at the original MW. In both glycosylated and nongly-
cosylated heavy chains heterogeneity remains. This heterogeneity will be further 
dealt with in chapter VII. 
From the data presented here one can conclude that DLA class I antigens consist of 
a nonglycosylated light chain, {3 2m, and a heavy chain which shows heterogeneity 
and which most likely contains an N-linked carbohydrate chain. 
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VI.4 Discussion 
As fucose is a component of HLA (Strominger et al., 1981) and H-2 class I antigens 
(Nathenson and Muramatsu, 1971), this sugar was the first choice for the 
investigation of the existence of a DLA sugar residue. From Fig. 2a it is evident that 
DLA antigens can be labelled by 3H-fucose. Up till now, the only evidencefor sugar 
residues in DLA antigens came from the isolation experiments with Sepharose-
lentillectin (van der Feltz et al., 1981 and Chapter II). As lentil lectin has specificity 
for a-D-glucose and a-D-mannose residues, this meant that DLA antigens 
contained either mannose or glucose, or both. The 3H-fucose incorporation means 
that DLA antigens also contain fucose. However, the band which represents the 
heavy chain is the only one visible in the gel. The polypeptide ofMW 12,000, which 
is normally seen when D LA antigens are labelled in.their protein moiety (Fig. 2b ), is 
absent in Fig. 2a. Incorporation of radioactive sugars in HLA and H-2 antigens 
gave identical results (Cresswell et al., 1974, Nathenson and Muramatsu, 1971). 
This is not surprising, as (3 2m is devoid of carbohydrate (Berggard and Beam, 
1968). 
Tunicamycin, an inhibitor of N-linked glycosylation, can be used to investigate 
the presence and size, or number of N-linked carbohydrate chains in many types of 
glycoproteins, e.g. MHC antigens (Dobberstein et al., 1979, Ploegh et al., 1981). In 
HLA and H-2 antigens synthesized in the presence oftunicamycin the heavy chain 
has a molecular weight which is lower than that of fully glycosylated heavy chain. 
The MW change is compatible with the presence of one N-linked carbohydrate 
chain in HLA and two in H-2 antigens, as had been found earlier by glycopeptide 
analysis (Nathenson and Muramatsu, 1971, Parham et al., 1977). 0-linked 
glycosylation, which might also contribute to heterogeneity of histocompatibility 
antigens has not been found in MHC products. 
DLA antigens from cells, grown in the presence of tunicamycin have a heavy chain 
which is approximately 3000 daltons lower in MW than that observed in control 
cells. This difference in MW is of the same order of magnitude as the difference in 
MW of glycosylated and nonglycosylated HLA heavy chains analysed under 
similar circumstances (Ploegh et al., 1981). It is therefore justified to assume that 
DLA class I antigens carry one N-linked carbohydrate side chain of a size similar to 
that seen for HLA antigens. 
Limited attempts were made to show that DLA antigens would be susceptible to 
cleavage by endo-,8-N-acetylglucosaminidase D. No clearcut results were obtained. 
In the case of HLA this enzyme can remove most of the ccirbohydrate side chain 
(Parham et al., 1977). 
Susceptibility of a glycoprotein to tunicamycin means that an N-linked sugar is 
present; susceptibility to endo-,8-N-acetylglucosaminidase D means. that this sugar 
is of the complex type. Radiolabelling in the presence of tunicamycin and 
incubation with endo-/3-N-acetylglucosaminidase D are both ways of estimating 
the size and number of carbohydrate chains present in a molecule. As for DLA 
antigens, it is likely that there is one N-linked sugar chain, but whether this chain is 
of the complex type or not is uncertain. 
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Biosynthetic experiments on nonglycosylated HLA antigens (Ploegh et al., 1981) 
have shown that glycosylation does not affect the association of (3 2m and heavy 
chain. From the experiments described here it is clear that the process of glycosyla-
tion is not required for the association of DLA heavy and light chains either. The 
same has been reported for HLA, as mentioned above, H-2 (Dobberstein et al., 
1979) and OMLA (owl monkey) antigens (Parham and Ploegh, 1980). Glycosyla-
tion is not necessary for membrane insertion and transport to the plasma 
membrane ofHLA (Ploegh et al., 1981) and H-2 (Dobberstein et al., 1979) antigens. 
Biosynthetic experiments will be needed to explore these processes for DLA 
antigens. The conformation of the HLA antigens is not influenced by lack of 
glycosylation in terms of susceptibility to proteolytic enzymes and the reactivity 
with various alloantisera (Ploegh et al., 1981). In contrast, Wilson and colleagues 
(1981) have described a monoclonal antibody which fails to react with non-
glycosylated HLA antigens, although the determinant recognized is supposedly 
protein in nature. The difference between the reagents used, a monoclonal antibody 
or a highly complex alloantiserum probably accounts for the different results. 
Unfortunately, only one alloantiserum was able to precipitate DLA antigens in the 
system used here (chapter V.3). It has not yet been reacted with tunicamycin-treated 
cell extracts. It can probably be used to precipitate nonglycosylated DLA antigens, 
but its broad specificity (anti-C II, cross-reacting with A2 and BS) makes it difficult 
to draw conclusions on the influence glycos)rlation may have on the alloantigenicity 
of DLA molecules. The old controversy on the biochemical nature of the 
alloantigenic determinant (carbohydrate: O'Neill et al., 1981, Sanderson et al., 
1971; protein: Nathenson and Muramatsu, 1971, Parham et al., 1977, Ploegh et al., 
1981) can at present not be directly resolved in the dog model. 
In conclusion: The DLA heavy chain is sensitive to tunicamycin and must therefore 
have anN-linked sugar side chain. The difference in MW of glycosylated and non-
glycosylated heavy chains is enough to accomodate one complex sugar side chain. 
The DLA light chain is unlikely to contain any sugar residue. 
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CHAPTER VII 
THE ALLOANTIGENIC SITE OF DLA CLASS I ANTIGENS 
VII.l Introduction 
In the preceding chapters, the groundwork was laid for the experiments described 
here. DLA class I antigens were found to be glycoproteins with one N-linked sugar 
side chain (chapter VI). They can be isolated from detergent solubilized, 
radiolabelled peripheral blood lymphocytes by immunoprecipitation with anti-
{32m serum (chapters IV, VI). 
From DLA serology, it is clear that DLA class I antigens are polymorphic. On the 
basis of serological data it was decided that there are three DLA class I loci which 
each consist of a variety of alleles (V riesendorp et al., 1977). In this chapter an 
attempt is made to find a molecular basis for the polymorphism observed. In other 
species, there is usually no polymorphism at all or very limited polymorphism in the 
light chain (Michaelson et al., 1980) and the alloantigenic site is assigned to the 
heavy chain. 
The first question we thus have to answer for the DLA antigens is: on which 
polypeptide chain lies the determinant with which the alloantisera react? The 
second question is: can we identify the products of different loci or alleles? A 
biochemical approach to these questions is to analyse DLA antigens by two-
dimensional (20) gel electrophoresis. This technique has been used to distinguish 
different MHC class I products by their heavy chain patterns (Jones, 1977, Vasilov 
et al., in press), and to establish that in HLA-DR antigens the light chain, rather 
than the heavy chain, is the variable one (Charron and McDevitt, 1979, Shackelford 
and Strominger, 1980). The DLA antigens to be analysed were isolated by immuno-
precipitation with the rabbit anti-dog-,B2m serum as described in chapter VI, 
assuming that the antiserum will react with ,B2m associated DLA class I antigens of 
all tissue-types, no matter where the alloantigenic site is located. As it is not known 
whether the alloantigenic determinant is protein, sugar or both in nature, 
experiments were carried out with DLA antigens labelled in the presence or absence 
of tunicamycin, an inhibitor of N-linked glycosylation (Chapter VI, Kuo and 
Lampen,'l974). After immunoprecipitation, DLA antigens were analysed by one-
and two-dimensional gel electrophoresis. 
The second question relating to the identification of different haplotypes or alleles 
is more difficult to answer. DLA antigens were isolated from two dog families with 
the anti-,B2m serum. Within a family, certain dogs have certain haplotypes in 
common and by comparison of different two-dimensional gel patterns tentative 
correlations of spots on the autoradiograms to tissue-type can be made. For one 
dog which was positive for DLA-Cl1, the pattern obtained with the one usable 
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alloantiserum (chapter V) was compared to the pattern obtained with the anti-J'l2m 
serum. 
Using the same methodology, DLA antigens on tumour cells and peripheral blood 
lymphocytes of the tumour bearer were analysed. It has been reported by several 
groups that ''alien" histocompatibility antigens can be found on tumour cells, that 
is to say, specificities can be found on tumour cells, usually in the mouse, in addition 
to, or instead of, the original specificities of the tumour bearer (J. Immunogenet., 
1980, Transplant. Proc., 1980, 1981). A biochemical way to investigate this is 
immunoprecipitation of radiolabelled detergent solubilized membrane antigens 
with anti-J32m serum and subsequent analysis by two-dimensional gel electrophore-
sis. Immunoprecipitation patterns of alien histocompatibility antigens show that 
the light chain has a MW of 12,000 daltons, so that it is likely that the light chains 
are identical to J'l2m (Parmiani et al., 1979, Schmidt et al., 1980). Most of the 
research concerning (alien) histocompatibility antigens on tumour cells has been 
performed with induced tumours in inbred rodents. We made an attempt to study 
spontaneous tumours in (outbred) dogs. 
VII.2 Materials and methods 
VII.2.1 Cells 
Peripheral blood lymphocytes from beagles and mongrel dogs were purified by 
centrifugation on Ficoll Isopaque. Peripheral blood lymphocytes from beagles 
were always used fresh, whereas mongrel, tumour bearer peripheral blood 
lymphocytes were cryopreserved and stored in liquid nitrogen until use. Tumour 
cell lines were derived from solid tumours of different histological type in mongrel 
dogs. Tumour material was given to us by drs. P. Lansdorp from our laboratory, 
presently working at the Centraal Laboratorium van de Bloedtransfusiedienst van 
bet Nederlandse Rode Kruis in Amsterdam and drs. G. Ruttemanfrom the Kliniek 
voor kleine huisdieren in Utrecht. Tumour cells were grown in RPMI 1640 
supplemented with 2 mM glutamine, 50 U/ml penicillin, 50 !'g/ml streptomycin 
and 10% foetal calf serum (all from Gibco Europe, Paisley, Scotland). Alternatively 
they were cultivated in Iscove's modified Dulbecco's medium supplemented with 
5% foetal calf serum (both from Gibco Europe, Paisley, Scotland) and antibiotics. 
In one case the cells from an early passage were transplanted into nude mice, and 
the solid tumours obtained were used to establish a cell line:. Cell lines were checked 
for mycoplasma infection at regular intervals. 
VII.2.2 Preparation of labelled cell extracts 
PHA stimulation and 35S-methionine labelling of peripheral blood lymphocytes 
was done as described in chapter VI (VI.2.2). In the case of one dog family (family 4, 
Table 1 ), 200 I'Ci 35 S-methionine/3ml culture was used instead of 100 I'Ci. For 35S-
methionine labelling of tumour cells, half confluent monolayers in 75 cm2 flasks 
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were incubated with 10 ml RPMI 1640 with the usual supplements but lacking 
methionine, for 1 hour in a C02 incubator at 37°C. 35 S-methionine was added, 
100 I'Ci per flask and after !6hours at 37"C, 5% CO, cells were trypsinized, washed 
and solubilized as described for peripheral blood lymphocytes. Tunicamycin 
(Calbiochem-Behring Corp., La Jolla, CA, U.S.A) was added to the cultures at a 
concentration of 3-5 J.Lglml where required. 
VII.2.3 Antisera and immunoprecipitation 
The rabbit anti-dog-/32m serum described in chapters Ill, IV and VI was used. 
Normal rabbit serum served as a control. Immunoprecipitation was basically as 
described in chapter VI (VI.2.3). For two-dimensional gel electrophoresis, the 
lysate of 107 cells was pretreated with 5 !'l normal rabbit serum and 75 1'1 
Staphylococcus aureus Cowan I (Staph A) and then incubated with 3 1'1 anti-/32m 
serum and 50 1'1 Staph A. After washing, the pellets were stored dry at -70°C. 
For one-dimensional gel electrophoresis, the pellets were eluted by boiling for 3 
minutes with sample buffer followed by alkylation (Dobberstein eta!., 1979). For 
two-dimensional electrophoresis, pellets were suspended in isoelectric focusing 
sample buffer (O'Farrell, 1975), kept at room temperature for 5-10 minutes and 
centrifuged. The resulting supernatant was applied to the isoelectric focusing gels. 
V!I.2.4 Gel electrophoresis 
One-dimensional gel electrophoresis was performed on 15 X 30 X 0.1 em, 7.5-15% 
linear gradient gels according to Dobberstein et a!. (1979). Two-dimensional gel 
electrophoresis was done by the method of O'Farrell (1975) with the modifications 
of Vasilov eta!. (in press). These modifications are briefly: the casting of 14 mm 
focusing gels in 200 1'1 capillaries and the use of a Studier type apparatus (Studier, 
1973) to which the capillaries are attached with a glass plate and modelling clay, for 
the first dimension. After equilibration in the appropriate buffer, focusing gels were 
sealed to 7.5-15% linear gradient gels using a I% agarose solution in sample buffer. 
Gradient gels were run as described above. Gels were fluorographed on Kodak 
XAR 5 film (Bonner and Laskey, !974). 
Most of the experiments described were performed at the Institute of Genetics, 
University of Cologne, F.R.G. with the invaluable assistance of H.L. Ploegh, A. 
Hahn and H. Molders. 
VII.3 Results 
It has been shown (chapter VI) that both glycosylated and nonglycosylated DLA 
antigens can display heterogeneity in the heavy chain when analysed on 7.5-15% 
linear gradient gels. Therefore a preliminary screening of DLA antigens from three 
(incomplete) dog families immune precipitated by the anti-/32m serum was done on 
a linear gradient gel. The method used is summarized in Fig. I (left column). 
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Figure 1. Summary of the immunoprecipitation schedules used. 
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VII.3.1 One-dimensional gel electrophoresis of glycosylated and nonglycosylated 
DLA antigens 
Typing results for the families described in this chapter are given in Table I. The 
cells of families 1-3 were labelled in the presence or absence of 5 l'g/ml 
tunicamycin. In Fig. 2 immunoprecipitates of cells grown without tunicamycin are 
shown. A band consisting of actin, a common contaminant ofimmunoprecipitates 
from lymphocytes (Barber and Delovitch, 1979) is present in all precipitates, 
including the control precipitate with normal rabbit serum (lane a). The other 
major bands are precipitated from all celllysates by the anti-,B2m serum and have 
apparent molecular weights of 43,000 and 12,000 daltons. Some heterogeneity of 
the heavy chain is observed. This could be due to different numbers of sialic acid 
moieties per heavy chain, as wa3 shown to be the case for HLA antigens (Parham et 
a!., 1974). 
The same dogs from families 1-3 were used for one-dimensional gel analysis of non-
glycosylated DLA antigens. The gel pattern of Fig. 3, from cells grown in the 
presence of tunicamycin, is evidently different from that in Fig. 2. The apparent 
Table 1. Tissue typing of the dogs described in Figures 2-6. 
dog DLA typing 
Family I. fathe·r dog I A3+10*, B-. C- I A!O, B6, C-
sib dog 2 A2, B5, Cll /A!O. B6, C-
sib dog 3 A3+10, B-. C-. /A9, B6, Cl2 
Family 2. father dog 4 A3+!0, B-. C- /A9, B6, C12 
sib dog 5 AI, BIJ, C- IA9, B6. Ci2 
sib dog 6 A9, B6, Cl2 /A9, B6. Cl2 
Family 3. father dog 7 A9, B6, Cl2 /A9, B6, Ci2 
mother dog 8 A2, B4, Cll /A9, B6. Cl2 
sib dog 9 A2. B4. Cll /A9, B6, Ci2 
Family 4. mother A7, B-. C- /A7, B-. C-
father A3+10, B-. C- /A9, B6, Ci2 
sib 1 A3+10, B-. C- IA7, B-. C-
sib 2 AHIO, B-, C- IA7. B-, C-
sib 3 A7, B-. C- /A9. B6. Cl2 
Family 5. mother A9, B4, Cl2 /A9, B6, Cl2 
father A9, B4. Cl2 /A2, B4. CII 
sib I A9, B4, Cl2 /A9. B4, Ci2 
sib 2 A9, B4. Cl2 /A2, B4. Cll 
sib 3 A9, B4, Cl2 /A9. B6, Ci2 
*DLA-A'-3 and DLA-AlO are difficult to separate by serology. 
Families 1-3 were used for the experiments described in Figs. 2 and 3. Family 4 is further described 
in Fig. 5 and family 5 in Fig. 6. 
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Figure 2. SDS-Polyacrylamide gel electrophoresis (7.5-15% linear gradient gel) of 15S-methionine 
labelled, detergent solubilized DLA antigens after immunoprecipitation with: normal rabbit serum 
(lane a) or rabbit anti-dog-j3lm serum (lanes b-j). 
lane a: dog 6 (Table 1) (control). 
lanes b-j: dogs 1-9 (Table 1). 
he: heavy chain, {32m: /32-microglobulin. 
MW of the DLA heavy chain is reduced to 40,000 daltons. The concentration of 
tunicamycin used (5 l'g/ml) is such that complete inhibition ofN-linked glycosyla-
tion occurred. Not even a faint band at the original MW can be found, even after 
long exposure times. 
The amount of radioactivity recovered in [32m is in some cases (lanes b,c,g) clearly 
greater than the amount in the heavy chain. As an antiserum against {3 2m was us-ed, 
free fJ 2m has probably been precipitated in addition to DLA-bound fJ 2m. 
Polymorphism as observed for mouse fJ 2m (Michaelson et al., 1980), was not 
evident in dog fJ 2m (Fig. 3). Although no N-linked sugar residues are present in 
DLA heavy chains from tunicamycin treated cells, heterogeneity of the heavy chain 
persists. 
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Figure 3. SDS-polyacrylamide gel ele-ctrophoresis (7.5-15% linear gradient gel) of 35 S-methionine 
labelled, detergent solubilized DLA antigens after immunoprecipitation with: normal rabbit serum 
(lane a) qr rabbit anti-dog-/3 2m serum (lanes b-j). 
lane a: ... dog 6 (Table I) (control). 
lanes b-j: dogs 1-9 (Table 1). 
All cells were radiolabelled in the presenCe of 5 .ug/ml tunicamycin. 
he: heavy chain, [32m: ,82-microglobulin. 
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We analysed the possibility of a correlation between the gel pattern of the heavy 
chain and the tissue-type of the dog (Table 1). Dog 1 and 2 (Fig. 3, lanes band c) 
have an identical pattern, although they have only one haplotype in common. Dog 
3 (lane d) has two heavy chain bands, one in the same position as dog 1 and 2, and 
the other of a slightly lower MW. This band could therefore correlate with DLA-A9 
and/or DLA-Cl2. Dog 4 (lane e) has a pattern identical to that of dog 3. They are 
DLA identical, but not related. The upper heavy chain band might contain DLA-
A3 and/or DLA-AlO. Dog 5 (lane f), a sib of dog 4, shows the greatest separation of 
the two heavy chain bands. The top one is of the same MWas the bottom one of dog 
4, which contains DLA-A9 and/or DLA-Cl2. If this is so, the lower band of dog 5 
contains DLA-Al and/or DLA-Bl3. The one band of dog 6 (lane g), homozygous 
for DLA-A9, B6 and Cl2, is in the same position as the DLA-A9, Cl2 band ofdog4 
and 5 (lower band, lane e and upper band, lane f). Dog 7 (lane h) is identical to dog 
6, both in tissue-type and gel pattern, although they are not related. Dog 8 (lane i) 
has heavy chains of two different mobilities, both different from those of dog 7. 
This must mean that the DLA-A9, B6, C12 haplotypes of father and mother are 
different. Although dog 9, their sib (lanej) is identical in tissue-type to dog 8, here 
the difference between the DLA-A9, B6, C12 haplotypes of the parents is visible 
again. Dog 9 has inherited DLA-A9, B6, Cl2 from his father(lane h) and DLA-A2, 
B4, Cll from his mother(lane i, upper band). In conclusion one can say that there is 
heterogeneity in both the sugar and the protein part ofthe heavy chain ofDLA class 
I antigens, and that it may be possible with more refined techniques to correlate 
heterogeneity of the heavy chain with tissue-type. 
VII.3.2 Two-dimensional gel electrophoresis of glycosylated and nonglycosylated 
DLA antigens 
Unfortunately the sibs used in the experments under VII.3.1 were sacrificed for 
other scientific purposes by the time the two-dimensional gel electrophoresis 
technique was set up. Two other families were therefore used (Table 1 ,family 4and 
5). DLA antigens were immunoprecipitated with anti-$2m serum (Fig. I, left 
column) and a representative example of a 2D pattern obtained is given in Fig. 4. 
The separation in the first dimension was done by isoelectric focusing, based on the 
charge of the molecules. A spot detected in a112D gels at a MW similar to that of the 
heavy chain, but slightly more acidic, represents actin, here on the left of the picture 
(denoted by "A"). The second dimension brought about a sepacation according to 
MW. The spot at the bottom of the picture, corresponding to $ 2m, has moved to the 
basic side of the pH gradient in the first dimension, and to a low MW ( 12,000) in the 
second dimension. The range of spots of about the same MW as actin, but more 
basic, represents the heavy chain. When certain samples had been focused in the 
first dimension in parallel, their second dimension gels were generally super-
imposable. The actin, {3 2m and minor constant spots can be aligned, after which the 
heavy chain spots can be compared. Fig. 4 is representative for all2D gels analysed 
with respect to both the specific pattern and the background, which is generally 
+ 
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Figure 4. Two-dimensional gel electrophoresis of JoS-methiomne labelled, detergent solubilized DLA 
antigens from sib 2, family 4 (Table 1), after immunoprecipitation with anti-dog-/32m serum. Isoelectric 
focusing was performed in the first dimension. The basic end of the isolelectric focusing gel is on the 
right. Perpendicular to the first dimension SDS-polyacrylamide gel electrophoresis (7.5-15% linear 
gradient gel) was carried out. No tunicamycin was used. "A" denotes actin, ".B2m" denotes f3r 
microglobulin. 
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low. In all individuals tested only one spot in the MW 12,000 region was found. 
In second dimension gels of samples which have undergone isoelectric focusing in 
parallel, the relative position of {32m to actin is constant. In accordance with the 
results from one-dimensional gels (Figs. 2 and 3), no heterogeneity of the light 
chain, {3 2m, was found. The heavy chain, on the other hand, does vary between dogs 
with different tissue-types (Figs. S and 6). Apart from variation between 
individuals, there is also heterogeneity within the individual. The sample shown in 
Fig. 4 was radiolabelled in the absence oftunicamycin, which implies that the heavy 
chain should be fully glycosylated. The slight heterogeneity in charge, ranging from 
a position close to actin towards a more basic pi, can be partly ascribed to varying 
amounts of sialic acid (Parham et al., 1974). The slight heterogeneity in MW (per 
cluster) may be due to neutral sugars. This will become clear when patterns of 
glycosylated and nonglycosylated DLA antigens are compared. 
For the moment, the most important conclusion is that polymorphism in DLA 
antigens is only detected in the heavy chain. For this reason, only the heavy chain 
pattern is shown in Figs. 5 and 6, where the two families are depicted. Tracings of all 
photographs have been made to clarify the correlation between spots and tissue-
type. 
Family 4 DLA antigens were radiolabelled both in the presence and in the 
absence of tunicamycin. Fig. Sa gives the patterns of glycosylated molecules and 
Fig. Sb those of nonglycosylated molecules. The concentration of tunicamycin, 
3 1-'g/ml, was such that only partial deglycosylation occurred. Therefore it is 
possible to superimpose the patterns of glycosylated heavy chains of each 
individual on the pattern of the partially deglycosylated heavy chains and to see 
new, nonglycosylated spots appear. These new spots are approximately 3000 
daltons lower in molecular weight than the glycosylated spots, as shown before in 
the one-dimensional gel analysis (Figs. 2 and 3), and they are found at a more basic 
position, as would be expected for molecules lacking the acidic neuraminic· acid 
residues. 
When the heavy chains were glycosylated (Fig. Sa) 3-4 clusters of different charge 
were found, each showing slight heterogeneity in molecular weight. Comparing 
Fig. Sa with Fig. Sb, where the nonglycosylated heavy chains are shown in addition 
to residual glycosylated chains we find 1-2 new spots in Fig. Sb which do not display 
any MW heterogeneity. They are found at a MW of about 3000 daltons lower than 
the clusters in Fig. Sa. As the only difference between the DLA antigens of the 
individuals in Fig. Sa and Sb is the presence or absence of sUgar residues, we can 
conclude that the MW heterogeneity per cluster in Fig. Sa is due to neutral sugars. 
The charge heterogeneity is partly due to sugar residues, because 3-4 clusters from 
Fig. Sa are reduced to 1-2 spots in Fig. Sb. Differences in the amount of sialic acid 
could account for the charge heterogeneity. 
Taking the intensity of the spots as a guideline, we compared the most intense spots 
of DLA antigens labelled in the presence (3 1-'g/ml) or absence oftunicamycin. It is 
clear that in all individuals tested, the nonglycosylated spots are more basic than the 
corresponding glycosylated spots. For example, the most intense glycosylated spot 
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Figure S. Two-dimensional gel analysis of DLA antigens from family 4 (Table I) after immunoprecipi-
tation with anti-f3zm serum. 
Figure Sa: 35 S-methionine labelling in the absence of tunicamycin. 
Figure Sb: .1 5S-methionine labelling in the presence of tunicamycin. 
Only the heavy chain region is shown. The basic end of the isoelectric focusing gelS is to the right. The 
samples of the mother(± tunicamycin), the father(± tunicamycin), sib I (~ tunicamycin), and sib 3 
(± tunicamycin) were subjected to isoe!ectric focusing in parallel. Sib I (+ tunicamycin) and sib 2 
(± tunicamycin) were analysed separately. 
Further legends in Fig. 4. 
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of the mother (Fig. Sa) corresponds to a nonglycosylated spot located to the right 
(more basic) side of the original one. In sib I, the two most intense spots of the 
glycosyiated DLA heavy chains are turned into two nonglycosylated spots to the 
right of the original location. It is striking that all clusters of spots are at equal 
distance from each other. After tunicamycin treatment, new spots are found of a 
lower MW, but also each time at the most basic postion of each series of clusters (i.e. 
containing no sialic acid). The charge difference is not only caused by sugar 
heterogeneity, but also by protein differences, as the nonglycosylated heavy chains 
usually prOduce more than one spot. In the 20 system used, each spot corresponds 
to one polypeptide chain (or, rarely, multiple overlapping polypeptide chains of 
exactly equal charge and apparent size). The recurring charge differences in the 
heavy chain after tunicamycin treatment found in the 20 analysis support the 
findings of the one-dimensional gel analysis. 
The assignment of haplotypes or alleles to the spots can only be tentative. The 
high percentage of "blanks" in tissue typing for the Band C loci (chapter 1.2) is 
unfortunate. If all products of all loci were present, one would expect three series of 
glycosylated spots in homozygotes and six in total heterozygotes. One can see at a 
glance that this is not the case for the present individuals. Which spots are shared by 
dogs with overlapping tissue-types? An answer to this question might provide a way 
out. In family 4, the mother is homozygous for DLA-A7, B-, C-, so the one spot 
found after tunicamycin treatment and the series of glycosylated spots can be 
ascribed to DLA-A7, B-, C-. These spots are shared by sib I, 2and 3. The father and 
sib I and 2 share the haplotype DLA-A3+ 10, B-, C- which must be the spot (Fig. 
Sb) or series of spots (Fig. Sa) slightly more acidic than DLA-A7, B-, C-. By 
exclusion, the DLA-A9, B6, Cl2 haplotype of the father is attributed to the most 
basic spot after tunicamycin treatment and the series to the right of the DLA-
A3+ 10 series in Fig. Sa. Sib 3 should share DLA-A9,B6,CI2 with thefatherbut the 
charge difference between DLA-A9,B6,Cl2 and DLA-A 7,B-,C- is so small that it is 
difficult to distinguish them. In fact, one might as well call the DLA-A 7 ,B-,C- of sib 
3 a DLA-A9,B6,Cl2. 
Figure 6 
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In family 5 (Fig. 6) the situation is less complicated. The father and mother were 
studied in the presence or absence oftunicamycin; the sibs were only tested for their 
glycosylated DLA antigens. When we compare the glycosylated heavy chains, 
strong resemblances are found between the mother and sib 3, and the father and sib 
2. Sib I is homozygous for DLA-A9,B4,Cl2. The most intense cluster is therefore 
attributed to DLA-A9 ,B4,CI2. This cluster is shared among the whole family. The 
difference between homozygosity and heterozygosity for DLA-A9,B4,CI2 is 
reflected in the intensity of the most basic cluster. Sib 1 's most basic cluster is about 
twice as intense as the most basic cluster of the rest of the family. Haplotype DLA-
A9,B6,CI2 is shared by the mother and sib 3 and is somewhat more acidic than 
DLA-A9,B4,C 12. DLA-A2,B4,Cll, very close to actin, is shared between sib 2 and 
the father. Tunicamycin treatment of the PBL of the mother caused a shift of the 
two most intense clusters to one position more basic and of a lower MW (denoted 
by the arrows). The same is true for the father. Once again, MW heterogeneity of 
glycosylated molecules within a cluster is due to the presence of neutral sugars and 
charge heterogeneity is due partly to sialic acid, partly to protein differences. 
Figure 6. Two-dimensional gel analysis 6f DLA antigens from family 5 (Table I) after immunopreci-
pitation with anti-/32m serum. Only the heavy chain region is shown. The basic end of the isoelectric 
focusing gels is to the right. Ail glycosylated samples were run in parallel. The two nonglycosylated 
samples were analysed in a different experiment. The arrows denote the nonglycosylated heavy chains. 
Further legends in Fig. 4. 
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Figure 6 (continued) 
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One alloantiserum, serum 1302, has been shown to immunoprecipitate DLA 
antigens (chapter V). The anti-/32m serum reacts with all DLA class I antigens and 
serum 1302 with only part of them. This cannot be visualized on a one-dimensional 
gel, but a two-dimensional gel analysis enables one to distinguish products of 
similar size and different charge. Figure 7 shows the patterns obtained on two-
dimensional gels after immunoprecipitation of DLA antigens from a dog which 
was typed as DLA-A9,B6,Cl2/ A2,B4,C11. The experiment was only done in the 
absence of tunicamycin. It is clear that the anti-,B2m serum precipitated heavy 
chains comprising four clusters of spots whereas the heavy chain precipitated by 
serum 1302 consists of only two clusters of spots. Neutral sugar variation is seen 
with both antisera. The dog used for this experiment was neither related to family 4 
nor to family 5. As the antiserum cross-reacts with DLA-A2 and DLA-BS, it is 
likely that the two clusters precipitated by serum 1302 represent haplotype DLA-
A2,B4,C11. The additional clusters found in the anti-/32m serum pattern then 
belong to haplotype DLA-A9,B6,Cl2. 
Instead of ascribing spots or clusters to products of different loci we suggest that 
the clusters correspond to whole haplotypes. Firm evidence for this is lacking, but 
this gives the best fit between typing data and two-dimensional gel analysis results. 
For example, when only the A locus products would be visible, the two DLA-A9's 
ofDLA-A9,B4,Cl2 and DLA-A9,B6,Cl2 (mother and sib 3, Fig. 6) would have to 
be different to account for the two series of Clusters. The same can be argued for the 
B locus (the two DLA-B4's ofDLA-A2,B4,Cll and DLA-A9,B4,Cl2 would have 
to be different in the father and sib 2, Fig. 6). If both A and B loci are expressed, the 
correlation between spots and tissue-type proposed above is the most logical one. 
The one-dimensional gel electrophoresis (Figs. 2 and 3) is also most easily explained 
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Figure 7. Two-dimensional gel analysis of DLA antigens from a dog of tissue-type DLA-A9, 86, 
C12/A2, 84, Cll after immunoprecipitation with alloamiserum 1302 (anti-DLA-Cll) and anti-.B2m 
serum. No tunicamycin was used. Only the heavy chain region is shown. The basic end oft he isoelectric 
focusing gels is to the right. The samples were run in parallel. Further legends in Fig. 4. 
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by attributing bands to haplotypes. The one haplotype which is shared between 
both families, DLA-A9,B6,Cl2, is found in similar positions (compare the pattern 
of family 4, the father, with family 5, the mother and sib 3). 
In fact, the two-dimensional gel anlaysis has not revealed anything which we had 
not yet deduced from the one-dimensional gels. Surpri~ingly few spots are found for 
the nonglycosylated DLA heavy chains compared to what is found in the case of 
HLA class I heavy chains (Vasilov eta!., in press). Nonetheless the same technique 
was applied to investigate DLA antigens on tumour cells. As all tumour material 
was obtained from mongrel dogs, which are certain to be less inbred than beagles, 
we hoped to detect more variety in these two-dimensional gels. 
VII.3.3 Two-dimensional gel electrophoresis ofnonglycosy!ated DLA antigens from 
tumour cells and tumour bearer peripheral blood lymphocytes 
As there had been ample indication for protein heterogeneity in the DLA heavy 
chain (Figs. 3, 5, 6), probably corresponding to different haplotypes, we decided to 
examine only nonglycosylated DLA antigens on tumour cells and tumour bearer 
peripheral blood lymphocytes. Figure I (p. 105, middle and right column) sum-
marizes the methods used. Unfortunately, the cryopreserved tumour bearer peri-
pheral blood lymphocytes were difficult to stimulate with PHA. 35 S-methionine in-
corporation was low and the films had to be exposed to the gels for 8 weeks. The 
background then developed renders it difficult to reproduce the photographs. 
Therefore only tracings are shown in Fig. 8. Samples of lymphocytes and tumour 
cells from one dog were always run in parallel. Tunicamycin (5 ,ug/ml) seems to have 
inhibited protein synthesis in addition to glycosylation in certain cases, as the heavy 
chain spots are far too weak in comparison with the actin spot. The gradient gels for 
the second dimension in Fig. 8 had a much smaller area between actin and [3 2m than 
those of Figs. 4-7. For this reason, the nonglycosylated heavy chains of Fig. 8 are 
much closer to actin in MW than those of Figs. 4-7. The spots below the heavy chain 
spots in Fig. 8 may be constant minor spots, usually of less intensity than the heavy 
chain. In the tumour cells, the maximum amount of nonglycosylated heavy chain 
spots is two, like in Figs. 5 and 6. One exception is found in the peripheral blood 
lymphocytes of HT70 where three nonglycosylated heavy chain spots of about 
equal intensity are visible. 
No great diversity of MHC products is found when one compares the patterns of 
the tumour cells with each other. When we compare tumour cells with peripheral 
blood lymphocytes of the same dog, only HT70 is a possible candidate for a 
difference in MHC antigens between tumour cells and PBL, as the lymphocytes 
have one spot more than the corresponding tumour cells. This spot probably 
corresponds to a DLA product. So instead of finding an alien· histocompatibility 
antigen on a tumour we found the loss of a DLA class I antigen. HT43 lymphocytes 
and tumour cells have similar two-dimensional gel patterns. The CR lymphocyte 
pattern is difficult to interpret, as the only spots visible are much lower in MW than 
one would expect for DLA class I antigens. The lymphocytes of the last dog (DG) 
did not give a visible pattern even after 8 weeks exposure. 
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Figure 8. Two-dimensional gel analysis of DLA antigens from tumour cells and peripheral blood 
lymphocytes of the tumour bearers after immunoprecipitation with anti-,82m serum. All samples were 
labelled in the presence oftunicamycin and they were all subjected to isoelectric focusing in parallel. No 
typing assignment is given. Abbreviations stand for the various tumours. Further legends in Fig. 4. 
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VII.4 Discussion 
The investigation into the DLA class I antigenic determinant has revealed some 
interesting aspects. Like in most other species, the light chain of DLA class I 
antigens is invariant and polymorphism resides in the heavy chain. When fully 
glycosylated, the heavy chain shows heterogeneity even in one-dimensional gels 
(Fig. 2). Nonglycosylated heavy chains still show variation in mobility on one-
dimensional gradient gels (Fig. 3), as has been shown in human and primate MHC 
antigens (Parham and Ploegh, 1980). Different HLA-A and -B, and H-2K and -D 
antigens can be distinguished on the basis of their mobility in SDS-polyacrylamide 
gel electrophoresis (Dobberstein et al., 1979, Krangel et al., 1979, Ploegh et al., 
1981). The variation in mobility of DLA heavy chains in Fig. 2 is probably of a 
similar kind. · 
The two-dimensional gel analyses confirm the finding that the heavy chains 
display both protein and sugar heterogeneity (Figs. 4-7). The sugar heterogeneity is 
caused by varying amounts of neutral and charged sugar residues. Neutral sugar 
variation, visible as slight MW differences and constant charge, was also 
demonstrated in two-dimensional gels of Thy-! (aT cell marker in the mouse), 
immunoprecipitated with a monoclonal anti-Thy-! antibody (Ledbetter and 
Herzenberg, 1979). The MW heterogeneity displayed by DLA antigens is not 
apparent when they are synthesized in the presence of tunicamycin (Fig. Sb ). 
Charge heterogeneity caused by sialic acid variation is described in HLA (Parham 
et al., 1974) and H-2 antigens (Kvist et al., 1977). HLA class I antigens can carry 0-
3 sialic acid residues which results in four spots for each product analysed by two-
dimensional gel electrophoresis. After neuraminidase treatment, this type of charge 
heterogeneity disappears. We did not check for the presence of sialic acid by use of 
neuraminidase. Indirect evidence that a sugar residue variation causes charge 
differences in DLA heavy chains is obtained by comparing the patterns of 
glycosylated and nonglycosylated heavy chains (Figs. Sa and Sb )where 3-4 clusters 
are reduced to 1-2 spots. As after tunicamycin treatment heterogeneity in charge 
persists, we conclude that there must be protein heterogeneity as well. 
An indication of the amount of sialic acid residues in DLA heavy chains can be 
obtained by establishing how many glycosylated clusters correspond to one 
nonglycosylated spot in Figs. S and 6. In family 4, Fig. S, the most intense 
glycosylated clusters correspond to DLA heavy chains with on~ sialic acid residue 
as in all cases the nonglycosylated spot (no sialic acid residues) appears one position 
to the right (basic) side. So, from what is detectable in Fig. S, one would conclude 
that DLA antigens contain either two, one or no sialic acid residue. This is 
especially clear in the mother, who is homozygous for DLA-A 7, B-, C- (Fig. Sa, 
topmost diagram). In family S, Fig. 6, the same reasoning can be applied. Sib I, 
homozygous for DLA-A9,B6,Cl2, and the father and sib 2, who seem to 
have non-overlapping series of spots for both haplotvpes, are the clearest examples. 
Pulse-chase experiments would have to be performed to corroborate the hypothesis 
that the heterogeneity of glycosylated DLA heavy chains represents terminal 
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modification of a limited number of polypeptide chains. If vertical and horizontal 
heterogeneity appear together as a function of chase, it is likely that one non-
glycosylated spot (representing one gene product) corresponds to several other 
glycosylated spots (representing one gene product with several terminal modifica-
tions). 
Almost all experiments described in this chapter were performed with DLA 
antigens immunoprecipitated by anti-,B2m serum. The advantage of using this 
antiserum is that in principle, all class I antigens should be isolated. In the case of 
HLA class I antigens it was found that there are additional class I gene products 
which are not recognized serologically but can be found upon 2D gel analysis of 
HLA antigens immunoprecipitated with anti-/32m serum (Vasilov et al., in press). 
The disadvantage of using anti-/32m serum is that it becomes more difficult to 
correlate spots on 20 gels with tissue-type. Comparison of patterns from 
individuals with overlapping MHC class I specificities can solve the problem. 
A better assignment of patterns to tissue-type may, however, be obtained by using 
a!loantisera (Blankenhorn eta!., 1980, Jones, 1977). Unfortunately only one dog 
alloantiserum is suitable for immunoprecipitation. This serum was used in the 
experiment in Fig. 7. It is clear that the alloantiserum pattern consists of two 
clusters whereas the anti-/32m pattern contains two additional clusters. The 
sequential immunoprecipitation experiments referred to in chapter V also sug-
gested that the OLA antigens reacting with alloantiserum 1302 \vere of a more 
limited specificity range than those reacting with the anti-/32m serum. Immuno-
precipitation of OLA antigens by a!loantiserum 1302 and 20 gel analysis should be 
repeated with OLA antigens labelled in the presence of tunicamycin to confirm the 
assignment of clusters to haplotypes. Moreover, immunoprecipitation of non-
glycosylated OLA antigens by the a!loantiserum would indicate that lack of 
glycosylation need not have any influence on the alloantigenicity of the molecule. 
The protein nature of the alloantigenic determinant would then be established. For 
the moment, we can only saY that the alloantigenic determinant is located on the 
heavy chain and that it is most probably protein in nature. 
The assignment of spots to different haplotypes or alleles was found to be 
difficult. In other systems, more MHC class I products are found by 20 gel analysis 
than by conventional serology (Jones, 1977, Vasilov eta!., in press). The dog MHC 
class I antigens, however, show very little variation in the heavy chain on 20 gels, 
especially in nonglycosylated heavy chains. Serological complexity is greater than 
that found in biochemical assays. The 20 gel analysis might not be the best method 
to study MHC antigens in the dog, although in other species it gives better 
resolution of different MHC products than does serology. 
By attributing spots to whole haplotypes, correlation of tissue typing data with 20 
gel patterns supported this as being the best hypothesis. One would have expected, 
however, that at least one nonglycosylated spot would be found for each locus. It is 
possible that OLA-C is not detected because it is too labile. HLA-C has been 
reported to be labile (Snary et a!., 1977) and not readily detected in 20 gels (Vasilov 
et al., in press). Another, rather theoretical, possibility is that there are one or two 
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DLA class I loci that express products that are not or only weakly associated with 
/32m. These would not have been identified by the anti-/32m serum used. A trivial 
explanation for the reiative lack of heterogeneity could be that heavy chains from 
certain loci do not contain methionine and therefore cannot be labelled with 35S-
methionine. Another possibility may be that the pi of some heavy chains lies 
outside the pH range covered in the first dimension (roughly pH 4-8). It is also 
possible that spots are overlapping in the 20 gels. For example, in Fig. 5 DLA-
A7,B-,C- is difficult to distinguish from DLA-A9,B6,Cl2. Peptide analysis by 
HPLC might reveal heterogeneity which is not detected by 20 gel analysis. 
One is tempted to think that the so-called DLA class I loci may in fact represent 
three determinants on one molecule rather than three different molecules, 
comparable to immunoglobulin allotypes. However, statistical analysis of sero-
logical data argues against this possibility. 
The serologically defined DLA antigens, which we have assumed to be homologous 
to murine class I antigens, may in fact also comprise class II antigens. It was 
recently suggested (Deeg et al., 1982) that !a-like antigens are present on most dog 
peripheral blood lymphocytes, quite contrary to what is found in other species. As 
these !a-like antigens would not react with an anti-,B2m serum, this could be another 
explanation for the discrepancy between our biochemical data and present-day 
serology. Metzger and colleagues (1981) described that they could not recognize 
products of different loci of SLA antigens by 20 electrophoresis. They suggest that 
the reason for this has to be looked for at the DNA level. 
The simplest explanation remains that, in the dogs described, only one product was 
detected per haplotype. The issue could be investigated by analysing recombinants 
or by using alloantisera. Recombinants are scarce, however, and· alloantisera 
generally do not work in immunoprecipitation (chapter V). Beagles do show a high 
linkage disequilibrium of certain alleles. This is supposed to be due to the founder 
effect (chapter 1.2). The limited biochemical complexity of the DLA antigens 
studied here may also be caused by this founder effect. 
In spite of the little variation in heavy chain spots for DLA antigens, a few things 
can be remarked upon. The DLA-A9,B6,Cl2 haplotype occurs in both families and 
in a very similar location to actin. Dogs that share haplotypes also share spots on 
the 20 gels. Homozygous dogs have simpler 20 patterns than heterozygous dogs, 
but the heavy chain spots are of double intensity, when compared with hetero-
zygotes. 
The investigation of the tumour cells has been difficult. More complicated 
patterns were expected as mongrel dogs are less inbred than beagles. Mongrels are 
difficult to tissue-type with the beagle typing sera (chapter 1.2). No attempt 
therefore was made to attribute spots in Fig. 6 to typing data. Bad typing, bad 35S-
methionine incorporation and very uniform 2D patterns made comparison of 
tumours and tumour bearer lymphocytes precarious. The fact that 35S-methionine 
incorporation was low in PHA-stimulated tumour bearer lymphocytes may have 
been caused by the addition of tunicamycin. Although freshly isolated peripheral 
blood lymphocytes can be metabolically radiolabelled in the presence of 5 11g/ml 
124 
tunicamycin (VII.3.1), this concentration may have been too high for the cryo-
preserved tumour bearer PBL. Tunicamycin is known to be able to decrease protein 
synthesis (Hickman et al., 1977). 
Tumour tissue and blood samples were taken on the day of operation. As a cell line 
had to be prepared from the tumour material, peripheral blood lymphocytes had to 
be stored in liquid nitrogen in the meantime. It was difficult to obtain blood 
samples at a more suitable time because the dogs used for this part of our 
investigation were pets from all over Holland. Although alien class I histo-
compatibility antigens do contain {32m, the association between [32m and the heavy 
chain is not always as strong as in "normal" histocompatibility antigens (Rogers et 
al., 1979). The choice of this antiserum for immunoprecipitation was unavoidable, 
however, as alloantisera had proved to be unsuitable. 
Despite the poor quality of the photographs used to draw Fig. 8, it was clear that in 
the case of one tumour, a melanoma (HT70), the peripheral blood lymphocytes of 
the tumour bearer showed one spot more than the tumour cells. This was confirmed 
by comparison of HT70 tumour cells and PBL in the 2D gel electrophoresis system 
used by Shackelford and Strominger (1980) where SDS-polyacrylamide gel electro-
phoresis precedes isoelectric focusing (results not shown). Because of the scarcity of 
material and the difficulties encountered in metabolic labelling of the cryopre-
served peripheral blood lymphocytes, lactoperoxidase-catalysed iodination of both 
tumour cells and tumour bearer PBL was carried out. After immunoprecipitation 
with anti-jl2m serum, 2D gel electrophoresis was performed (VII.2.4). When 2D gel 
patterns of 125 I-labelled H-2 (Jones, 1977) and HLA-DR (Charron and McDevitt, 
1980) antigens are compared with patterns obtained in short labelling experiments 
with 35 S-methionine, the 1251-labelled spots correspond to the larger and more 
acidic 35 S-methionine labelled spots, i.e. the end products which have reached the 
cell surface. The patterns of the 125I-labelled tumour cells and tumour bearer PBL 
were difficult to interpret (results not shown). The tumour cell line patterns looked 
very much alike, comprising two clusters of almost identical pi and slightly 
different MW. Two PBL patten1s contained six spots of identical MW and different 
pl reminiscent ofthe patterns obtained with HLA class I antigens (Vasilov et al., in 
press). 
Even if the 2D gel analysis ofDLA antigens immunoprecipitated from tumour cells 
and tumour bearer PBL would give a clearer picture, it remains to be seen if 
differences in DLA antigens between these cell types can be detected by a technique 
in which the dog does not reveal nearly as much heterogeneity as other species 
studied so far. The reason for the discrepancy between the amount of DLA 
products defined in serology and the amount of DLA products demonstrated by 
2D gel analysis has not yet been found. 
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CHAPTER VIII 
GENERAL DISCUSSION 
VIII.! Introduction 
When one is faced with the problem of biochemically characterizing MHC antigens 
of a species that has not been investigated in this way before, the first thing to do is 
to find out which techniques have been applied by others in this type of research. In 
the general introduction to this thesis a brief summary has been given of the most 
successful experimental protocols for the isolation ofMHC antigens (chapter I.4). 
Prerequisites are: 1) cells or tissue which contain sufficient MHC antigens as a 
starting material and 2) antisera directed against MHC antigens, either for 
monitoring the purity of the products during the isolation procedure or for use in 
the isolation procedure directly. 
As a starting material, dog spleens were easily obtainable from donors for 
transplantation experiments carried out in our laboratory. Alternatively, peri-
pheral blood lymphocytes could be collected from our stock of beagles. Tissue 
typing sera, by definition directed to the alloantigenic determinant(s) on DLA 
antigens, were available from planned immunizations or pregnancy sera (Vriesen-
dorp et al., 1971). In all species investigated, the light polypeptide chain of the MHC 
class I antigens is identical to /32m, a protein found in several body fluids. An 
antiserum against /32m will therefore react with DLA antigens of different 
specificities. Consequently, we thought it necessary to raise an antiserum against 
dog [31m. This was not an insuperable problem, however, as dogs who had received 
a kidney transplant were at hand. The level of urinary /3 2m is usually raised after 
kidney transplantation. /32m was isolated by biochemical techniques as described in 
chapter III and the purification was monitored with a sample of a rabbit anti-dog-
/32m antiserum given to us by Dr. Paulik (Smithies and Poulik, 1972a). Subsequent-
ly, rabbit antisera were prepared against the purified /32m. 
Appropriately equipped, we set out to investigate DLA antigens, bearing in mind 
the model of the HLA-B7 molecule as it has been summarized in chapter 1.3. 
In order to obtain DLA antigens, two approaches were taken: 1) the isolation of 
DLA antigens on a preparative scale by papain digestion and biochemical purifica-
tion (chapter II) and 2) the isolation on an analytical scale by detergent solubiliza-
tion and immunoprecipitation (chapters IV and V). In chapter 1.9 some questions 
were formulated which were approached in the chapters II-VII. We gained 
knowledge about the chemical composition of the DLA antigens during the large 
scale isolation procedure (chapter II) and by radiolabelling them with different 
tracers (chapters IV and VI). The role of /32m was investigated in immunoprecipita-
tion studies (chapter IV) using the rabbit anti-dog-,82 m serum described in chapter 
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III. SDS-po1yacrylamide gel patterns of DLA antigens immunoprecipitated with 
anti-,B2m serum were compared to patterns obtained after immunoprecipitation 
with antisera directed against the heavy chain (chapter V). The localization and the 
nature of the alloantigenic site was examined by 2D gel analysis of radiolabelled 
DLA antigens after reaction with anti-/l2m serum (chapter VII). In this same 
chapter, DLA antigens of tumour cells were investigated. 
In the following paragraphs the results will be discussed and brought into 
perspective. For clarity's sake this is done mostly following the sequence of the 
chapters. Some of the issues, however, are only resolved by taking together the 
results described in several chapters. 
VIII.2 Large scale isolation of DLA class I antigens 
DLA class I antigens have originally been defined by alloantisera in the micro-
lymphocytotoxicity test. We used an entirely different method for the isolation of 
these molecules independent of antisera (chapter II). Once they were isolated, they 
were tested for biological activity in the system in which they were originally 
defined. DLA class I antigens behaved like glycoproteins in the isolation 
procedure. They are susceptible to papain cleavage, their elution from a Sephadex 
G-150 column can be followed by measuring the absorbance at 280 nm, and they 
have affinity for lentil lectin. Lentil lectin affinity chromatography was the last 
purification step. When DEAE ion exchange chromatography was used as the final 
purification method, no useful material was obtained. In the HLA system, DEAE 
chromatography is an excellent way of separating different class I antigens (Turner 
et a!., 1975). R. Robb et a!. ( 1976) introduced the anti-/l2 m immunoadsorbent 
column for efficient purification of HLA antigens. In our hands an anti-,82m 
immunoadsorbent column was difficult to elute (chapter 111.4). 
In the case of HLA, both class I and class II antigens have affinity for lentil lectin. 
Separation according to molecUlar weight is required after lentil lectin chromato-
graphy (Springer eta!., 1977). Using the parameters for class II polypeptide chains 
of man and mice (29,000 and 34,000 daltons, 28,000 and 33,000 daltons), we 
decided that in our preparations the amount of putative class II antigens was 
negligible as judged by SDS-polyacrylamide electrophoresis gels stained for 
protein. When the papain digested molecules were radioiodinated, however, and 
immunoprecipitated by the anti-HC serum, extra bands of 19,000, 30,000 and 
39,000 daltons of respectable intensity were visible on SDS-polyacrylamide gels 
(chapter V, Fig. 2). This means that amongst others molecules of an approximate 
molecular weight of 30,000 daltons (putative DLA class II antigens) were present in 
the lentil lectin eluates. The reason that they were detected better after radio-
iodination may be that their tyrosine residues (which are labelled by lactoperoxi-
dase-catalysed iodination) are more easily accessible than those of DLA class I 
antigens, although on a molar basis they were in a minority. 
Unfortunately no dog MHC monoclonal antibodies were available; otherwise a 
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series of monoclonal antibody columns would have been used for the final purifi-
cation step as described for HLA (Parham, 1979). Whatever the optimal method 
for purification of DLA antigens may be, the purity and the yield that we have 
obtained so far can be improved upon. 
In all species studied so far, the major part of the extracellular portion of the 
MHC class I antigens is cleaved off the membrane by papain with the alloantigenic 
site intact. The same is true in the dog. The molecules isolated by papain digestion 
reacted with specific alloantisera which could then no longer lyse lymphocytes in 
the cytotoxicity test (chapter II). Therefore the alloantigenic site was preserved. The 
major part of the heavy chain was recovered; the difference in molecular weight 
between the heavy chain of the papain digested (37,000) and the detergent 
solubilized (41,700-43,000) DLA heavy chains (chapters II, IV) is 4,500 to 6,000 
daltons. This difference in MW between papain digested and detergent solubilized 
DLA antigens is comparable to the MW difference found in HLA antigens isolated 
in these two ways (Cresswell et al., 1973, Springer et al., 1974). Papain digestion of 
the detergent solubilized HLA molecules yielded an intermediate product ofMW 
39,000 and an end product of MW 34,000 (Springer et al., 1974). The NH2-terminal 
amino acid sequences of papain digested and detergent solubilized HLA heavy 
chains were identical, which indicates that the papain cleavage site is close to the 
carboxyl-terminus (Springer and Strominger, 1976). 
Although spleen-derived MHC antigens comprise several allelic forms, in the 
case of HLA class I antigens from three loci, amino acid sequencing is possible. As 
HLA-A and -B products display long stretches of homology, mixed specificities 
obtained from spleens are well suited to investigate the variable regions between 
differing loci and allelic products (Tragardh et al. !979a,c). 
As mentioned before, it was difficult to determine the NH 2-terminal amino acids 
from the isolated DLA heavy chains. Nevertheless, a few amino acids could be 
identified which correspond with HLA and H-2 terminal amino acids (chapter IV, 
Fig. 7b). 
The DLA light chain had an NH2-terminal sequence in agreement with the 
sequence published for dog urinary {3 2m (Smithies and Paulik, 1972a and Chapter 
IV, Fig. 7a). In all MHC class I antigens studied, the light chain is identical to {32m 
(Bjorck et al., 1977, Chardon et al., 1978, Grey et al., 1973, Katagiri et al., 1975, 
Rask et al., 1974, Zaalberg et al., 1976). Only in the case of HLA is this formally 
established by amino acid sequencing of both the light chain and urinary /3 2m 
(Bridgen et al., 1976, Peterson et al., 1972). 
Because of the relationship between /32m and the heavy chain, attempts were 
made to immunoprecipitate the papain digested DLA class I antigens with the 
rabbit anti-dog urinary {32m serum described in chapter III. SDS-polyacrylamide 
gel electrophoresis profiles of the immunoprecipitates after fluorogfaphy (chapter 
IV, Fig. 2) were identical to the gel patterns of the purified antigens after staining 
for protein with Coomassie Brilliant Blue (chapter II, Fig. 4). This is additional 
evidence for the association of /32m and the DLA heavy chain. 
An advantage of large scale isolation by papain digestion is the availability of 
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sufficient material for crystallization experiments. Crystallization is only possible 
with very pure material, so additional immunoadsorbents would be necessary to 
obtain DLA antigens pure enough for this purpose. The shape of the crystals gives 
information about the three-dimensional structure of the molecule, which is 
important in view of the site of the alloantigenic determinant(s) and the possible 
evolutionary relationship between immunoglobulins and MHC class I antigens. 
References are made to attempts to crystallize HLA (Korman eta!., 1982, Ploegh et 
a!., 1981) and SLA (Metzger et al., !981) antigens in order to see if the hypervariable 
spots in the amino acid sequence form one or more hypervariable site(s). 
MHC antigen molecules of one specificity can be used for immunization in 
order to raise monoclonal antibodies against polymorphic MHC determinants 
(Brodsky et a!., 1979, Parham and Bodmer, 1978, Radka et al., !982). Our 
material will be used for that purpose, but in addition to that we decided to 
raise a conventional heterologous antiserum in rabbits which would be able to react 
with all DLA heavy chains (chapter V). The serum obtained gave a high 
background in immunoprecipitation experiments with papain and detergent 
solubilized DLA antigens (chapter V, Figs. 2, 3). This background could be reduced 
by absorption of the serum onto and elution from thrombocytes (chapter V, Fig. 5). 
Alternatively, the unabsorbed antiserum gave a fairly clean two chain precipitate 
when intact cells were used instead of solubilized antigen (chapter V, Fig. 4). The 
reaction between the anti-heavy chain (inti-HC) serum and intact cells could only 
be partly inhibited by purified {32 m, so the antiserum definitely contains antibodies 
recognizing heavy chain determinants. 
VIII.3 Small scale isolation of DLA class I antigens 
VIII.3.1 The anti-dog urinary {3 2m serum 
Some of the questions regarding the biochemical composition of DLA class I 
antigens have been answered in chapter II, and were discussed in the previous 
section. Other problems, however, such as the nature of the DLA alloantigenic site, 
could be approached more accurately by immunochemical techniques. 
An immunoprecipitation assay was set up (chapter IV) with the use of the rabbit 
anti-dog-/32m serum described in chapter III. Preliminary evidence for the DLA 
light chain being identical to /32m has already been discussed in the previous section. 
In certain cases, antisera against {32m from closely related species can be used for 
immunoprecipitation of MHC antigens (Giphart et a!., 1978, Kvist eta!., 1977, 
Rask et' al., 1974 and Vitetta et al., !976). As for the dog, immunoprecipitation with 
a rabbit anti-human-,B2m serum did not result in a typical DLA pattern 
(unpublished observation). Smithies and Poulik (1972a) did not observe cross-
reactivity of an anti-human-,B2m serum with dog ,B2m, and their rabbit anti-dog-
,B2m sera did not react with human ,B2m either. 
Our rabbit anti-dog-,B2 m serum proved to be suitable for our purpose. It was a fairly 
strong antiserum as is to be expected from a heterologous antiserum. In theory, 
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OLA heavy chains of all specificities should be co-precipitated with {3 2m. In one 
case, anti-/32m antiserum was said to dissociate MHC heavy chains from {3 2m 
(Nakamura eta!., 1975). This generally happens at longer incubation times than 
those required for immunoprecipitation. Although our rabbit anti-dog-/32 m serum 
contains impurities (chapter III.3), the immunoprecipitation patterns of this serum 
with membrane preparations are not affected by this. 
In the mouse {3 2m on the membrane is not only associated with MHC class I heavy 
chains but also with H-Y, Qa-2 and TL (other membrane proteins) (Fellous eta!., 
1978, Michaelson eta!., 1977, and Vitetta eta!., 1976); in man with possible TL 
homologues (van Agthoven and Terhorst, 1982, Gazit et a!., 1980, Tada eta!., 
1978). Both TL and Qa-2 heavy chains have molecular weights very close to MHC 
class I heavy chains. On peripheral blood lymphocytes, however, the MHC 
antigens are much greater in number than TL or Qa-2 antigens. TL antigens are 
found predominantly on thymocytes and leukaemia cells. Qa-2 antigens are found 
on mature T cells (Michaelson eta!., 1977). We used PHA-stimulated peripheral 
blood lymphocytes for most experiments. PHA is a T cell mitogen. As MHC 
antigens outnumber Qa-2 and TL antigens on T cells, it is likely that the molecules 
immunoprecipitated by the anti-/3 2m serum from PHA-stimulated PBL are mainly 
DLA antigens. 
{3 2m is a highly conserved molecule amongst all species investigated. There is 
considerable sequence homology between /32m and the CH3 domain of immuno-
globulin (Peterson eta!., 1972, Smithies and Paulik, 1972b ). Based on the chemical 
and physical-chemical properties of HLA and H-2 antigens, a common evolution-
ary origin for these molecules has been suggested (Peterson et al., 1975, Terhorst et 
al., 1977). When more information on the amino acid sequence of HLA class I 
heavy chains became available, statistically significant homology was found 
between the second disulfide loop of HLA heavy chains and constant region 
domains of immunoglobulin (Orr eta!., 1979, Tragiirdh eta!., 1979b). Recently, 
significant sequence homology was reported between immunoglobulin constant 
region domains and the carboxyl-terminal domain of the HLA-DR light (Kaufman 
and Strominger, 1982) and heavy (Korman et al., 1982) chain. The fact that dog 
MHC class I antigens contain /32m as the light chain extends the amino acid 
sequence homology between certain domains of MHC antigens and immuno-
globulin to yet another species. 
Interaction between {3 2m from several species and RT-1 (rat MHC) antigen has 
been shown to be possible by Logdberg and colleagues (1980). This was taken as 
evidence for the evolutionary conservation of the /32m binding site on the MHC 
heavy chain. Exchange between human /32 m and mouse H-2 antigens on the cell 
surface or in solution was achieved by Schmidt eta!. (1981 ). These techniques could 
be valuable in the elucidation of the structure of histocompatibility antigens in 
species where {32m or anti-/32m sera are not available. 
The role of {3 2m in the structure of histocompatibility antigens is only tentative. 
{32m is supposed to play a part in the transport of HLA antigens to the cell 
membrane. Daudi cells, which lack /3 2m, have been shown to posses intracellular 
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HLA heavy chains (Ploegh et a!., 1979) while they do not express them on the 
membrane. After fusion with other human cell lines or mouse cells, HLA specifi-
cities have been detected on the hybrid cell membrane which could not be ascribed 
to the fusion partner (Arce-Gomez et a!., 1978, Fellous eta!., 1977). The Daudi 
HLA heavy chain had apparently been rescued by the {3 2m from the fusion partner, 
D. Lancet and colleagues (1979) have suggested that {3 2m might stabilize the heavy 
chain conformation for antigenic activity. One of the most widely used HLA 
monoclonal antibodies, W6/32, which is directed against a heavy chain determi-
nant, reacts only with {32m associated heavy chains, so {3 2m influences the 
conformation of the heavy chain (Parham eta!., 1979). Nevertheless, the H-2 heavy 
chain can still react with H-2 alloantisera after careful separation from {3 2m (K vist 
eta!., 1977). 
The function of {3 2m in the dog has not been analysed. It was used as a starting point 
for the immunochemical isolation of DLA antigens. 
VIII.3.2 Irnmunoprecipitation of DLA antigens by the anti-/32m serum 
In our studies we have analysed DLA antigens from several sources. The immune-
precipitation of DLA antigens isolated from spleens has been discussed in section 
VIII.2. DLA antigens have also been immunoprecipitated after incubation of intact 
PBL or membranes with the antiserum. PBL were labelled by lactoperoxidase-
catalysed radioiodination or metabolically by incorporation of 35S-methionine 
(chapter IV) or 3H-fucose (chapter VI). The non-ionic detergents NNPIO or NP-40 
were used to solubilize the DLA antigens. In all cases, a heavy chain of 41,700-
43,000 daltons was precipitated together, in the case of 125 1- and 35 S-labelled cells, 
with the light chain of 12,000 daltons. This indicates that DLA antigens are 
glycoproteins, that they can be solubilized by detergent and that they consist of two 
polypeptide chains of MW 41,700-43,000 and 12,000. As observed previously, the 
antiserum directed against urinary /32m of MW 12,000 co-precipitates another 
polypeptide chain, as in the immunoprecipitation of papain solubilized DLA 
antigens (chapter IV, VIII.2). The molecular weight of the detergent solubilized 
heavy chain is somewhat larger than that of the papain digested heavy chain, which 
is to be expected, as detergent solubilizes the whole molecule and papain the major 
part. As all gels used for analysis of immunoprecipitation patterns were run under 
reducing circumstances, no evidence could be found for a structure consisting of 
four chains or more. Four chain structures have been found in preparations of 
detergent solubilized HLA antigens but were later shown to be artefacts 
(Stromihger eta!., 1977). At any rate, the two chain structure ofDLA antigens after 
detergent solubilization shows that the two chain structure of papain digested DLA 
antigens was not caused by papain cleavage of one large chain. 
DLA antigens behaved like glycoproteins in the large scale isolation procedure, and 
their ability to incorporate sugar and amino acid confirms this. The 3H-fucose 
labelled DLA antigens (chapter VI) provide an interesting case; immunoprecipita-
tion with an antiserum directed against the light chain resulted in a gel pattern of the 
heavy chain only. Like in other species (Nathenson and Muramatsu, 1971, Parham 
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et al., 1977) the heavy chain carries a sugar side chain whereas /32m is devoid of 
carbohydrate. 
The anti-,82m serum has been further characterized in an experiment where 
immunoprecipitation of DLA antigens by the anti-/32m serum was inhibited by 
purified urinary /32m. The anti-/32m serum could also react with denatured light 
chains from a DLA preparation that had been boiled in 1% SDS (chapter IV). 
The anti-,B2m serum has been used to corroborate the location of the DLA 
antigens. From the microlymphocytotoxicity test it is already clear that the 
antigenic determinant(s) must be on the outside of the cells. Lactoperoxidase-
catalysed iodination only labels surface proteins with accessible tyrosine residues. 
1251-labelled DLA antigens can be precipitated with the anti-,B2m serum from 
lactoperoxidase-catalysed radioiodinated cells. When intact, 35S-methionine 
labelled cells were incubated with the anti-,82m serum before solubilization, the 
anti-,82m serum could also react with DLA molecules. Therefore the location of 
those determinants which could react with alloantisera (in the microlymphocyto-
toxicity test) and with the anti-,82m serum (in immunoprecipitation) is on the 
outside of the cell membrane. 
More elegant experiments have been performed with HLA and H-2 antigens to 
show that they were located on the cell membrane (Henning et al., 1976, Snary et 
al., 1974, Springer and Strominger, 1976). The transmembrane location of the HLA 
heavy chain was demonstrated by lactoperoxidase-catalysed iodination of inside-
out membrane vesicles (Walsh and Crumpton, 1977). HLA antigens were labelled 
whereas membrane immunoglobulins were not. 
The advantage of using detergent over papain for the isolation ofMHC antigens is 
that the whole molecule is recovered, so that insertion into the plasma membrane 
can be studied. Functional characteristics of membrane molecules can be 
investigated by incorporating them into liposomes. Both HLA (Turner and 
Sanderson, 1978) and RT-1 (Willoughby et al., 1978) antigens have been 
incorporated. Some experiments on the function of HLA antigens inserted into 
liposomes have been summarized in chapter 1.4.2. Dog MHC antigens have not 
been studied in this way yet. 
Vlll.3.3 lmmunoprecipitation of DLA antigens by sera directed against the heavy 
chain 
As mentioned in section VIII.2, an antiserum was raised in rabbits by immuniza-
tion with the DLA heavy chain (described in chapter V.2.1'). This serum gave a high 
background when it was reacted with DLA antigens in solution. Therefore intact 
cells were reacted with the serum before detergent solubilization and in this way the 
antiserum turned out to be useful. The gel patterns obtained were similar to those 
seen with the anti-/32 m serum (chapter V, Fig. 4). 
Since the anti-HC serum could react with DLA antigens on intact cells, the location 
of the DLA antigens on the cell membrane was corroborated. Whereas purified 
urinary /32m could completely inhibit the reaction between DLA antigens and the 
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anti-/32m serum, it could only partially inhibit the reaction between DLA antigens 
and the anti-HC serum. This is evidence that the two antisera react with different 
determinants. As both sera react with non-polymorphic "backbone" structures, 
they should react with DLA antigens of all specificities. The anti-HC serum did not 
react with DLA antigens in solution which were denatured by boiling in I% SDS. 
Hence the serum may not be able to detect in vitro translated DLA products which 
have not as yet assumed their native three-dimensional conformation. 
Most alloantisera did not react readily with DLA antigens in the immuno-
precipitatioD. technique (chapter V). Other investigators have experienced the same 
difficulties (Allison et al., !978). One of the reasons could be that alloantisera 
generally have a much lower titre than heterologous antisera. One alloantiserum, 
however, did react with DLA antigens in solution (chapter V),just like the anti-fl2m 
serum (chapter IV). This alloantiserum is directed against DLA-Cll but it cross-
reacts with several specificities (A.M. Dekkers-Bijma, personal communication). 
Whatever the specificity, the determinant for this serum is located on the heavy 
chain, because the serum cannot be inhibited by purified urinary {32m. The finding 
that both the anti-/l2m serum (anti-light chain) and the alloantiserum (anti-heavy 
chain) yielded the same precipitation pattern consisting of a light chain of 12,000 
daltons and a heavy chain of 43,000 daltons (chapter V, Fig. 6) confirms the 
association of /32m with the DLA heavy chain. Sequential immunoprecipitation 
studies verified that the anti-/32m serum re8.cts with cells of all specificities whereas 
the alloantiserum is more limited in specificity. 
In summary, small scale isolation of DLA antigens has provided information 
concerning the chemical composition ofDLA antigens, the two chain structure, the 
susceptibility to detergent solubilization and the MW of the component chains then 
obtained. The association of {3 2m and heavy chain and the location on the outside of 
the cell surface were also established for DLA antigens. The alloantigenic site was 
investigated with the techniques described above together with one- and two-
dimensional gel electrophoresis. 
VIII.3.4 The alloantigenic site 
The investigation of the DLA alloantigenic site was concentrated on two issues: 1) 
the location on either heavy or light chain, 2) the chemical composition; sugar 
and/or protein. The presence of a sugar moiety on the DLA heavy chain was 
demonstrated in the experiments described in chapter VI. Some heterogeneity in 
the heavy chains from dogs of different tissue-types was observed on SDS-poly-
acrylamide gradient gels, whereas /l2m was invariant (chapter VII, Fig. 2). Even 
nonglycosylated DLA heavy chains showed microheterogeneity on SDS-poly-
acrylamide gradient gels (chapter VII, Fig. 3). On two-dimensional gels it became 
even clearer that the DLA heavy chain is polymorphic, whereas the light chain does 
not vary between dogs (chapter VII, Figs. 4-7). Thus the DLA alloantigenic site is 
located on the heavy chain. 
The question of the nature of the alloantigenic specificities is more difficult to 
answer. On the two-dimensional gels, nonglycosylated DLA heavy chains from 
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dogs of different tissue-type still displayed different spots, confirming what was 
observed previously on one-dimensional gels. There was extensive sugar hetero-
geneity in fully glycosylated DLA heavy chains in addition to the protein hetero-
geneity. Therefore, the alloantigenic site is certainly protein in nature, but we 
cannot as yet make a definite statement about the role of the sugar moiety. The 
neutral sugar variation observed (chapter VII, Figs. 4-7) is not a general feature of 
MHC antigens. 
The importance of the sugar chain in the alloantigenic site should be studied by 
immunoprecipitation of nonglycosylated versus glycosylated DLA antigens with 
an array of alloantisera. Unfortunately, up till now, only one alloantiserum has 
been found to be suitable for immunoprecipitation (chapter V). The origin of the 
charge heterogeneity found in DLA heavy chains upon 2D gel analysis has been 
discussed in chapter VII.4. It was suggested that this is partly due to protein 
differences, and partly to differences in the amount of sialic acid. In spite of the 
uncertainty regarding the chemical nature of the alloantigenic determinant, it was 
possible to tentatively assign 2D gel patterns to haplotypes. 
Two-dimensional gel electrophoresis ofMHC antigens can be employed as a way of 
"biochemical tissue-typing" (Vasilov et al., in press), also called "molecular gena-
typing" (Charron and McDevitt, 1980) or "haplotype-specific molecular finger-
printing" (Jones, 1977). Jones used alloantisera for immunoprecipitation and she 
could demonstrate that identical haplotypes from different mouse strains were 
identical in 2D gel pattern. Different haplotypes appeared different on 2D gels. She 
noticed the molecular complexity of the 2D gel patterns and suggested that most of 
the complexity is due to different glycosylation stages. Due to the labelling pro-
cedure employed (4-5 hours of 35S-methionine incorporation), precursors as well as 
end products were found. When lactoperoxidase-catalysed radioiodinated mole-
cules (end products) were used for immunoprecipitation, some heterogeneity was 
left. She suggests that the spots may represent multiple gene products. 
It is also possible to assign 2D patterns to haplotypes by comparing immune-
precipitates of MHC antigens from various homozygous typing cells using anti-
backbone sera (Charron and McDevitt, 1980, Vasilov et al., in press). An indication 
for the existence of the second HLA-DR locus was obtained in this way (Charron 
and McDevitt, 1980, Shackelford and Strominger, 1980). In homozygous typing 
cells, evidence was found for up to three additional HLA class I gene products apart 
from HLA-A, -B, and -C (Vasilov et al., in press). In general, more products are 
found on 2D gels after immunoprecipitation of H-2 or HLA class I or class II 
antigens than would be expected from serology. 
In the dog, however, the situation is quite different. Neutral and charged sugar 
variation contribute to the complexity of the 2D gel patterns of fully glycosylated 
DLA heavy chains. However, nonglycosylated DLA molecules obtained after 
radiolabelling in the presence of tunicamycin, show surprisingly little hetero-
geneity. Some possible causes have already been mentioned in chapter VII.4. 
With respect to MHC polymorphism, there is one species that has attracted 
attention because of its lack of serologically detectable MHC class I antigens. The 
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Syrian hamster alloantisera only detect class II-like molecules; class I poly-
morphism is deficient even between wild and inbred hamsters (Phillips et al., 1981 ). 
A trivial explanation for this is that all domestic inbred hamsters are derived from 
an original trio caught in 1930 (Duncan and Streilein, 1977). This does not explain, 
however, why alloantisera produced between "wild" and inbred hamsters do not 
detect class I products. The arguments developed by Duncan and Streilein (1977) to 
account for the lack of class I alloantigenicity (class I identity, antigenic 
determinants not detected by B cells, lack of a class I locus) do not hold true in the 
case of the dog. In the dog, alloantisera directed against class I antigens are found, 
but biochemically the polymorphism seems to be smaller than would be predicted 
from serology. The most logical correlation between 20 gel patterns and tissue-
type was found when spots were assigned to haplotypes rather than individual locus 
products (chapter VII.3.2). As in the Syrian hamster, inbreeding probably plays a 
role, but in the Syrian hamster there is a straightforward lack of class I antigens, 
whereas in the dog there is a discrepancy between serological and biochemical data. 
This issue has already been discussed in chapter VII.4. One possible explanation 
must be stressed again. That is that the number of DLA class I loci is in fact smaller 
than assumed. The evidence for a DLA-A and -B locus is indisputable (Joint report 
of the 2nd international workshop on canine immunogenetics, 1976; J. d'Amaro, 
personal communication). The existence qfDLA-C is not well-founded, statistically 
speaking. The possibility that one of the "class I" loci is in fact a class II locus 
cannot be ruled out in view of recent data on the distribution of !a-like antigens on 
dog peripheral blood lymphocytes (Deeg et al., 1982). 
Another problem is the alloantisera which are selected for beagle tissue typing and 
which are unsuitable for tissue typing mongrel dogs (chapter 1.2). Althougb the 
beagle used to be considered as an outbred preclinical model, our colony does tend 
to accumulate certain DLA specificities in preference to others. If the investigation 
into the DLA alloantigenic determinants could have been performed in tissue-
typed mongrel dogs, more variety might have been detected. It is very likely that 
mongrel dogs will have combinations ofDLA-A, -Band -C products different from 
those present in the beagle, which are very much influenced by the linkage dis-
equilibrium (chapter 1.2). The mongrel dogs used for the examination of DLA 
antigens on tumour cells were, as was to be expected, also difficult to tissue-type. 
VIII.3.5 DLA antigens on tumour cells 
After the characterization of DLA antigens on peripheral blood lymphocytes, we 
decided' to examine DLA antigens on tumour cells. Originally we planned to use 
alloantisera for immunoprecipitation of DLA antigens from tumour cells. 
Unfortunately the alloantisera, which are difficult to work with in mongrel dogs 
anyway (chapter !.2) did not give interpretable immunoprecipitation patterns, with 
one exception (chapter V). Another fundamental problem was that we worked with 
tumour cell lines, which represent inevitably a selection of cells from the original 
tumour. The in vivo relevance of our data would therefore have to be considered 
carefully. PBL were chosen as a control because DLA antigens are defined by their 
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presence on PEL. One has also to consider using the normal tissue equivalent of the 
tumour studied. As most of t~e tumours we obtained were melanoma or mammary 
carcinoma cells, we tried to establish cultures of melanocytes and mammary 
epithelial cells. This turned out to be very difficult. Therefore we chose for the 
approach described in chapter VII.3.3, Vll.4, using anti-/32 m serum for immuno-
precipitation of DLA antigens from tumour cells and PBL of the tumour bearer. 
Analysis was done by 20 gel electrophoresis. In one dog, a difference between 
tumour cells and PEL was demonstrated (chapter VII.3.3). It is questionable, in 
retrospect, whether the 20 gel analysis of anti-/32m precipitated DLA antigens on 
tumour cells and PBL was the best way to detect possible differences in DLA 
content on both types of cells. Given the failure of other methods (described briefly 
above), it was the most promising approach. 
It is a certainty that, by establishing conditions for the biochemical investigation of 
DLA antigens on tumour cells, we have learned a lot about the biochemistry of 
DLA antigens on peripheral blood lymphocytes. A beginning has been made with 
the "detailed biochemical characterization" necessary to establish the "'true and 
final picture of the detailed structure of the SO part of the (dog) MHC" as suggested 
by Vriesendorp in 1973 (chapter I.l). 
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CHAPTER IX 
SUMMARY 
In this thesis, an immunochemical analysis of dog Major Histocompatibility 
Complex (MHC) antigens, also called DLA antigens, is described. MHC antigens 
play a prominent role in the immune system, particularly in the recognition of 
foreign material. They can be divided into four classes. As only DLA class I 
antigens have been defined by well characterized reagents (antisera), they were 
chosen as the object of the investigation. 
In chapter I, a short historical survey of research into histocompatibility antigens 
in general, and DLA antigens in particular is given. Some fundamental methods for 
the isolation ofMHC antigens as well as a model of the structure of a human MHC 
antigen, HLA-B7, are described. These have served as a guideline for our 
experiments. More recent developments in the investigation of the MHC antigens 
are mentioned to show the scope of present-day MHC research. The importance of 
the function of the MHC antigens in relation to immunological reactions and 
(malignant) disease is indicated. 
For a thorough investigation ofDLA class I antigens some basic knowledge of their 
biochemical nature is indispensable. The first questions we tried to answer regarded 
the isolation procedure of DLA class I antigens, their chemical composition and 
their molecuiar weight. Subsequently we investigated the light and the heavy chain, 
the localization of the alloantigenic site and the presence of DLA antigens on 
tumour cells. 
Chapter II deals with large scale isolation of DLA antigens from spleens by 
papain digestion of crude membrane preparations. The DLA antigens are 
susceptible to cleavage by papain and behave like proteins in the rest of the isolation 
procedure. After papain digestion, they consist of two polypeptide chains of37,000 
and 12,000 daltons. They bind spontaneously to a Sepharose-lentillectin column 
and must therefore contain a carbohydrate residue. The isolated products can 
specifically inhibit microlymphocytotoxicity tests using dog peripheral blood 
lymphocytes and DLA typing serum. 
The next step of our investigation is described in chapter III. In order to assess 
whether the DLA light chain is identical to {31m, as is the case in other species, it was 
necessary to raise an antiserum against dog {3 2m. The isolation of {3 1m from urine of 
a dog kidney transplant recipient is described. Two rabbits were immunized with 
purified dog f3 2m. This yielded antisera which reacted with dog /32m in Ouchterlony 
tests and on immuno-electrophoresis. The antisera are cytotoxic for dog peripheral 
blood lymphocytes. 
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In chapter IV it is demonstrated that the DLA light chain is identical to {32m. 
Radiolabelled papain solubilized DLA molecules reacted with anti-/32m serum in 
the immunoprecipitation assay. They are shown to consist of two polypeptide 
chains of 37,000 and 12,000 daltons. Detergent solubilization of peripheral blood 
lymphocytes or PBL membranes also yields molecules reactive with the anti-j32m 
serum. After detergent solubilization, the MW of the component chains is 41,700 
and 12,000 daltons. It was shown that the reaction of the anti-/32m serum with DLA 
molecules can be inhibited by purified /3 2m. 
The limited NH 2-terminal amino acid sequence of the heavy chain from papain 
solubilized DLA antigens shows homology with corresponding chains of MEC 
products of other species. The NH2-terminal amino acid sequence of the DLA light 
chain points to identity with dog urinary [3 2m. 
The protein nature of the DLA antigens is confirmed by the fact that they can be 
radio labelled by lactoperoxidase-catalysed iodination and incorporation of 35S-
methionine. DLA antigens can be immunoprecipitated after incubation of intact 
cells with antiserum, which means that they are located on the outside of the plasma 
membrane. 
Most experiments from chapter IV have been repeated using antisera against the 
heavy chain instead of antiserum against the light chain (j32 m). This is described in 
chapter V. Both an anti-heavy chain backbone (anti-EC) serum and an alloanti-
serum can immunoprecipitate DLA antigens from different sources, isolated either 
by papain digestion or by detergent solubilization. In addition to DLA antigens, 
the anti-EC serum precipitates polypeptide chains of 19,000, 30,000, and 39,000 
daltons. It is possible that there are class II antigens amongst these. This was not 
tested any further due to lack of class II specific antisera. Taken together the results 
of chapter IV and V demonstrate the two chain structure ofDLA class I antigens. 
The presence of a carbohydrate chain on the heavy chain ofDLA class I antigens 
was established by the experiments described in chapter VI. Metabolic labelling of 
PEA-stimulated dog peripheral b\ood lymphocytes with 3E-fucose and subsequent 
immunoprecipitation with anti-,82m serum yields a gel pattern of the DLA heavy 
chain only. Metabolic labelling of PEA-stimulated PBL with 35 S-methionine in the 
presence of tunicamycin, an inhibitor of N-linked glycosylation, results in a DLA 
heavy chain of 40,000 daltons, about 3000 daltons lower than the MW of the 
glycosylated heavy chains analysed in the same gel system. The light chain remains 
unaltered in the presence of tunicamycin. The nonglycosylated DLA antigens can 
be immunoprecipitated with anti-/32m serum as easily as their glycosylated counter-
parts. This shows that N-linked glycosylation is not necessary for the association of 
the DLA heavy chain with {3 2m. 
Chapter VII is devoted to the alloantigenic site. For that purpose DLA antigens 
from the members of several dog families were isolated from radiolabelled 
peripheral blood lymphocytes by immunoprecipitation with anti-/32m serum. They 
were analysed by one- and two-dimensional gel electrophoresis. Heterogeneity is 
found in the heavy chain, whereas the light chain from different dogs is constant. 
Therefore the alloantigenic site is located on the heavy chain. Comparison of 
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glycosylated and nonglycosylated DLA antigens shows that there is heterogeneity 
in the heavy chain even when there is no N-Iinked sugar chain present. The chemical 
nature of the alloantigenic determinant could be sugar and/ or protein according to 
the above experiments. A definite answer cannot be given at present. 
Dogs of differing tissue-types have DLA antigens showing different two-
dimensional gel patterns. A tentative assignment of patterns to DLA haplotype is 
presented. When an alloantiserum is used in parallel with anti-/32 m serum against 
DLA antigens of one dog, the two-dimensional gel pattern of the anti-,B2m serum 
contains more spots in the heavy chain area than the pattern of the alloantiserum. 
This confirms that the alloantiserurn reacts with the DLA antigens from a limited 
number of tissue-types. The data of the biochemical analysis of DLA antigens, 
immunoprecipitated by anti-,B2m serum, after two-dimensional gel electrophoresis 
suggest that DLA antigens are much more limited than HLA antigens and that 
there may be only one DLA class I locus. Finally, DLA antigens on tumour cells 
were studied and compared with DLA antigens on peripheral blood lymphocytes of 
the tumour bearer. In one case out of four there may have been a loss ofDLA on the 
tumour cell. The difficulties encountered in the study ofDLA antigens on tumour 
cells are discussed in chapter VII. 
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CHAPTER X 
SAMENVATTING 
In dit proefschrift wordt een immunochemische analyse van de antigenen van bet 
belangrijkste histocompatibi1iteitscomp1ex (MHC) van de hond beschreven. Bij de 
hond heet het MHC DLA complex; wij spreken daarom van DLA antigenen. MHC 
antigenen spelen een centrale rol in bet immuunsysteem, in bet bijzonder bij de 
herkenning van microOrganismen en lichaamsvreemde stoffen. Zij kunnen worden 
verdeeld in vier klassen. Omdat aileen DLA klasse I antigenen gedefinieerd zijn 
door goed gekarakteriseerde reagentia (antisera), werden zij gekozen als voorwerp 
van onderzoek. 
In hoofdstuk I wordt een kort historisch overzicht gegeven van bet onderzoek 
naar MHC antigenen in bet algemeen, en DLA antigenen in bet bijzonder. 
Beschreven worden enkele fundamentele methoden voor de isolering van MHC 
antigenen, alsmede een model voor de structuur van een bumaan MHC antigeen, 
namelijk HLA-B7. Deze methoden en dit model hebben als leidraad gediend voor 
ons onderzoek. Voorts worden recente ontwikkelingen in bet onderzoek van de 
MHC antigenen vermeld om de reikwijdte van bet MHC onderzoek van de laatste 
tijd te illustreren. Het belang van de functie van de MHC antigenen in verband met 
immunologiscbe reakties en met bet v66rkomen van (kwaadaardige) ziekten wordt 
aangegeven. 
Voor een grondig onderzoek van DLA klasse I antigenen is enige bas ale kennis van 
hun biochemische eigenschappen onontbeerlijk. De eerste vragen die wij trachtten 
te beantwoorden betroffen de methode van isoleren van DLA klasse I antigenen, 
hun chemische samenstelling en' hun molecuulgewicbt. Vervolgens onderzochten 
wij de lichte en de zware keten; wij bepaalden de plaats van de alloantigene deter-
minant( en) en wij bestudeerden DLA antigenen op tumorcellen. 
Hoofdstuk II behandelt de isolering van DLA antigenen op grate schaal. 
Hiervoor werden ruwe membraanextracten van milten ge"incubeerd met het enzym 
papain e. Het b1ijkt dat de DLA antigenen door papalne afgesplitst worden en dat 
zij zich als eiwitten gedragen tijdens de verdere zuivering. Na de papa"ine behande-
ling bestaan zij uit twee polypeptideketens van 37.000 en 12.000 dalton. Zij hebben 
de eigenschap spontaan te binden aan een Sepharose-linzen-lectine kolom, waaruit 
blijkt dat zij een suikerketen bevatten. De gelsoleerde produkten kunnen in de 
microlymfocytotoxiciteitstest de reaktie tussen hondelymfocyten en DLA typeer-
serum specifiek rem men. 
De volgende stap in ons onderzoek wordt beschreven in hoofdstuk III. Het was 
noodzakelijk een antiserum op te wekken tegen /32m van de bond, om te 
onderzoeken of de lichte DLA keten identiek is aan /32 m, zoals dat bij andere 
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soorten bet geval is. Daartoe werd {3 2m uit urine van een bond met een getrans-
planteerde nier ge·isoleerd. Twee konijnen werden ge·immuniseerd met gezuiverd 
honde [32m. Oat leverde antisera op die met honde [32m reageerden in de Ouchter-
lony test en in immuno-electrophorese proeven. Deze antisera zijn cytotoxisch voor 
honde-perifere-bloed-lymfocyten. 
In hoofdstuk IV wordt aangetoond dat de Iichte DLA keten identiek is aan [3 2m. 
Radioactief gemerkte DLA moleculen die met behulp van papalne gezuiverd waren 
reageerden met anti-,82m serum in de immunoprecipitatie-techniek. Oak met 
behulp van deze methode werd aangetoond dat zij bestaan uit twee polypeptide-
ketens van 37.000 en 12.000 dalton. Behandeling van perifere blood lymfocyten of 
hun membranen met detergens levert ook moleculen die met het anti-f32m serum 
kunnen reageren. Na behandeling met detergens is het molecuulgewicht van de 
beide ketens respectievelijk 41.700 en 12.000 dalton. De reaktie van bet anti-/32m 
serum met DLA moleculen bleek te kunnen worden geremd door gezuiverd {3 2m. 
De beperkte informatie over de aminozuurvolgorde aan het NH 2-uiteinde van de 
zware DLA keten na isolering door middel van papalne laat zien dater homologie 
bestaat met overeenkomstige ketens van MHC producten bij andere soorten. De 
aminozuurvolgorde aan het NH 2-uiteinde van de Iichte DLA keten wijst erop dat 
deze keten identiek is aan {3 2m uit honde-urine. 
Het feit dat DLA antigenen radioactief gemerkt kunnen worden met 125 I door 
mid del van lactoperoxidase of door inbouw van 35 S-methionine tUdens het kweken 
van de cellen in vitro bevestigt dat DLA antigenen eiwitten zijn. Na incubatie van 
intacte cellen met antiserum is immuunprecipitatie van DLA antigenen mogelijk, 
hetgeen inhoudt dat zij zich aan de buitenkant van de plasmamembraan bevinden. 
De meeste proeven uit hoofdstuk IV zijn herhaald met antisera die gericht zijn 
tegen de zware keten in plaats van de lichte keten (,B2m). Zij worden beschreven in 
hoofdstuk V. Zowel een antiserum gericht tegen het constante deel van de zware 
keten (anti-HC) als een alloantiserum kan reageren met DLA antigenen, die door 
rniddel van papa·ine of detergens uit respectievelijk milt en en lymfocyten gelsoleerd 
werden. Het anti-HC serum reageert niet alleen met DLA antigenen maar ook met 
polypeptide ketens van 19.000, 30.000 en 39.000 dalton. Het is mogelijk dat bier 
klasse II antigen en bij zijn. Dit werd niet verder onderzocht omdat er geen klasse II 
specifieke antisera beschikbaar waren. Het onderzoek dat beschreven wordt in de 
hoofdstukken IV en V toont aan dat D LA klasse I antigenen uit twee ketens 
bestaan. 
De aanwezigheid van een suikerketen aan de zware keten van DLA klasse I 
antigenen werd vastgesteld door middel van proeven die beschreven zijn in 
hoofdstuk VI. Na radioactief merken van PHA gestimuleerde honde-perifere-
bloed-lymfocyten met 3H-fucose geeft immuunprecipitatie daarvan met anti-,B2m 
serum een gelpatroon van uitsluitend zware DLA ketens. Merken van PHA 
gestimuleerde lymfocyten met 35S-methionine in aanwezigheid van tunicamycine, 
een remmervan N-gebonden glycosylering, geeft als resultaat een zware DLA keten 
van 40.000 dalton, ongeveer 3000 dalton minder dan bet molecuulgewicht van 
geglycosyleerde zware ketens in hetzelfde gelsysteem. De lichte keten verandert niet 
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in aanwezigheid van tunicamycine. De niet geglycosyleerde DLA antigenen 
reageren even goed met het anti-j32m serum in immuunprecipitaties als de geglyco-
syleerde. Dit toont aan dat N-gebonden glycosylering niet noodzakelijk is voor de 
associatie van de zware DLA keten met {32m. 
Hoofdstuk VII is gewijd aan de localisering van de alloantigene determinant( en). 
Daartoe werden DLA antigen en gelsoleerd uit radioactief gemerkte perifere-bloed-
lymfocyten van verschillende hondefamilies door middel van immuunprecipitatie 
met anti-,B2m serum. Deze DLA antigenen werden geanalyseerd door middel van 
een- en twee-dimensionale gelelectroforese. In de zware keten werd heterogeniteit 
vastgesteld; terwijl de Iichte keten van verschillende honden constant bleek te zijn. 
Daarom kunnen verschillen in weefseltypering herleid worden tot verschillen in de 
zware keten. Vergelijking van geglycosyleerde met niet-geglycosyleerde DLA 
antigenen laat zien, dat er zelfs nog heterogeniteit in de zware keten gevonden 
wordt, wanneer er geen N-gebonden suikerketen is. De alloantigene determinant 
zou volgens bovenvermelde experimenten een suiker- en/of eiwitgroep kunnen 
zijn. Op dit moment kan daarover geen definitieve uitspraak worden gedaan. 
Honden met verschillende weefseltypering hebben DLA antigenen met verschil-
lende twee-dimensionale gelpatronen. Een voorlopige identificatie van patronen 
volgens DLA haplotype wordt voorgesteld. Bij vergelijking van het gebruik van een 
alloantiserum met dat van het anti-,B2m serum tegen DLA antigenen van een hond, 
blijkt het twee-dimensionale gelpatroon van het anti-,B2m serum meer stippen in het 
zware keten gebied te bevatten dan het patroon van het alloantiserum. Dit bevestigt 
dat het alloantiserum aileen reageert met DLA antigenen van een beperkt aantal 
typeringen. De gegevens van de biochemische analyse van DLA antigenen, na 
immuunprecipitatie met anti-,B2m serum, gevolgd door twee-dimensionale gel-
electroforese, suggereren dat DLA antigenen minder heterogeen zijn dan HLA 
antigenen en dat er misschien maar een D LA klasse I locus is. 
Tenslotte werden DLA antigenen op tumorcellen bestudeerd en vergeleken met de 
DLA antigenen op de perifere-bloed-lymfocyten van de tumordrager. In een geval 
(van de vier) was er rnisschien verlies van DLA op de tumorcel. De moeilijkheden 
die werden ondervonden bij het bestuderen van DLA antigenen op tumorcellen, 
worden besproken in hoofdstuk VII. 
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